<div class="col col-lg-10">
	<div id="divDocumentHeader" class="sticky-top bg-white" style="">
		<span id="lblError" class="text-danger"></span>
		<br>
		<div id="divDocumentTitle">
			<span id="lblDocumentStatusBadge" class="badge badge-warning document-view-title-badge d-none"></span>
			<span id="lblReferenceArticleBadge" class="badge badge-warning document-view-title-badge ">LCD Reference Article</span>
			<span id="lblArticleTypeBadge" class="badge badge-warning document-view-title-badge ">Billing and Coding Article</span>
			<br>
			<h1 id="h1PageTitle" class="text-orange"><span id="lblPageTitle">Billing and Coding: Molecular Pathology Procedures</span></h1>

			<div class="w-100">
				<div class="d-inline float-left mt-2">
					<p class="mb-2"><span id="lblTitleId">A56199</span></p>
				</div>
				<div class="d-inline float-right d-print-none">
					<div id="noRow" class="d-none" data-page-action=""></div>

					<a href="#" id="aExpandAll" class="no-link log-click" data-page-action="Clicked the Expand All link">Expand All</a> |
					<a href="#" id="aCollapseAll" class="no-link log-click pr-2" data-page-action="Clicked the Collapse All link">Collapse All</a>
					<button type="button" id="btnEmail" class="btn btn-dark document-buttons log-click" data-page-action="Clicked the Email Article Document button." title="Email Document" data-toggle="modal" data-target="#emailButtonModal" control-id="ControlID-1"><svg class="svg-inline--fa fa-envelope fa-w-16" aria-hidden="true" data-prefix="fas" data-icon="envelope" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" data-fa-i2svg=""><path fill="currentColor" d="M502.3 190.8c3.9-3.1 9.7-.2 9.7 4.7V400c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V195.6c0-5 5.7-7.8 9.7-4.7 22.4 17.4 52.1 39.5 154.1 113.6 21.1 15.4 56.7 47.8 92.2 47.6 35.7.3 72-32.8 92.3-47.6 102-74.1 131.6-96.3 154-113.7zM256 320c23.2.4 56.6-29.2 73.4-41.4 132.7-96.3 142.8-104.7 173.4-128.7 5.8-4.5 9.2-11.5 9.2-18.9v-19c0-26.5-21.5-48-48-48H48C21.5 64 0 85.5 0 112v19c0 7.4 3.4 14.3 9.2 18.9 30.6 23.9 40.7 32.4 173.4 128.7 16.8 12.2 50.2 41.8 73.4 41.4z"></path></svg><!-- <i class="fas fa-envelope"></i> --><span>&nbsp;Email Document</span></button>
					<button type="submit" id="btnDownload" class="btn btn-dark document-buttons log-click" data-page-action="Clicked the Download Document button." title="Download Document" formaction="/medicare-coverage-database/view/article.aspx?articleId=56199&amp;handler=CreatePdf" control-id="ControlID-2"><svg class="svg-inline--fa fa-arrow-to-bottom fa-w-12" aria-hidden="true" data-prefix="fas" data-icon="arrow-to-bottom" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512" data-fa-i2svg=""><path fill="currentColor" d="M360 480H24c-13.3 0-24-10.7-24-24v-24c0-13.3 10.7-24 24-24h336c13.3 0 24 10.7 24 24v24c0 13.3-10.7 24-24 24zm-66.4-280.5L228 265.1V56c0-13.3-10.7-24-24-24h-24c-13.3 0-24 10.7-24 24v209.1l-65.6-65.6c-9.4-9.4-24.6-9.4-33.9 0l-17 17c-9.4 9.4-9.4 24.6 0 33.9L175 385.9c9.4 9.4 24.6 9.4 33.9 0l135.5-135.5c9.4-9.4 9.4-24.6 0-33.9l-17-17c-9.3-9.4-24.5-9.4-33.8 0z"></path></svg><!-- <i class="fas fa-arrow-to-bottom"></i> --><span>&nbsp;Download</span></button>
					<button type="button" id="btnAddToBasket" class="btn btn-dark document-buttons log-click" data-page-action="Clicked the Add to Basket button." title="Add to Basket" control-id="ControlID-3"><svg class="svg-inline--fa fa-shopping-basket fa-w-18" aria-hidden="true" data-prefix="fas" data-icon="shopping-basket" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><path fill="currentColor" d="M576 216v16c0 13.255-10.745 24-24 24h-8l-26.113 182.788C514.509 462.435 494.257 480 470.37 480H105.63c-23.887 0-44.139-17.565-47.518-41.212L32 256h-8c-13.255 0-24-10.745-24-24v-16c0-13.255 10.745-24 24-24h67.341l106.78-146.821c10.395-14.292 30.407-17.453 44.701-7.058 14.293 10.395 17.453 30.408 7.058 44.701L170.477 192h235.046L326.12 82.821c-10.395-14.292-7.234-34.306 7.059-44.701 14.291-10.395 34.306-7.235 44.701 7.058L484.659 192H552c13.255 0 24 10.745 24 24zM312 392V280c0-13.255-10.745-24-24-24s-24 10.745-24 24v112c0 13.255 10.745 24 24 24s24-10.745 24-24zm112 0V280c0-13.255-10.745-24-24-24s-24 10.745-24 24v112c0 13.255 10.745 24 24 24s24-10.745 24-24zm-224 0V280c0-13.255-10.745-24-24-24s-24 10.745-24 24v112c0 13.255 10.745 24 24 24s24-10.745 24-24z"></path></svg><!-- <i class="fas fa-shopping-basket"></i> --><span>&nbsp;Add to basket</span></button>
				</div>
			</div>

			<div class="clearfix"></div>
		</div>

		<div id="divBanners" class="row d-none">
			<div id="divDraftBanner" class="col-12 d-none ">
				<div class="w-100 text-center h-100">
					<div class="py-2 mb-2 document-view-status-banner h-100">
						<span class="document-view-status-title text-uppercase"><svg class="svg-inline--fa fa-lightbulb fa-w-12 fa-lg" aria-hidden="true" data-prefix="far" data-icon="lightbulb" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512" data-fa-i2svg=""><path fill="currentColor" d="M272 428v28c0 10.449-6.68 19.334-16 22.629V488c0 13.255-10.745 24-24 24h-80c-13.255 0-24-10.745-24-24v-9.371c-9.32-3.295-16-12.18-16-22.629v-28c0-6.627 5.373-12 12-12h136c6.627 0 12 5.373 12 12zM128 176c0-35.29 28.71-64 64-64 8.837 0 16-7.164 16-16s-7.163-16-16-16c-52.935 0-96 43.065-96 96 0 8.836 7.164 16 16 16s16-7.164 16-16zm64-128c70.734 0 128 57.254 128 128 0 77.602-37.383 60.477-80.98 160h-94.04C101.318 236.33 64 253.869 64 176c0-70.735 57.254-128 128-128m0-48C94.805 0 16 78.803 16 176c0 101.731 51.697 91.541 90.516 192.674 3.55 9.249 12.47 15.326 22.376 15.326h126.215c9.906 0 18.826-6.078 22.376-15.326C316.303 267.541 368 277.731 368 176 368 78.803 289.195 0 192 0z"></path></svg><!-- <i class="far fa-lightbulb fa-lg"></i> --> Draft Article</span>
						<div class="document-view-status-note">Draft Articles are works in progress and not necessarily a reflection of the current billing and coding practices. Revisions to codes are carefully and thoroughly reviewed and are not intended to change the original intent of the LCD.</div>
					</div>
				</div>
			</div>
			<div id="divStatusBanner" class="col-12 d-none ">
				<div class="w-100 text-center h-100">
					<div class="py-2 document-view-status-banner h-100">
						<span class="document-view-status-title text-uppercase"><span id="lblStatusBanner"></span></span>
						<div class="document-view-status-note"><span id="lblStatusNote"></span></div>
					</div>
				</div>
			</div>
			<div id="divReferenceArticleBanner" class="col-12 d-none ">
				<div class="w-100 text-center h-100">
					<div class="py-2 document-view-status-banner h-100">
						<span class="document-view-status-title text-uppercase"><span id="lblReferenceArticleBanner"></span></span>
						<div class="document-view-status-note"><span id="lblReferenceStatusNote"></span></div>
					</div>
				</div>
			</div>
		</div>
	</div>

	<div id="pnlStickyNote" class="document-view-sticky-note-section d-none">
		<div class="p-3 document-view-sticky-note-title">
			<h2><svg class="svg-inline--fa fa-bookmark fa-w-12" aria-hidden="true" data-prefix="fas" data-icon="bookmark" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512" data-fa-i2svg=""><path fill="currentColor" d="M0 512V48C0 21.49 21.49 0 48 0h288c26.51 0 48 21.49 48 48v464L192 400 0 512z"></path></svg><!-- <i class="fas fa-bookmark"></i> --> Document Note</h2>
		</div>

		<div id="divStickyNoteFields" class="document-view-sticky-note-fields d-print-block">
			<div id="divStickyNote" class="document-view-section-field">
				<span id="lblStickyNote" class="document-view-section-text"></span>
			</div>

			<div id="divStickyNoteHistory" class="d-none">
				<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="StickyNoteHistory" title="Expand/Collapse the Note History section" data-page-action="Clicked to Expand/Collapse the Note History section.">
					<h3 class="d-inline">Note History</h3>
					<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-down fa-w-14 document-view-section-chevron" id="iStickyNoteHistoryChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-down" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M207.029 381.476L12.686 187.132c-9.373-9.373-9.373-24.569 0-33.941l22.667-22.667c9.357-9.357 24.522-9.375 33.901-.04L224 284.505l154.745-154.021c9.379-9.335 24.544-9.317 33.901.04l22.667 22.667c9.373 9.373 9.373 24.569 0 33.941L240.971 381.476c-9.373 9.372-24.569 9.372-33.942 0z"></path></svg><!-- <i class="fas fa-chevron-down document-view-section-chevron" id="iStickyNoteHistoryChevron"></i> --></div>
				</div>

				<div id="divStickyNoteHistoryFields" class="document-view-fields d-print-block" style="display: none;">
					<div id="divStickyNoteHistoryField" class="document-view-section-field">
						<span id="lblStickyNoteHistory" class="document-view-section-text"></span>
					</div>
				</div>
			</div>
		</div>
	</div>

	<div id="pnlContractorInformation" class="document-view-section">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="ContractorInformation" title="Expand/Collapse the Contractor Information section" data-page-action="Clicked to Expand/Collapse the Contractor Information section.">
			<h2 class="document-view-section-title d-inline">Contractor Information</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-down fa-w-14 document-view-section-chevron" id="iContractorInformationChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-down" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M207.029 381.476L12.686 187.132c-9.373-9.373-9.373-24.569 0-33.941l22.667-22.667c9.357-9.357 24.522-9.375 33.901-.04L224 284.505l154.745-154.021c9.379-9.335 24.544-9.317 33.901.04l22.667 22.667c9.373 9.373 9.373 24.569 0 33.941L240.971 381.476c-9.373 9.372-24.569 9.372-33.942 0z"></path></svg><!-- <i class="fas fa-chevron-down document-view-section-chevron" id="iContractorInformationChevron"></i> --></div>
		</div>

		<div id="divContractorInformationFields" class="document-view-fields d-print-block" style="display: none;">
			<div id="divOneDocContractDisplay" class="document-view-section-field">
				<table id="gdvOneDocContractDisplay" class="table table-striped table-lg" summary="The Contracts associated with the document.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Contractor Name</th>
							<th scope="col">Contract Type</th>
							<th scope="col">Contract Number</th>
							<th scope="col">Jurisdiction</th>
							<th scope="col">States</th>
						</tr>
					</thead>
					<tbody>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="269" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part A
									</td>
									<td>
										06101 - MAC A
									</td>
									<td>
										J - 06
									</td>
									<td>
										Illinois<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="273" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part B
									</td>
									<td>
										06102 - MAC B
									</td>
									<td>
										J - 06
									</td>
									<td>
										Illinois<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="270" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part A
									</td>
									<td>
										06201 - MAC A
									</td>
									<td>
										J - 06
									</td>
									<td>
										Minnesota<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="274" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part B
									</td>
									<td>
										06202 - MAC B
									</td>
									<td>
										J - 06
									</td>
									<td>
										Minnesota<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="271" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part A
									</td>
									<td>
										06301 - MAC A
									</td>
									<td>
										J - 06
									</td>
									<td>
										Wisconsin<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="275" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										MAC - Part B
									</td>
									<td>
										06302 - MAC B
									</td>
									<td>
										J - 06
									</td>
									<td>
										Wisconsin<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="297" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13101 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										Connecticut<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="299" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13102 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										Connecticut<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="298" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13201 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										New York - Entire State<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="300" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13202 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										New York - Downstate<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="301" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13282 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										New York - Upstate<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="302" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										13292 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										New York - Queens<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="307" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14111 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										Maine<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="309" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14112 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										Maine<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="304" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14211 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										Massachusetts<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="310" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14212 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										Massachusetts<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="305" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14311 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										New Hampshire<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="311" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14312 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										New Hampshire<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="303" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14411 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										Rhode Island<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="313" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14412 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										Rhode Island<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="306" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14511 - MAC A
									</td>
									<td>
										J - K
									</td>
									<td>
										Vermont<br>
									</td>
								</tr>
								<tr>
									<td>
										<a href="#" class="contractor-detail-link system-link" data-toggle="modal" data-target="#modalContractorDetail" data-contractor-id="312" data-contractor-version="1">
											National Government Services, Inc.
										</a>
									</td>
									<td>
										A and B and HHH MAC
									</td>
									<td>
										14512 - MAC B
									</td>
									<td>
										J - K
									</td>
									<td>
										Vermont<br>
									</td>
								</tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>

	<div id="pnlArticleInformation" class="document-view-section">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="ArticleInformation" title="Expand/Collapse the Article Information section" data-page-action="Clicked to Expand/Collapse the Article Information section.">
			<h2 id="h2ArticleInformation" class="document-view-section-title d-inline">Article Information</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iArticleInformationChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iArticleInformationChevron"></i> --></div>
		</div>

		<div id="divArticleInformationFields" class="document-view-fields d-print-block">
			<h3 id="h3GeneralInformationHeader" class="document-view-section-header">General Information</h3>

			<div class="row">
				<div class="col-12 col-md-6 align-top">
					<div id="divDraftSourceId" class="document-view-section-field d-none">
						<span id="lblDraftSourceIdSubheader" class="document-view-section-subheader">Source Article ID</span><br>
						<span id="lblDraftSourceId" class="document-view-section-text">N/A</span>
					</div>

					<div id="divArticleId" class="document-view-section-field">
						<span id="lblArticleIdSubheader" class="document-view-section-subheader">Article ID</span><br>
						<span id="lblArticleId" class="document-view-section-text">A56199</span>
					</div>

					<div id="divOriginalIcd9ArticleIds" class="document-view-section-field d-none">
						<span id="lblOriginalIcd9ArticleIdsSubheader" class="document-view-section-subheader">Original ICD-9 Article ID</span><br>
						<span id="lblOriginalIcd9ArticleIds" class="document-view-section-text">Not Applicable</span>
					</div>

					<div id="divArticleTitle" class="document-view-section-field">
						<span id="lblArticleTitleSubheader" class="document-view-section-subheader">Article Title</span><br>
						<span id="lblArticleTitle" class="document-view-section-text">Billing and Coding: Molecular Pathology Procedures</span>
					</div>

					<div id="divArticleType" class="document-view-section-field">
						<span id="lblArticleTypeSubheader" class="document-view-section-subheader">Article Type</span><br>
						<span id="lblArticleType" class="document-view-section-text">Billing and Coding</span>
					</div>

					<div id="divDateInformation" class="">
						<div id="divOriginalEffectiveDate" class="document-view-section-field">
							<span id="lblOriginalEffectiveDateSubheader" class="document-view-section-subheader">Original Effective Date</span><br>
							<span id="lblOriginalEffectiveDate" class="document-view-section-text">01/01/2019</span>
						</div>

						<div id="divRevisionEffectiveDate" class="document-view-section-field ">
							<span id="lblRevisionEffectiveDateSubheader" class="document-view-section-subheader">Revision Effective Date</span><br>
							<span id="lblRevisionEffectiveDate" class="document-view-section-text">10/01/2024</span>
						</div>

						<div id="divRevisionEndingDate" class="document-view-section-field ">
							<span id="lblRevisionEndingDateSubheader" class="document-view-section-subheader">Revision Ending Date</span><br>
							<span id="lblRevisionEndingDate" class="document-view-section-text">N/A</span>
						</div>

						<div id="divRetirementDate" class="document-view-section-field ">
							<span id="lblRetirementDateSubheader" class="document-view-section-subheader">Retirement Date</span><br>
							<span id="lblRetirementDate" class="document-view-section-text">N/A</span>
						</div>
					</div>
				</div>

				<div class="col-12 col-md-6 align-top">
					<div id="divCopyrightStatement" class="document-view-section-field">
						<span id="lblCopyrightStatementSubheader" class="document-view-section-subheader"></span><br>
						<span id="lblCopyrightStatement" class="document-view-section-text">
<p style="font-size: 0.75rem">
CPT codes, descriptions, and other data only are copyright <span>2023</span> American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
</p>
<p style="font-size: 0.75rem">
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not
recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services.
The AMA assumes no liability for data contained or not contained herein.
</p>
<p style="font-size: 0.75rem">
Current Dental Terminology © <span>2023</span> American Dental Association. All rights reserved.
</p>
<p style="font-size: 0.75rem">
Copyright © <span>2024</span>, the American Hospital Association, Chicago, Illinois. Reproduced with permission.
No portion of the AHA copyrighted materials contained within this publication may be
copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and
descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work
without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.
</p>
<p style="font-size: 0.75rem">
Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes,
resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions;
and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only
authorized with an express license from the American Hospital Association.
The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or
accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the
preparation of this material, or the analysis of information provided in the material. The views and/or positions
presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are
not endorsed by the AHA or any of its affiliates.
</p>
</span> 
					</div>
				</div>
			</div>

			<div id="divCmsNationalCoveragePolicy" class="document-view-section-field ">
				<h3 id="h3CmsNationalCoveragePolicyHeader" class="document-view-section-header">CMS National Coverage Policy</h3>
				<span id="lblCmsNationalCoveragePolicy" class="document-view-section-text">N/A</span>
			</div>

			<h3 id="h3ArticleGuidanceHeader" class="document-view-section-header">Article Guidance</h3>

			<div id="divArticleText" class="document-view-section-field">
				<span id="lblArticleTextSubheader" class="document-view-section-subheader">Article Text</span><br>
				<span id="lblArticleText" class="document-view-section-text"><p style="line-height: normal;">This article contains coding and other guidelines that complement the Local Coverage Determination (LCD) for Molecular Pathology Procedures.</p>
<p><span style="line-height: 107%;"><strong>Specific Coding of Molecular Testing Panels</strong></span></p>
<p><span style="line-height: 107%;">The submission of claims using individual gene CPT codes, when either 5-50 or &gt;50 gene panels are ordered, is considered incorrect coding. Correct coding requires that when a panel code is ordered, it should be billed, rather than the individual gene codes. CPT code 81445, 81449, 81450, or 81451 should be billed when 5 to 50 genes are ordered. </span>CPT code 81455, or 81456, should be billed when 51 or greater genes are ordered for molecular biomarkers. <span style="text-decoration: underline;">Please refer to Local Coverage Determination L37810 Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms and the associated Article A56867</span>. <span style="line-height: 107%;">When a panel with greater than one or less than five genes is ordered, use the corresponding existing panel CPT code or CPT code 81479 if none exists. </span></p>
<p><span style="line-height: 107%;"><strong>Coding Information</strong></span></p>
<p><span style="line-height: 107%;">Coding guidance in this article is categorized into four, distinct CPT/HCPCS sections: </span></p>
<p style="line-height: normal; padding-left: 30px;">· CPT/HCPCS section-Group1-<u>Tier 1 Covered Codes</u> for which limited coverage may be provided for the genetic tests and for which specific ICD-10-CM diagnosis to CPT procedure groupings may be listed</p>
<p style="line-height: normal; padding-left: 30px;">· CPT/ HCPCS section-Group 2-<u>Tier 1 Codes that require Individual Review</u> for which coverage may be provided for the genetic tests submitted, if documentation supports medical necessity, and for which specific ICD-10-CM diagnosis to CPT procedure groupings may be listed.</p>
<p style="line-height: normal; padding-left: 30px;">· CPT/HCPCS section-Group 3-<u>Tier 1 Non-covered Codes</u> for which genetic testing is unlikely to impact therapeutic decision-making in the clinical management of the patient and will be denied automatically as not medically necessary.</p>
<p style="line-height: normal; padding-left: 30px;">· CPT/HCPCS section-Group 4- <u>Tier 2/NOC Covered Code/Gene Combinations</u> for which limited coverage may be provided for specific genes listed in the Group 4 paragraph; <u>Tier 2/NOC Individual Review Code/Gene Combinations</u>; <u>Tier 2/NOC Non-covered Code/Gene Combinations</u>.</p>
<p style="line-height: normal; background: white;">Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.<br><br>For services requiring a referring/ordering physician, the name and NPI of the referring/ordering physician must be reported on the claim.<br><br>A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.<br><br>The diagnosis code(s) must best describe the patient's condition for which the service was performed.</p>
<p style="line-height: normal; background: white;"><strong>Modifier 91</strong></p>
<p style="line-height: normal; background: white;">Please use Modifier 91 as appropriate, based on the Medicare Claims Processing Manual Chapter 16, Laboratory Services Section 100.5.1. Modifier 91 may be is used <em>"to indicate that a test was performed more than once on the same day for </em><em>the same patient., only when it is necessary to obtain multiple results in the course of treatment."</em></p>
<p style="background: white; line-height: normal;"><strong><span style="line-height: 107%;">Documentation Requirements</span></strong></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;"> Documentation must be adequate to verify that coverage guidelines listed above have been met. Thus, the medical record must contain documentation that the testing is expected to influence treatment of the condition toward which the testing is directed. The laboratory or billing provider must have on file the physician requisition which sets forth the diagnosis or condition (ICD-10-CM code) that warrants the test(s). </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">Examples of documentation requirements of the ordering physician/nonphysician practitioner (NPP) include, but are not limited to, history and physical or exam findings that support the decision making, problems/diagnoses, relevant data (e.g., lab testing, imaging results). </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">Documentation requirements of the performing laboratory (when requested) include, but are not limited to, lab accreditation, test requisition, test record/procedures, reports (preliminary and final), and quality control record. </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">Documentation requirements for LDT(s)/protocols (when requested) include diagnostic test/assay, lab/manufacturer, names of comparable assays/services (if relevant), description of assay, analytical validity evidence, clinical validity evidence, and clinical utility. </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">Providers are required to code to specificity however, if CPT 81479 (unlisted molecular pathology procedure) is used the documentation must clearly identify the unique molecular pathology procedure performed. When multiple procedure codes are submitted on a claim (unique and/or unlisted) the documentation supporting each code should be easily identifiable. If on review the contractor cannot link a billed code to the documentation, these services will be denied based on Title XVIII of the Social Security Act, §1833(e). For these tests, the ordering provider must provide to the laboratory copies of the signed informed consent documentation. </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">When the documentation does not meet the criteria for the service rendered or the documentation does not establish the medical necessity for the services, such services will be denied as not reasonable and necessary.</span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;"><strong> Utilization Guidelines</strong> </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;">Screening services such as pre-symptomatic genetic tests and services used to detect an undiagnosed disease or disease predisposition are not a Medicare benefit and are not covered. Similarly, Medicare may not reimburse the costs of tests/examinations that assess the risk of a condition unless the risk assessment clearly and directly affects the management of the patient. </span></p>
<p style="background: white; line-height: normal;"><span style="line-height: 107%;"><span style="line-height: 107%;">A specific genetic test may only be performed once in a lifetime per beneficiary for inherited conditions; however, when medically reasonable and necessary, genetic testing may be done on acquired conditions such as malignancies (including separate malignancies developing at different times) as they are treated and are being followed, in order to assess response or other relevant clinical criteria. Likewise, there are situations where medical record and literature documentation are able to demonstrate that serial testing can be reasonably predicted to provide additional clinically useful information. When the record documents that this information, such as confirmed significant response to current therapy, is likely to assist in modifying treatment, serial testing can be considered reasonable and necessary and eligible for coverage.&nbsp;<br>&nbsp;</span></span></p></span>
			</div>
		</div>
	</div>

	<div id="pnlResponseToComments" class="document-view-section d-none">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="ResponseToComments" title="Expand/Collapse the Response To Comments section" data-page-action="Clicked to Expand/Collapse the Response To Comments section.">
			<h2 class="document-view-section-title d-inline">Response To Comments</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iResponseToCommentsChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iResponseToCommentsChevron"></i> --></div>
		</div>

		<div id="divResponseToCommentsFields" class="document-view-fields d-print-block">
			<div id="divResponseToComments" class="document-view-section-field">
				<table id="gdvResponseToComments" class="table table-striped table-lg d-none" summary="The Response to Comment data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Number</th>
							<th scope="col">Comment</th>
							<th scope="col">Response</th>
						</tr>
					</thead>
					<tbody>
								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								</tr>
					</tbody>
				</table>

				<span id="lblResponseToComments" class="document-view-section-text d-none">N/A</span>
			</div>
		</div>
	</div>

	<div id="pnlCodingInformation" class="document-view-section ">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="CodingInformation" title="Expand/Collapse the Coding Information section" data-page-action="Clicked to Expand/Collapse the Coding Information section.">
			<h2 class="document-view-section-title d-inline">Coding Information</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iCodingInformationChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iCodingInformationChevron"></i> --></div>
		</div>

		<div id="divCodingInformationFields" class="document-view-fields d-print-block">
			<div id="divBillCodesOldLocationTop" class="w-100 document-view-section-code-field-top d-none"></div>
			<div id="divBillCodesOldLocation" class="document-view-section-code-field d-none">
				<h3 id="h3BillCodesOldLocationHeader" class="document-view-section-header">Bill Type Codes</h3>

				<p class="document-view-section-text"><span id="lblBillCodesOldLocationIntro"></span></p>

				<table id="gdvBillCodesOldLocation" class="table table-striped table-lg " summary="The Bill Type Code data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody class="bill-codes-display">


</tbody>
				</table>

				<span id="lblBillCodesOldLocation" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divRevenueCodesOldLocationTop" class="w-100 document-view-section-code-field-top d-none"></div>
			<div id="divRevenueCodesOldLocation" class="document-view-section-code-field d-none">
				<h3 id="h3RevenueCodesOldLocationHeader" class="document-view-section-header">Revenue Codes</h3>

				<p class="document-view-section-text"><span id="lblRevenueCodesOldLocationIntro"></span></p>
				<span id="lblRevenueCodesOldLocationParagraph" class="document-view-section-text"></span>

				<table id="gdvRevenueCodesOldLocation" class="table table-striped table-lg " summary="The Revenue Code data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody class="revenue-codes-display">


</tbody>
				</table>

				<span id="lblRevenueCodesOldLocation" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divHcpcsCodesTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divHcpcsCodes" class="document-view-section-code-field ">
				<h3 id="h3HcpcsCodesHeader" class="document-view-section-header">CPT/HCPCS Codes</h3>

				<div id="divHcpcsCodesExpandCollapse" class="py-3 w-100 text-right d-print-none ">
					<a href="#" id="aExpandAllHcpcsCodes" class="no-link log-click" data-page-action="Clicked the Expand All CPT/HCPCS groups link">Expand All</a> |
					<a href="#" id="aCollapseAllHcpcsCodes" class="no-link log-click" data-page-action="Clicked the Collapse All CPT/HCPCS groups link">Collapse All</a>
				</div>

				<div id="rptHcpcsGroups" class="">


	<div id="divHcpcsCodesGroup1" class="document-view-code-group-section">
		<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcsCodesGroup1">
			<h4 class="document-view-code-group-title d-inline">Group 1</h4>
			<span id="lblTotalHcpcsCodes" class="document-view-section-text" style="margin-left: 7px;">(99 Codes)</span>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup1Chevron"></i> --></div>
		</div>

		<div id="divHcpcsCodesGroup1Fields" class="document-view-code-group-fields hcpcs-code-group-fields d-print-block">
			<span class="document-view-section-subheader">Group 1 Paragraph</span>
			<span class="document-view-section-text"><p style="line-height: normal;"><strong><u>Tier 1 Covered Codes</u></strong></p>
<p style="line-height: normal;">Limited coverage may be provided for the genetic tests, submitted under the following CPT codes:</p>
<p style="line-height: normal;">Please refer to the Indications and Limitations of Coverage section (L35000)&nbsp;and the ICD-10-CM diagnosis to CPT procedure groupings below.</p>
<p>&nbsp;</p></span>

			<span class="document-view-section-subheader">Group 1 Codes</span>

				<table id="gdvHcpcsCodes1" class="table table-striped table-lg" summary="The CPT/HCPCS Code data">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody>
							<tr>
								<td>
									81120
								</td>
								<td>
									IDH1 (ISOCITRATE DEHYDROGENASE 1 [NADP+], SOLUBLE) (EG, GLIOMA), COMMON VARIANTS (EG, R132H, R132C)
								</td>
							</tr>
							<tr>
								<td>
									81121
								</td>
								<td>
									IDH2 (ISOCITRATE DEHYDROGENASE 2 [NADP+], MITOCHONDRIAL) (EG, GLIOMA), COMMON VARIANTS (EG, R140W, R172M)
								</td>
							</tr>
							<tr>
								<td>
									81162
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED), BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL SEQUENCE ANALYSIS AND FULL DUPLICATION/DELETION ANALYSIS (IE, DETECTION OF LARGE GENE REARRANGEMENTS)
								</td>
							</tr>
							<tr>
								<td>
									81163
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED), BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81164
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED), BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL DUPLICATION/DELETION ANALYSIS (IE, DETECTION OF LARGE GENE REARRANGEMENTS)
								</td>
							</tr>
							<tr>
								<td>
									81165
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81166
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL DUPLICATION/DELETION ANALYSIS (IE, DETECTION OF LARGE GENE REARRANGEMENTS)
								</td>
							</tr>
							<tr>
								<td>
									81167
								</td>
								<td>
									BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL DUPLICATION/DELETION ANALYSIS (IE, DETECTION OF LARGE GENE REARRANGEMENTS)
								</td>
							</tr>
							<tr>
								<td>
									81168
								</td>
								<td>
									CCND1/IGH (T(11;14)) (EG, MANTLE CELL LYMPHOMA) TRANSLOCATION ANALYSIS, MAJOR BREAKPOINT, QUALITATIVE AND QUANTITATIVE, IF PERFORMED
								</td>
							</tr>
							<tr>
								<td>
									81170
								</td>
								<td>
									ABL1 (ABL PROTO-ONCOGENE 1, NON-RECEPTOR TYROSINE KINASE) (EG, ACQUIRED IMATINIB TYROSINE KINASE INHIBITOR RESISTANCE), GENE ANALYSIS, VARIANTS IN THE KINASE DOMAIN
								</td>
							</tr>
							<tr>
								<td>
									81175
								</td>
								<td>
									ASXL1 (ADDITIONAL SEX COMBS LIKE 1, TRANSCRIPTIONAL REGULATOR) (EG, MYELODYSPLASTIC SYNDROME, MYELOPROLIFERATIVE NEOPLASMS, CHRONIC MYELOMONOCYTIC LEUKEMIA), GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81176
								</td>
								<td>
									ASXL1 (ADDITIONAL SEX COMBS LIKE 1, TRANSCRIPTIONAL REGULATOR) (EG, MYELODYSPLASTIC SYNDROME, MYELOPROLIFERATIVE NEOPLASMS, CHRONIC MYELOMONOCYTIC LEUKEMIA), GENE ANALYSIS; TARGETED SEQUENCE ANALYSIS (EG, EXON 12)
								</td>
							</tr>
							<tr>
								<td>
									81206
								</td>
								<td>
									BCR/ABL1 (T(9;22)) (EG, CHRONIC MYELOGENOUS LEUKEMIA) TRANSLOCATION ANALYSIS; MAJOR BREAKPOINT, QUALITATIVE OR QUANTITATIVE
								</td>
							</tr>
							<tr>
								<td>
									81207
								</td>
								<td>
									BCR/ABL1 (T(9;22)) (EG, CHRONIC MYELOGENOUS LEUKEMIA) TRANSLOCATION ANALYSIS; MINOR BREAKPOINT, QUALITATIVE OR QUANTITATIVE
								</td>
							</tr>
							<tr>
								<td>
									81208
								</td>
								<td>
									BCR/ABL1 (T(9;22)) (EG, CHRONIC MYELOGENOUS LEUKEMIA) TRANSLOCATION ANALYSIS; OTHER BREAKPOINT, QUALITATIVE OR QUANTITATIVE
								</td>
							</tr>
							<tr>
								<td>
									81209
								</td>
								<td>
									BLM (BLOOM SYNDROME, RECQ HELICASE-LIKE) (EG, BLOOM SYNDROME) GENE ANALYSIS, 2281DEL6INS7 VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81210
								</td>
								<td>
									BRAF (B-RAF PROTO-ONCOGENE, SERINE/THREONINE KINASE) (EG, COLON CANCER, MELANOMA), GENE ANALYSIS, V600 VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81212
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED), BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; 185DELAG, 5385INSC, 6174DELT VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81215
								</td>
								<td>
									BRCA1 (BRCA1, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81216
								</td>
								<td>
									BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81217
								</td>
								<td>
									BRCA2 (BRCA2, DNA REPAIR ASSOCIATED) (EG, HEREDITARY BREAST AND OVARIAN CANCER) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81218
								</td>
								<td>
									CEBPA (CCAAT/ENHANCER BINDING PROTEIN [C/EBP], ALPHA) (EG, ACUTE MYELOID LEUKEMIA), GENE ANALYSIS, FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81219
								</td>
								<td>
									CALR (CALRETICULIN) (EG, MYELOPROLIFERATIVE DISORDERS), GENE ANALYSIS, COMMON VARIANTS IN EXON 9
								</td>
							</tr>
							<tr>
								<td>
									81220
								</td>
								<td>
									CFTR (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR) (EG, CYSTIC FIBROSIS) GENE ANALYSIS; COMMON VARIANTS (EG, ACMG/ACOG GUIDELINES)
								</td>
							</tr>
							<tr>
								<td>
									81221
								</td>
								<td>
									CFTR (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR) (EG, CYSTIC FIBROSIS) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81222
								</td>
								<td>
									CFTR (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR) (EG, CYSTIC FIBROSIS) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81223
								</td>
								<td>
									CFTR (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR) (EG, CYSTIC FIBROSIS) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81224
								</td>
								<td>
									CFTR (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR) (EG, CYSTIC FIBROSIS) GENE ANALYSIS; INTRON 8 POLY-T ANALYSIS (EG, MALE INFERTILITY)
								</td>
							</tr>
							<tr>
								<td>
									81225
								</td>
								<td>
									CYP2C19 (CYTOCHROME P450, FAMILY 2, SUBFAMILY C, POLYPEPTIDE 19) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3, *4, *8, *17)
								</td>
							</tr>
							<tr>
								<td>
									81226
								</td>
								<td>
									CYP2D6 (CYTOCHROME P450, FAMILY 2, SUBFAMILY D, POLYPEPTIDE 6) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3, *4, *5, *6, *9, *10, *17, *19, *29, *35, *41, *1XN, *2XN, *4XN)
								</td>
							</tr>
							<tr>
								<td>
									81227
								</td>
								<td>
									CYP2C9 (CYTOCHROME P450, FAMILY 2, SUBFAMILY C, POLYPEPTIDE 9) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3, *5, *6)
								</td>
							</tr>
							<tr>
								<td>
									81235
								</td>
								<td>
									EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) (EG, NON-SMALL CELL LUNG CANCER) GENE ANALYSIS, COMMON VARIANTS (EG, EXON 19 LREA DELETION, L858R, T790M, G719A, G719S, L861Q)
								</td>
							</tr>
							<tr>
								<td>
									81236
								</td>
								<td>
									EZH2 (ENHANCER OF ZESTE 2 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT) (EG, MYELODYSPLASTIC SYNDROME, MYELOPROLIFERATIVE NEOPLASMS) GENE ANALYSIS, FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81237
								</td>
								<td>
									EZH2 (ENHANCER OF ZESTE 2 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT) (EG, DIFFUSE LARGE B-CELL LYMPHOMA) GENE ANALYSIS, COMMON VARIANT(S) (EG, CODON 646)
								</td>
							</tr>
							<tr>
								<td>
									81245
								</td>
								<td>
									FLT3 (FMS-RELATED TYROSINE KINASE 3) (EG, ACUTE MYELOID LEUKEMIA), GENE ANALYSIS; INTERNAL TANDEM DUPLICATION (ITD) VARIANTS (IE, EXONS 14, 15)
								</td>
							</tr>
							<tr>
								<td>
									81246
								</td>
								<td>
									FLT3 (FMS-RELATED TYROSINE KINASE 3) (EG, ACUTE MYELOID LEUKEMIA), GENE ANALYSIS; TYROSINE KINASE DOMAIN (TKD) VARIANTS (EG, D835, I836)
								</td>
							</tr>
							<tr>
								<td>
									81256
								</td>
								<td>
									HFE (HEMOCHROMATOSIS) (EG, HEREDITARY HEMOCHROMATOSIS) GENE ANALYSIS, COMMON VARIANTS (EG, C282Y, H63D)
								</td>
							</tr>
							<tr>
								<td>
									81261
								</td>
								<td>
									IGH@ (IMMUNOGLOBULIN HEAVY CHAIN LOCUS) (EG, LEUKEMIAS AND LYMPHOMAS, B-CELL), GENE REARRANGEMENT ANALYSIS TO DETECT ABNORMAL CLONAL POPULATION(S); AMPLIFIED METHODOLOGY (EG, POLYMERASE CHAIN REACTION)
								</td>
							</tr>
							<tr>
								<td>
									81262
								</td>
								<td>
									IGH@ (IMMUNOGLOBULIN HEAVY CHAIN LOCUS) (EG, LEUKEMIAS AND LYMPHOMAS, B-CELL), GENE REARRANGEMENT ANALYSIS TO DETECT ABNORMAL CLONAL POPULATION(S); DIRECT PROBE METHODOLOGY (EG, SOUTHERN BLOT)
								</td>
							</tr>
							<tr>
								<td>
									81263
								</td>
								<td>
									IGH@ (IMMUNOGLOBULIN HEAVY CHAIN LOCUS) (EG, LEUKEMIA AND LYMPHOMA, B-CELL), VARIABLE REGION SOMATIC MUTATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81264
								</td>
								<td>
									IGK@ (IMMUNOGLOBULIN KAPPA LIGHT CHAIN LOCUS) (EG, LEUKEMIA AND LYMPHOMA, B-CELL), GENE REARRANGEMENT ANALYSIS, EVALUATION TO DETECT ABNORMAL CLONAL POPULATION(S)
								</td>
							</tr>
							<tr>
								<td>
									81265
								</td>
								<td>
									COMPARATIVE ANALYSIS USING SHORT TANDEM REPEAT (STR) MARKERS; PATIENT AND COMPARATIVE SPECIMEN (EG, PRE-TRANSPLANT RECIPIENT AND DONOR GERMLINE TESTING, POST-TRANSPLANT NON-HEMATOPOIETIC RECIPIENT GERMLINE [EG, BUCCAL SWAB OR OTHER GERMLINE TISSUE SAMPLE] AND DONOR TESTING, TWIN ZYGOSITY TESTING, OR MATERNAL CELL CONTAMINATION OF FETAL CELLS)
								</td>
							</tr>
							<tr>
								<td>
									81266
								</td>
								<td>
									COMPARATIVE ANALYSIS USING SHORT TANDEM REPEAT (STR) MARKERS; EACH ADDITIONAL SPECIMEN (EG, ADDITIONAL CORD BLOOD DONOR, ADDITIONAL FETAL SAMPLES FROM DIFFERENT CULTURES, OR ADDITIONAL ZYGOSITY IN MULTIPLE BIRTH PREGNANCIES) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)
								</td>
							</tr>
							<tr>
								<td>
									81267
								</td>
								<td>
									CHIMERISM (ENGRAFTMENT) ANALYSIS, POST TRANSPLANTATION SPECIMEN (EG, HEMATOPOIETIC STEM CELL), INCLUDES COMPARISON TO PREVIOUSLY PERFORMED BASELINE ANALYSES; WITHOUT CELL SELECTION
								</td>
							</tr>
							<tr>
								<td>
									81268
								</td>
								<td>
									CHIMERISM (ENGRAFTMENT) ANALYSIS, POST TRANSPLANTATION SPECIMEN (EG, HEMATOPOIETIC STEM CELL), INCLUDES COMPARISON TO PREVIOUSLY PERFORMED BASELINE ANALYSES; WITH CELL SELECTION (EG, CD3, CD33), EACH CELL TYPE
								</td>
							</tr>
							<tr>
								<td>
									81270
								</td>
								<td>
									JAK2 (JANUS KINASE 2) (EG, MYELOPROLIFERATIVE DISORDER) GENE ANALYSIS, P.VAL617PHE (V617F) VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81272
								</td>
								<td>
									KIT (V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG) (EG, GASTROINTESTINAL STROMAL TUMOR [GIST], ACUTE MYELOID LEUKEMIA, MELANOMA), GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS (EG, EXONS 8, 11, 13, 17, 18)
								</td>
							</tr>
							<tr>
								<td>
									81273
								</td>
								<td>
									KIT (V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG) (EG, MASTOCYTOSIS), GENE ANALYSIS, D816 VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81275
								</td>
								<td>
									KRAS (KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG) (EG, CARCINOMA) GENE ANALYSIS; VARIANTS IN EXON 2 (EG, CODONS 12 AND 13)
								</td>
							</tr>
							<tr>
								<td>
									81276
								</td>
								<td>
									KRAS (KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG) (EG, CARCINOMA) GENE ANALYSIS; ADDITIONAL VARIANT(S) (EG, CODON 61, CODON 146)
								</td>
							</tr>
							<tr>
								<td>
									81287
								</td>
								<td>
									MGMT (O-6-METHYLGUANINE-DNA METHYLTRANSFERASE) (EG, GLIOBLASTOMA MULTIFORME) PROMOTER METHYLATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81301
								</td>
								<td>
									MICROSATELLITE INSTABILITY ANALYSIS (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) OF MARKERS FOR MISMATCH REPAIR DEFICIENCY (EG, BAT25, BAT26), INCLUDES COMPARISON OF NEOPLASTIC AND NORMAL TISSUE, IF PERFORMED
								</td>
							</tr>
							<tr>
								<td>
									81305
								</td>
								<td>
									MYD88 (MYELOID DIFFERENTIATION PRIMARY RESPONSE 88) (EG, WALDENSTROM'S MACROGLOBULINEMIA, LYMPHOPLASMACYTIC LEUKEMIA) GENE ANALYSIS, P.LEU265PRO (L265P) VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81307
								</td>
								<td>
									PALB2 (PARTNER AND LOCALIZER OF BRCA2) (EG, BREAST AND PANCREATIC CANCER) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81308
								</td>
								<td>
									PALB2 (PARTNER AND LOCALIZER OF BRCA2) (EG, BREAST AND PANCREATIC CANCER) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81309
								</td>
								<td>
									PIK3CA (PHOSPHATIDYLINOSITOL-4, 5-BIPHOSPHATE 3-KINASE, CATALYTIC SUBUNIT ALPHA) (EG, COLORECTAL AND BREAST CANCER) GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS (EG, EXONS 7, 9, 20)
								</td>
							</tr>
							<tr>
								<td>
									81310
								</td>
								<td>
									NPM1 (NUCLEOPHOSMIN) (EG, ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, EXON 12 VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81311
								</td>
								<td>
									NRAS (NEUROBLASTOMA RAS VIRAL [V-RAS] ONCOGENE HOMOLOG) (EG, COLORECTAL CARCINOMA), GENE ANALYSIS, VARIANTS IN EXON 2 (EG, CODONS 12 AND 13) AND EXON 3 (EG, CODON 61)
								</td>
							</tr>
							<tr>
								<td>
									81314
								</td>
								<td>
									PDGFRA (PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA POLYPEPTIDE) (EG, GASTROINTESTINAL STROMAL TUMOR [GIST]), GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS (EG, EXONS 12, 18)
								</td>
							</tr>
							<tr>
								<td>
									81315
								</td>
								<td>
									PML/RARALPHA, (T(15;17)), (PROMYELOCYTIC LEUKEMIA/RETINOIC ACID RECEPTOR ALPHA) (EG, PROMYELOCYTIC LEUKEMIA) TRANSLOCATION ANALYSIS; COMMON BREAKPOINTS (EG, INTRON 3 AND INTRON 6), QUALITATIVE OR QUANTITATIVE
								</td>
							</tr>
							<tr>
								<td>
									81316
								</td>
								<td>
									PML/RARALPHA, (T(15;17)), (PROMYELOCYTIC LEUKEMIA/RETINOIC ACID RECEPTOR ALPHA) (EG, PROMYELOCYTIC LEUKEMIA) TRANSLOCATION ANALYSIS; SINGLE BREAKPOINT (EG, INTRON 3, INTRON 6 OR EXON 6), QUALITATIVE OR QUANTITATIVE
								</td>
							</tr>
							<tr>
								<td>
									81332
								</td>
								<td>
									SERPINA1 (SERPIN PEPTIDASE INHIBITOR, CLADE A, ALPHA-1 ANTIPROTEINASE, ANTITRYPSIN, MEMBER 1) (EG, ALPHA-1-ANTITRYPSIN DEFICIENCY), GENE ANALYSIS, COMMON VARIANTS (EG, *S AND *Z)
								</td>
							</tr>
							<tr>
								<td>
									81334
								</td>
								<td>
									RUNX1 (RUNT RELATED TRANSCRIPTION FACTOR 1) (EG, ACUTE MYELOID LEUKEMIA, FAMILIAL PLATELET DISORDER WITH ASSOCIATED MYELOID MALIGNANCY) GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS (EG, EXONS 3-8)
								</td>
							</tr>
							<tr>
								<td>
									81335
								</td>
								<td>
									TPMT (THIOPURINE S-METHYLTRANSFERASE) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3)
								</td>
							</tr>
							<tr>
								<td>
									81338
								</td>
								<td>
									MPL (MPL PROTO-ONCOGENE, THROMBOPOIETIN RECEPTOR) (EG, MYELOPROLIFERATIVE DISORDER) GENE ANALYSIS; COMMON VARIANTS (EG, W515A, W515K, W515L, W515R)
								</td>
							</tr>
							<tr>
								<td>
									81339
								</td>
								<td>
									MPL (MPL PROTO-ONCOGENE, THROMBOPOIETIN RECEPTOR) (EG, MYELOPROLIFERATIVE DISORDER) GENE ANALYSIS; SEQUENCE ANALYSIS, EXON 10
								</td>
							</tr>
							<tr>
								<td>
									81340
								</td>
								<td>
									TRB@ (T CELL ANTIGEN RECEPTOR, BETA) (EG, LEUKEMIA AND LYMPHOMA), GENE REARRANGEMENT ANALYSIS TO DETECT ABNORMAL CLONAL POPULATION(S); USING AMPLIFICATION METHODOLOGY (EG, POLYMERASE CHAIN REACTION)
								</td>
							</tr>
							<tr>
								<td>
									81341
								</td>
								<td>
									TRB@ (T CELL ANTIGEN RECEPTOR, BETA) (EG, LEUKEMIA AND LYMPHOMA), GENE REARRANGEMENT ANALYSIS TO DETECT ABNORMAL CLONAL POPULATION(S); USING DIRECT PROBE METHODOLOGY (EG, SOUTHERN BLOT)
								</td>
							</tr>
							<tr>
								<td>
									81342
								</td>
								<td>
									TRG@ (T CELL ANTIGEN RECEPTOR, GAMMA) (EG, LEUKEMIA AND LYMPHOMA), GENE REARRANGEMENT ANALYSIS, EVALUATION TO DETECT ABNORMAL CLONAL POPULATION(S)
								</td>
							</tr>
							<tr>
								<td>
									81345
								</td>
								<td>
									TERT (TELOMERASE REVERSE TRANSCRIPTASE) (EG, THYROID CARCINOMA, GLIOBLASTOMA MULTIFORME) GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS (EG, PROMOTER REGION)
								</td>
							</tr>
							<tr>
								<td>
									81347
								</td>
								<td>
									SF3B1 (SPLICING FACTOR [3B] SUBUNIT B1) (EG, MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, COMMON VARIANTS (EG, A672T, E622D, L833F, R625C, R625L)
								</td>
							</tr>
							<tr>
								<td>
									81348
								</td>
								<td>
									SRSF2 (SERINE AND ARGININE-RICH SPLICING FACTOR 2) (EG, MYELODYSPLASTIC SYNDROME, ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, COMMON VARIANTS (EG, P95H, P95L)
								</td>
							</tr>
							<tr>
								<td>
									81351
								</td>
								<td>
									TP53 (TUMOR PROTEIN 53) (EG, LI-FRAUMENI SYNDROME) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81352
								</td>
								<td>
									TP53 (TUMOR PROTEIN 53) (EG, LI-FRAUMENI SYNDROME) GENE ANALYSIS; TARGETED SEQUENCE ANALYSIS (EG, 4 ONCOLOGY)
								</td>
							</tr>
							<tr>
								<td>
									81370
								</td>
								<td>
									HLA CLASS I AND II TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); HLA-A, -B, -C, -DRB1/3/4/5, AND -DQB1
								</td>
							</tr>
							<tr>
								<td>
									81371
								</td>
								<td>
									HLA CLASS I AND II TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); HLA-A, -B, AND -DRB1 (EG, VERIFICATION TYPING)
								</td>
							</tr>
							<tr>
								<td>
									81372
								</td>
								<td>
									HLA CLASS I TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); COMPLETE (IE, HLA-A, -B, AND -C)
								</td>
							</tr>
							<tr>
								<td>
									81373
								</td>
								<td>
									HLA CLASS I TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); ONE LOCUS (EG, HLA-A, -B, OR -C), EACH
								</td>
							</tr>
							<tr>
								<td>
									81374
								</td>
								<td>
									HLA CLASS I TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); ONE ANTIGEN EQUIVALENT (EG, B*27), EACH
								</td>
							</tr>
							<tr>
								<td>
									81375
								</td>
								<td>
									HLA CLASS II TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); HLA-DRB1/3/4/5 AND -DQB1
								</td>
							</tr>
							<tr>
								<td>
									81376
								</td>
								<td>
									HLA CLASS II TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); ONE LOCUS (EG, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, OR -DPA1), EACH
								</td>
							</tr>
							<tr>
								<td>
									81377
								</td>
								<td>
									HLA CLASS II TYPING, LOW RESOLUTION (EG, ANTIGEN EQUIVALENTS); ONE ANTIGEN EQUIVALENT, EACH
								</td>
							</tr>
							<tr>
								<td>
									81378
								</td>
								<td>
									HLA CLASS I AND II TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS), HLA-A, -B, -C, AND -DRB1
								</td>
							</tr>
							<tr>
								<td>
									81379
								</td>
								<td>
									HLA CLASS I TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS); COMPLETE (IE, HLA-A, -B, AND -C)
								</td>
							</tr>
							<tr>
								<td>
									81380
								</td>
								<td>
									HLA CLASS I TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS); ONE LOCUS (EG, HLA-A, -B, OR -C), EACH
								</td>
							</tr>
							<tr>
								<td>
									81381
								</td>
								<td>
									HLA CLASS I TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS); ONE ALLELE OR ALLELE GROUP (EG, B*57:01P), EACH
								</td>
							</tr>
							<tr>
								<td>
									81382
								</td>
								<td>
									HLA CLASS II TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS); ONE LOCUS (EG, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, OR -DPA1), EACH
								</td>
							</tr>
							<tr>
								<td>
									81383
								</td>
								<td>
									HLA CLASS II TYPING, HIGH RESOLUTION (IE, ALLELES OR ALLELE GROUPS); ONE ALLELE OR ALLELE GROUP (EG, HLA-DQB1*06:02P), EACH
								</td>
							</tr>
							<tr>
								<td>
									81449
								</td>
								<td>
									SOLID ORGAN NEOPLASM, GENOMIC SEQUENCE ANALYSIS PANEL, 5-50 GENES, INTERROGATION FOR SEQUENCE VARIANTS AND COPY NUMBER VARIANTS OR REARRANGEMENTS, IF PERFORMED; RNA ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81456
								</td>
								<td>
									SOLID ORGAN OR HEMATOLYMPHOID NEOPLASM OR DISORDER, 51 OR GREATER GENES, GENOMIC SEQUENCE ANALYSIS PANEL, INTERROGATION FOR SEQUENCE VARIANTS AND COPY NUMBER VARIANTS OR REARRANGEMENTS, OR ISOFORM EXPRESSION OR MRNA EXPRESSION LEVELS, IF PERFORMED; RNA ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81518
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 11 GENES (7 CONTENT AND 4 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHMS REPORTED AS PERCENTAGE RISK FOR METASTATIC RECURRENCE AND LIKELIHOOD OF BENEFIT FROM EXTENDED ENDOCRINE THERAPY
								</td>
							</tr>
							<tr>
								<td>
									81519
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 21 GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS RECURRENCE SCORE
								</td>
							</tr>
							<tr>
								<td>
									81520
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA GENE EXPRESSION PROFILING BY HYBRID CAPTURE OF 58 GENES (50 CONTENT AND 8 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS A RECURRENCE RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81522
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA, GENE EXPRESSION PROFILING BY RT-PCR OF 12 GENES (8 CONTENT AND 4 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS RECURRENCE RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81523
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA, NEXT-GENERATION SEQUENCING GENE EXPRESSION PROFILING OF 70 CONTENT GENES AND 31 HOUSEKEEPING GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS INDEX RELATED TO RISK TO DISTANT METASTASIS
								</td>
							</tr>
							<tr>
								<td>
									81552
								</td>
								<td>
									ONCOLOGY (UVEAL MELANOMA), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 15 GENES (12 CONTENT AND 3 HOUSEKEEPING), UTILIZING FINE NEEDLE ASPIRATE OR FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS RISK OF METASTASIS
								</td>
							</tr>
							<tr>
								<td>
									81595
								</td>
								<td>
									CARDIOLOGY (HEART TRANSPLANT), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME QUANTITATIVE PCR OF 20 GENES (11 CONTENT AND 9 HOUSEKEEPING), UTILIZING SUBFRACTION OF PERIPHERAL BLOOD, ALGORITHM REPORTED AS A REJECTION RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									0027U
								</td>
								<td>
									JAK2 (JANUS KINASE 2) (EG, MYELOPROLIFERATIVE DISORDER) GENE ANALYSIS, TARGETED SEQUENCE ANALYSIS EXONS 12-15
								</td>
							</tr>
							<tr>
								<td>
									0070U
								</td>
								<td>
									CYP2D6 (CYTOCHROME P450, FAMILY 2, SUBFAMILY D, POLYPEPTIDE 6) (EG, DRUG METABOLISM) GENE ANALYSIS, COMMON AND SELECT RARE VARIANTS (IE, *2, *3, *4, *4N, *5, *6, *7, *8, *9, *10, *11, *12, *13, *14A, *14B, *15, *17, *29, *35, *36, *41, *57, *61, *63, *68, *83, *XN)
								</td>
							</tr>
					</tbody>
				</table>

		</div>
	</div>
	<div id="divHcpcsCodesGroup2" class="document-view-code-group-section">
		<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcsCodesGroup2">
			<h4 class="document-view-code-group-title d-inline">Group 2</h4>
			<span id="lblTotalHcpcsCodes" class="document-view-section-text" style="margin-left: 7px;">(52 Codes)</span>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup2Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup2Chevron"></i> --></div>
		</div>

		<div id="divHcpcsCodesGroup2Fields" class="document-view-code-group-fields hcpcs-code-group-fields d-print-block">
			<span class="document-view-section-subheader">Group 2 Paragraph</span>
			<span class="document-view-section-text"><p></p><p style="line-height: normal;"><strong><u>Tier 1 Individual Review Codes</u></strong></p>
<p style="line-height: normal;">Coverage may be provided for the genetic tests submitted under the following Tier 1 CPT codes, if documentation supports medical necessity:</p>
<p style="line-height: normal;">Please refer to the Indications and Limitations of Coverage section (L35000)&nbsp;and the ICD-10-CM diagnosis to CPT procedure groupings below. Not all procedure codes have related diagnosis codes listed.</p>
<p style="line-height: normal;">&nbsp;</p><p></p></span>

			<span class="document-view-section-subheader">Group 2 Codes</span>

				<table id="gdvHcpcsCodes2" class="table table-striped table-lg" summary="The CPT/HCPCS Code data">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody>
							<tr>
								<td>
									81177
								</td>
								<td>
									ATN1 (ATROPHIN 1) (EG, DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81178
								</td>
								<td>
									ATXN1 (ATAXIN 1) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81179
								</td>
								<td>
									ATXN2 (ATAXIN 2) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81180
								</td>
								<td>
									ATXN3 (ATAXIN 3) (EG, SPINOCEREBELLAR ATAXIA, MACHADO-JOSEPH DISEASE) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81181
								</td>
								<td>
									ATXN7 (ATAXIN 7) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81182
								</td>
								<td>
									ATXN8OS (ATXN8 OPPOSITE STRAND [NON-PROTEIN CODING]) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81183
								</td>
								<td>
									ATXN10 (ATAXIN 10) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81184
								</td>
								<td>
									CACNA1A (CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 A) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81185
								</td>
								<td>
									CACNA1A (CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 A) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81186
								</td>
								<td>
									CACNA1A (CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 A) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81187
								</td>
								<td>
									CNBP (CCHC-TYPE ZINC FINGER NUCLEIC ACID BINDING PROTEIN) (EG, MYOTONIC DYSTROPHY TYPE 2) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81188
								</td>
								<td>
									CSTB (CYSTATIN B) (EG, UNVERRICHT-LUNDBORG DISEASE) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81189
								</td>
								<td>
									CSTB (CYSTATIN B) (EG, UNVERRICHT-LUNDBORG DISEASE) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81190
								</td>
								<td>
									CSTB (CYSTATIN B) (EG, UNVERRICHT-LUNDBORG DISEASE) GENE ANALYSIS; KNOWN FAMILIAL VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81191
								</td>
								<td>
									NTRK1 (NEUROTROPHIC RECEPTOR TYROSINE KINASE 1) (EG, SOLID TUMORS) TRANSLOCATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81192
								</td>
								<td>
									NTRK2 (NEUROTROPHIC RECEPTOR TYROSINE KINASE 2) (EG, SOLID TUMORS) TRANSLOCATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81193
								</td>
								<td>
									NTRK3 (NEUROTROPHIC RECEPTOR TYROSINE KINASE 3) (EG, SOLID TUMORS) TRANSLOCATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81194
								</td>
								<td>
									NTRK (NEUROTROPHIC RECEPTOR TYROSINE KINASE 1, 2, AND 3) (EG, SOLID TUMORS) TRANSLOCATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81233
								</td>
								<td>
									BTK (BRUTON'S TYROSINE KINASE) (EG, CHRONIC LYMPHOCYTIC LEUKEMIA) GENE ANALYSIS, COMMON VARIANTS (EG, C481S, C481R, C481F)
								</td>
							</tr>
							<tr>
								<td>
									81277
								</td>
								<td>
									CYTOGENOMIC NEOPLASIA (GENOME-WIDE) MICROARRAY ANALYSIS, INTERROGATION OF GENOMIC REGIONS FOR COPY NUMBER AND LOSS-OF-HETEROZYGOSITY VARIANTS FOR CHROMOSOMAL ABNORMALITIES
								</td>
							</tr>
							<tr>
								<td>
									81288
								</td>
								<td>
									MLH1 (MUTL HOMOLOG 1, COLON CANCER, NONPOLYPOSIS TYPE 2) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; PROMOTER METHYLATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81292
								</td>
								<td>
									MLH1 (MUTL HOMOLOG 1, COLON CANCER, NONPOLYPOSIS TYPE 2) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81293
								</td>
								<td>
									MLH1 (MUTL HOMOLOG 1, COLON CANCER, NONPOLYPOSIS TYPE 2) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81294
								</td>
								<td>
									MLH1 (MUTL HOMOLOG 1, COLON CANCER, NONPOLYPOSIS TYPE 2) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81295
								</td>
								<td>
									MSH2 (MUTS HOMOLOG 2, COLON CANCER, NONPOLYPOSIS TYPE 1) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81296
								</td>
								<td>
									MSH2 (MUTS HOMOLOG 2, COLON CANCER, NONPOLYPOSIS TYPE 1) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81297
								</td>
								<td>
									MSH2 (MUTS HOMOLOG 2, COLON CANCER, NONPOLYPOSIS TYPE 1) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81298
								</td>
								<td>
									MSH6 (MUTS HOMOLOG 6 [E. COLI]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81299
								</td>
								<td>
									MSH6 (MUTS HOMOLOG 6 [E. COLI]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81300
								</td>
								<td>
									MSH6 (MUTS HOMOLOG 6 [E. COLI]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81306
								</td>
								<td>
									NUDT15 (NUDIX HYDROLASE 15) (EG, DRUG METABOLISM) GENE ANALYSIS, COMMON VARIANT(S) (EG, *2, *3, *4, *5, *6)
								</td>
							</tr>
							<tr>
								<td>
									81312
								</td>
								<td>
									PABPN1 (POLY[A] BINDING PROTEIN NUCLEAR 1) (EG, OCULOPHARYNGEAL MUSCULAR DYSTROPHY) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81317
								</td>
								<td>
									PMS2 (POSTMEIOTIC SEGREGATION INCREASED 2 [S. CEREVISIAE]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81318
								</td>
								<td>
									PMS2 (POSTMEIOTIC SEGREGATION INCREASED 2 [S. CEREVISIAE]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81319
								</td>
								<td>
									PMS2 (POSTMEIOTIC SEGREGATION INCREASED 2 [S. CEREVISIAE]) (EG, HEREDITARY NON-POLYPOSIS COLORECTAL CANCER, LYNCH SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81320
								</td>
								<td>
									PLCG2 (PHOSPHOLIPASE C GAMMA 2) (EG, CHRONIC LYMPHOCYTIC LEUKEMIA) GENE ANALYSIS, COMMON VARIANTS (EG, R665W, S707F, L845F)
								</td>
							</tr>
							<tr>
								<td>
									81321
								</td>
								<td>
									PTEN (PHOSPHATASE AND TENSIN HOMOLOG) (EG, COWDEN SYNDROME, PTEN HAMARTOMA TUMOR SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81322
								</td>
								<td>
									PTEN (PHOSPHATASE AND TENSIN HOMOLOG) (EG, COWDEN SYNDROME, PTEN HAMARTOMA TUMOR SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81323
								</td>
								<td>
									PTEN (PHOSPHATASE AND TENSIN HOMOLOG) (EG, COWDEN SYNDROME, PTEN HAMARTOMA TUMOR SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81333
								</td>
								<td>
									TGFBI (TRANSFORMING GROWTH FACTOR BETA-INDUCED) (EG, CORNEAL DYSTROPHY) GENE ANALYSIS, COMMON VARIANTS (EG, R124H, R124C, R124L, R555W, R555Q)
								</td>
							</tr>
							<tr>
								<td>
									81343
								</td>
								<td>
									PPP2R2B (PROTEIN PHOSPHATASE 2 REGULATORY SUBUNIT BBETA) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81344
								</td>
								<td>
									TBP (TATA BOX BINDING PROTEIN) (EG, SPINOCEREBELLAR ATAXIA) GENE ANALYSIS, EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81353
								</td>
								<td>
									TP53 (TUMOR PROTEIN 53) (EG, LI-FRAUMENI SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81357
								</td>
								<td>
									U2AF1 (U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1) (EG, MYELODYSPLASTIC SYNDROME, ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, COMMON VARIANTS (EG, S34F, S34Y, Q157R, Q157P)
								</td>
							</tr>
							<tr>
								<td>
									81360
								</td>
								<td>
									ZRSR2 (ZINC FINGER CCCH-TYPE, RNA BINDING MOTIF AND SERINE/ARGININE-RICH 2) (EG, MYELODYSPLASTIC SYNDROME, ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, COMMON VARIANT(S) (EG, E65FS, E122FS, R448FS)
								</td>
							</tr>
							<tr>
								<td>
									81418
								</td>
								<td>
									DRUG METABOLISM (EG, PHARMACOGENOMICS) GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE TESTING OF AT LEAST 6 GENES, INCLUDING CYP2C19, CYP2D6, AND CYP2D6 DUPLICATION/DELETION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81419
								</td>
								<td>
									EPILEPSY GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE ANALYSES FOR ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, AND ZEB2
								</td>
							</tr>
							<tr>
								<td>
									81441
								</td>
								<td>
									INHERITED BONE MARROW FAILURE SYNDROMES (IBMFS) (EG, FANCONI ANEMIA, DYSKERATOSIS CONGENITA, DIAMOND-BLACKFAN ANEMIA, SHWACHMAN-DIAMOND SYNDROME, GATA2 DEFICIENCY SYNDROME, CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA) SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 30 GENES, INCLUDING BRCA2, BRIP1, DKC1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, GATA1, GATA2, MPL, NHP2, NOP10, PALB2, RAD51C, RPL11, RPL35A, RPL5, RPS10, RPS19, RPS24, RPS26, RPS7, SBDS, TERT, AND TINF2
								</td>
							</tr>
							<tr>
								<td>
									81529
								</td>
								<td>
									ONCOLOGY (CUTANEOUS MELANOMA), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 31 GENES (28 CONTENT AND 3 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS RECURRENCE RISK, INCLUDING LIKELIHOOD OF SENTINEL LYMPH NODE METASTASIS
								</td>
							</tr>
							<tr>
								<td>
									81542
								</td>
								<td>
									ONCOLOGY (PROSTATE), MRNA, MICROARRAY GENE EXPRESSION PROFILING OF 22 CONTENT GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS METASTASIS RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81554
								</td>
								<td>
									PULMONARY DISEASE (IDIOPATHIC PULMONARY FIBROSIS [IPF]), MRNA, GENE EXPRESSION ANALYSIS OF 190 GENES, UTILIZING TRANSBRONCHIAL BIOPSIES, DIAGNOSTIC ALGORITHM REPORTED AS CATEGORICAL RESULT (EG, POSITIVE OR NEGATIVE FOR HIGH PROBABILITY OF USUAL INTERSTITIAL PNEUMONIA [UIP])
								</td>
							</tr>
							<tr>
								<td>
									81599
								</td>
								<td>
									UNLISTED MULTIANALYTE ASSAY WITH ALGORITHMIC ANALYSIS
								</td>
							</tr>
					</tbody>
				</table>

		</div>
	</div>
	<div id="divHcpcsCodesGroup3" class="document-view-code-group-section">
		<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcsCodesGroup3">
			<h4 class="document-view-code-group-title d-inline">Group 3</h4>
			<span id="lblTotalHcpcsCodes" class="document-view-section-text" style="margin-left: 7px;">(119 Codes)</span>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup3Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup3Chevron"></i> --></div>
		</div>

		<div id="divHcpcsCodesGroup3Fields" class="document-view-code-group-fields hcpcs-code-group-fields d-print-block">
			<span class="document-view-section-subheader">Group 3 Paragraph</span>
			<span class="document-view-section-text"><p></p><p style="line-height: normal;"><strong><u>Tier 1 Non-covered Codes</u></strong></p>
<p><span style="line-height: 107%;">Genetic testing procedures submitted under the following CPT codes are unlikely to impact therapeutic decision-making in the clinical management of the patient and will be denied automatically as not medically necessary: </span></p><p></p></span>

			<span class="document-view-section-subheader">Group 3 Codes</span>

				<table id="gdvHcpcsCodes3" class="table table-striped table-lg" summary="The CPT/HCPCS Code data">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody>
							<tr>
								<td>
									<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aHcpcsRange system-link no-click log-click" data-page-action="Clicked on aHcpcsRange for 81105 - 81112 in Group 3" id="56199|108|81105|81112|81105|81112|3|N">81105 - 81112</a>
								</td>
								<td>
									HUMAN PLATELET ANTIGEN 1 GENOTYPING (HPA-1), ITGB3 (INTEGRIN, BETA 3 [PLATELET GLYCOPROTEIN IIIA], ANTIGEN CD61 [GPIIIA]) (EG, NEONATAL ALLOIMMUNE THROMBOCYTOPENIA [NAIT], POST-TRANSFUSION PURPURA), GENE ANALYSIS, COMMON VARIANT, HPA-1A/B (L33P) - HUMAN PLATELET ANTIGEN 15 GENOTYPING (HPA-15), CD109 (CD109 MOLECULE) (EG, NEONATAL ALLOIMMUNE THROMBOCYTOPENIA [NAIT], POST-TRANSFUSION PURPURA), GENE ANALYSIS, COMMON VARIANT, HPA-15A/B (S682Y)
								</td>
							</tr>
							<tr>
								<td>
									81161
								</td>
								<td>
									DMD (DYSTROPHIN) (EG, DUCHENNE/BECKER MUSCULAR DYSTROPHY) DELETION ANALYSIS, AND DUPLICATION ANALYSIS, IF PERFORMED
								</td>
							</tr>
							<tr>
								<td>
									81171
								</td>
								<td>
									AFF2 (ALF TRANSCRIPTION ELONGATION FACTOR 2 [FMR2]) (EG, FRAGILE X INTELLECTUAL DISABILITY 2 [FRAXE]) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81172
								</td>
								<td>
									AFF2 (ALF TRANSCRIPTION ELONGATION FACTOR 2 [FMR2]) (EG, FRAGILE X INTELLECTUAL DISABILITY 2 [FRAXE]) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE AND METHYLATION STATUS)
								</td>
							</tr>
							<tr>
								<td>
									81173
								</td>
								<td>
									AR (ANDROGEN RECEPTOR) (EG, SPINAL AND BULBAR MUSCULAR ATROPHY, KENNEDY DISEASE, X CHROMOSOME INACTIVATION) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81174
								</td>
								<td>
									AR (ANDROGEN RECEPTOR) (EG, SPINAL AND BULBAR MUSCULAR ATROPHY, KENNEDY DISEASE, X CHROMOSOME INACTIVATION) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81200
								</td>
								<td>
									ASPA (ASPARTOACYLASE) (EG, CANAVAN DISEASE) GENE ANALYSIS, COMMON VARIANTS (EG, E285A, Y231X)
								</td>
							</tr>
							<tr>
								<td>
									81201
								</td>
								<td>
									APC (ADENOMATOUS POLYPOSIS COLI) (EG, FAMILIAL ADENOMATOSIS POLYPOSIS [FAP], ATTENUATED FAP) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81202
								</td>
								<td>
									APC (ADENOMATOUS POLYPOSIS COLI) (EG, FAMILIAL ADENOMATOSIS POLYPOSIS [FAP], ATTENUATED FAP) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81203
								</td>
								<td>
									APC (ADENOMATOUS POLYPOSIS COLI) (EG, FAMILIAL ADENOMATOSIS POLYPOSIS [FAP], ATTENUATED FAP) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81204
								</td>
								<td>
									AR (ANDROGEN RECEPTOR) (EG, SPINAL AND BULBAR MUSCULAR ATROPHY, KENNEDY DISEASE, X CHROMOSOME INACTIVATION) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE OR METHYLATION STATUS)
								</td>
							</tr>
							<tr>
								<td>
									81205
								</td>
								<td>
									BCKDHB (BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE) (EG, MAPLE SYRUP URINE DISEASE) GENE ANALYSIS, COMMON VARIANTS (EG, R183P, G278S, E422X)
								</td>
							</tr>
							<tr>
								<td>
									81228
								</td>
								<td>
									CYTOGENOMIC (GENOME-WIDE) ANALYSIS FOR CONSTITUTIONAL CHROMOSOMAL ABNORMALITIES; INTERROGATION OF GENOMIC REGIONS FOR COPY NUMBER VARIANTS, COMPARATIVE GENOMIC HYBRIDIZATION [CGH] MICROARRAY ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81229
								</td>
								<td>
									CYTOGENOMIC (GENOME-WIDE) ANALYSIS FOR CONSTITUTIONAL CHROMOSOMAL ABNORMALITIES; INTERROGATION OF GENOMIC REGIONS FOR COPY NUMBER AND SINGLE NUCLEOTIDE POLYMORPHISM (SNP) VARIANTS, COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MICROARRAY ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81230
								</td>
								<td>
									CYP3A4 (CYTOCHROME P450 FAMILY 3 SUBFAMILY A MEMBER 4) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANT(S) (EG, *2, *22)
								</td>
							</tr>
							<tr>
								<td>
									81231
								</td>
								<td>
									CYP3A5 (CYTOCHROME P450 FAMILY 3 SUBFAMILY A MEMBER 5) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3, *4, *5, *6, *7)
								</td>
							</tr>
							<tr>
								<td>
									81232
								</td>
								<td>
									DPYD (DIHYDROPYRIMIDINE DEHYDROGENASE) (EG, 5-FLUOROURACIL/5-FU AND CAPECITABINE DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANT(S) (EG, *2A, *4, *5, *6)
								</td>
							</tr>
							<tr>
								<td>
									81234
								</td>
								<td>
									DMPK (DM1 PROTEIN KINASE) (EG, MYOTONIC DYSTROPHY TYPE 1) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81238
								</td>
								<td>
									F9 (COAGULATION FACTOR IX) (EG, HEMOPHILIA B), FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81239
								</td>
								<td>
									DMPK (DM1 PROTEIN KINASE) (EG, MYOTONIC DYSTROPHY TYPE 1) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE)
								</td>
							</tr>
							<tr>
								<td>
									81240
								</td>
								<td>
									F2 (PROTHROMBIN, COAGULATION FACTOR II) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, 20210G&gt;A VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81241
								</td>
								<td>
									F5 (COAGULATION FACTOR V) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, LEIDEN VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81242
								</td>
								<td>
									FANCC (FANCONI ANEMIA, COMPLEMENTATION GROUP C) (EG, FANCONI ANEMIA, TYPE C) GENE ANALYSIS, COMMON VARIANT (EG, IVS4+4A&gt;T)
								</td>
							</tr>
							<tr>
								<td>
									81243
								</td>
								<td>
									FMR1 (FRAGILE X MESSENGER RIBONUCLEOPROTEIN 1) (EG, FRAGILE X SYNDROME, X-LINKED INTELLECTUAL DISABILITY [XLID]) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81244
								</td>
								<td>
									FMR1 (FRAGILE X MESSENGER RIBONUCLEOPROTEIN 1) (EG, FRAGILE X SYNDROME, X-LINKED INTELLECTUAL DISABILITY [XLID]) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE AND PROMOTER METHYLATION STATUS)
								</td>
							</tr>
							<tr>
								<td>
									81247
								</td>
								<td>
									G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) (EG, HEMOLYTIC ANEMIA, JAUNDICE), GENE ANALYSIS; COMMON VARIANT(S) (EG, A, A-)
								</td>
							</tr>
							<tr>
								<td>
									81248
								</td>
								<td>
									G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) (EG, HEMOLYTIC ANEMIA, JAUNDICE), GENE ANALYSIS; KNOWN FAMILIAL VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81249
								</td>
								<td>
									G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) (EG, HEMOLYTIC ANEMIA, JAUNDICE), GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81250
								</td>
								<td>
									G6PC (GLUCOSE-6-PHOSPHATASE, CATALYTIC SUBUNIT) (EG, GLYCOGEN STORAGE DISEASE, TYPE 1A, VON GIERKE DISEASE) GENE ANALYSIS, COMMON VARIANTS (EG, R83C, Q347X)
								</td>
							</tr>
							<tr>
								<td>
									81251
								</td>
								<td>
									GBA (GLUCOSIDASE, BETA, ACID) (EG, GAUCHER DISEASE) GENE ANALYSIS, COMMON VARIANTS (EG, N370S, 84GG, L444P, IVS2+1G&gt;A)
								</td>
							</tr>
							<tr>
								<td>
									81252
								</td>
								<td>
									GJB2 (GAP JUNCTION PROTEIN, BETA 2, 26KDA, CONNEXIN 26) (EG, NONSYNDROMIC HEARING LOSS) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81253
								</td>
								<td>
									GJB2 (GAP JUNCTION PROTEIN, BETA 2, 26KDA, CONNEXIN 26) (EG, NONSYNDROMIC HEARING LOSS) GENE ANALYSIS; KNOWN FAMILIAL VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81254
								</td>
								<td>
									GJB6 (GAP JUNCTION PROTEIN, BETA 6, 30KDA, CONNEXIN 30) (EG, NONSYNDROMIC HEARING LOSS) GENE ANALYSIS, COMMON VARIANTS (EG, 309KB [DEL(GJB6-D13S1830)] AND 232KB [DEL(GJB6-D13S1854)])
								</td>
							</tr>
							<tr>
								<td>
									81255
								</td>
								<td>
									HEXA (HEXOSAMINIDASE A [ALPHA POLYPEPTIDE]) (EG, TAY-SACHS DISEASE) GENE ANALYSIS, COMMON VARIANTS (EG, 1278INSTATC, 1421+1G&gt;C, G269S)
								</td>
							</tr>
							<tr>
								<td>
									81257
								</td>
								<td>
									HBA1/HBA2 (ALPHA GLOBIN 1 AND ALPHA GLOBIN 2) (EG, ALPHA THALASSEMIA, HB BART HYDROPS FETALIS SYNDROME, HBH DISEASE), GENE ANALYSIS; COMMON DELETIONS OR VARIANT (EG, SOUTHEAST ASIAN, THAI, FILIPINO, MEDITERRANEAN, ALPHA3.7, ALPHA4.2, ALPHA20.5, CONSTANT SPRING)
								</td>
							</tr>
							<tr>
								<td>
									81258
								</td>
								<td>
									HBA1/HBA2 (ALPHA GLOBIN 1 AND ALPHA GLOBIN 2) (EG, ALPHA THALASSEMIA, HB BART HYDROPS FETALIS SYNDROME, HBH DISEASE), GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81259
								</td>
								<td>
									HBA1/HBA2 (ALPHA GLOBIN 1 AND ALPHA GLOBIN 2) (EG, ALPHA THALASSEMIA, HB BART HYDROPS FETALIS SYNDROME, HBH DISEASE), GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81260
								</td>
								<td>
									IKBKAP (INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B-CELLS, KINASE COMPLEX-ASSOCIATED PROTEIN) (EG, FAMILIAL DYSAUTONOMIA) GENE ANALYSIS, COMMON VARIANTS (EG, 2507+6T&gt;C, R696P)
								</td>
							</tr>
							<tr>
								<td>
									81269
								</td>
								<td>
									HBA1/HBA2 (ALPHA GLOBIN 1 AND ALPHA GLOBIN 2) (EG, ALPHA THALASSEMIA, HB BART HYDROPS FETALIS SYNDROME, HBH DISEASE), GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81271
								</td>
								<td>
									HTT (HUNTINGTIN) (EG, HUNTINGTON DISEASE) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EG, EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81274
								</td>
								<td>
									HTT (HUNTINGTIN) (EG, HUNTINGTON DISEASE) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE)
								</td>
							</tr>
							<tr>
								<td>
									81283
								</td>
								<td>
									IFNL3 (INTERFERON, LAMBDA 3) (EG, DRUG RESPONSE), GENE ANALYSIS, RS12979860 VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81284
								</td>
								<td>
									FXN (FRATAXIN) (EG, FRIEDREICH ATAXIA) GENE ANALYSIS; EVALUATION TO DETECT ABNORMAL (EXPANDED) ALLELES
								</td>
							</tr>
							<tr>
								<td>
									81285
								</td>
								<td>
									FXN (FRATAXIN) (EG, FRIEDREICH ATAXIA) GENE ANALYSIS; CHARACTERIZATION OF ALLELES (EG, EXPANDED SIZE)
								</td>
							</tr>
							<tr>
								<td>
									81286
								</td>
								<td>
									FXN (FRATAXIN) (EG, FRIEDREICH ATAXIA) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81289
								</td>
								<td>
									FXN (FRATAXIN) (EG, FRIEDREICH ATAXIA) GENE ANALYSIS; KNOWN FAMILIAL VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81290
								</td>
								<td>
									MCOLN1 (MUCOLIPIN 1) (EG, MUCOLIPIDOSIS, TYPE IV) GENE ANALYSIS, COMMON VARIANTS (EG, IVS3-2A&gt;G, DEL6.4KB)
								</td>
							</tr>
							<tr>
								<td>
									81291
								</td>
								<td>
									MTHFR (5,10-METHYLENETETRAHYDROFOLATE REDUCTASE) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, COMMON VARIANTS (EG, 677T, 1298C)
								</td>
							</tr>
							<tr>
								<td>
									81302
								</td>
								<td>
									MECP2 (METHYL CPG BINDING PROTEIN 2) (EG, RETT SYNDROME) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81303
								</td>
								<td>
									MECP2 (METHYL CPG BINDING PROTEIN 2) (EG, RETT SYNDROME) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81304
								</td>
								<td>
									MECP2 (METHYL CPG BINDING PROTEIN 2) (EG, RETT SYNDROME) GENE ANALYSIS; DUPLICATION/DELETION VARIANTS
								</td>
							</tr>
							<tr>
								<td>
									81324
								</td>
								<td>
									PMP22 (PERIPHERAL MYELIN PROTEIN 22) (EG, CHARCOT-MARIE-TOOTH, HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES) GENE ANALYSIS; DUPLICATION/DELETION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81325
								</td>
								<td>
									PMP22 (PERIPHERAL MYELIN PROTEIN 22) (EG, CHARCOT-MARIE-TOOTH, HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES) GENE ANALYSIS; FULL SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81326
								</td>
								<td>
									PMP22 (PERIPHERAL MYELIN PROTEIN 22) (EG, CHARCOT-MARIE-TOOTH, HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES) GENE ANALYSIS; KNOWN FAMILIAL VARIANT
								</td>
							</tr>
							<tr>
								<td>
									81327
								</td>
								<td>
									SEPT9 (SEPTIN9) (EG, COLORECTAL CANCER) PROMOTER METHYLATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81328
								</td>
								<td>
									SLCO1B1 (SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1) (EG, ADVERSE DRUG REACTION), GENE ANALYSIS, COMMON VARIANT(S) (EG, *5)
								</td>
							</tr>
							<tr>
								<td>
									81329
								</td>
								<td>
									SMN1 (SURVIVAL OF MOTOR NEURON 1, TELOMERIC) (EG, SPINAL MUSCULAR ATROPHY) GENE ANALYSIS; DOSAGE/DELETION ANALYSIS (EG, CARRIER TESTING), INCLUDES SMN2 (SURVIVAL OF MOTOR NEURON 2, CENTROMERIC) ANALYSIS, IF PERFORMED
								</td>
							</tr>
							<tr>
								<td>
									81330
								</td>
								<td>
									SMPD1 (SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL) (EG, NIEMANN-PICK DISEASE, TYPE A) GENE ANALYSIS, COMMON VARIANTS (EG, R496L, L302P, FSP330)
								</td>
							</tr>
							<tr>
								<td>
									81331
								</td>
								<td>
									SNRPN/UBE3A (SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N AND UBIQUITIN PROTEIN LIGASE E3A) (EG, PRADER-WILLI SYNDROME AND/OR ANGELMAN SYNDROME), METHYLATION ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81336
								</td>
								<td>
									SMN1 (SURVIVAL OF MOTOR NEURON 1, TELOMERIC) (EG, SPINAL MUSCULAR ATROPHY) GENE ANALYSIS; FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81337
								</td>
								<td>
									SMN1 (SURVIVAL OF MOTOR NEURON 1, TELOMERIC) (EG, SPINAL MUSCULAR ATROPHY) GENE ANALYSIS; KNOWN FAMILIAL SEQUENCE VARIANT(S)
								</td>
							</tr>
							<tr>
								<td>
									81346
								</td>
								<td>
									TYMS (THYMIDYLATE SYNTHETASE) (EG, 5-FLUOROURACIL/5-FU DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANT(S) (EG, TANDEM REPEAT VARIANT)
								</td>
							</tr>
							<tr>
								<td>
									81349
								</td>
								<td>
									CYTOGENOMIC (GENOME-WIDE) ANALYSIS FOR CONSTITUTIONAL CHROMOSOMAL ABNORMALITIES; INTERROGATION OF GENOMIC REGIONS FOR COPY NUMBER AND LOSS-OF-HETEROZYGOSITY VARIANTS, LOW-PASS SEQUENCING ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81350
								</td>
								<td>
									UGT1A1 (UDP GLUCURONOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1) (EG, DRUG METABOLISM, HEREDITARY UNCONJUGATED HYPERBILIRUBINEMIA [GILBERT SYNDROME]) GENE ANALYSIS, COMMON VARIANTS (EG, *28, *36, *37)
								</td>
							</tr>
							<tr>
								<td>
									81355
								</td>
								<td>
									VKORC1 (VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1) (EG, WARFARIN METABOLISM), GENE ANALYSIS, COMMON VARIANT(S) (EG, -1639G&gt;A, C.173+1000C&gt;T)
								</td>
							</tr>
							<tr>
								<td>
									<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aHcpcsRange system-link no-click log-click" data-page-action="Clicked on aHcpcsRange for 81361 - 81364 in Group 3" id="56199|108|81361|81364|81361|81364|3|N">81361 - 81364</a>
								</td>
								<td>
									HBB (HEMOGLOBIN, SUBUNIT BETA) (EG, SICKLE CELL ANEMIA, BETA THALASSEMIA, HEMOGLOBINOPATHY); COMMON VARIANT(S) (EG, HBS, HBC, HBE) - HBB (HEMOGLOBIN, SUBUNIT BETA) (EG, SICKLE CELL ANEMIA, BETA THALASSEMIA, HEMOGLOBINOPATHY); FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81410
								</td>
								<td>
									AORTIC DYSFUNCTION OR DILATION (EG, MARFAN SYNDROME, LOEYS DIETZ SYNDROME, EHLER DANLOS SYNDROME TYPE IV, ARTERIAL TORTUOSITY SYNDROME); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 9 GENES, INCLUDING FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, AND MYLK
								</td>
							</tr>
							<tr>
								<td>
									81411
								</td>
								<td>
									AORTIC DYSFUNCTION OR DILATION (EG, MARFAN SYNDROME, LOEYS DIETZ SYNDROME, EHLER DANLOS SYNDROME TYPE IV, ARTERIAL TORTUOSITY SYNDROME); DUPLICATION/DELETION ANALYSIS PANEL, MUST INCLUDE ANALYSES FOR TGFBR1, TGFBR2, MYH11, AND COL3A1
								</td>
							</tr>
							<tr>
								<td>
									81412
								</td>
								<td>
									ASHKENAZI JEWISH ASSOCIATED DISORDERS (EG, BLOOM SYNDROME, CANAVAN DISEASE, CYSTIC FIBROSIS, FAMILIAL DYSAUTONOMIA, FANCONI ANEMIA GROUP C, GAUCHER DISEASE, TAY-SACHS DISEASE), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 9 GENES, INCLUDING ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, AND SMPD1
								</td>
							</tr>
							<tr>
								<td>
									81413
								</td>
								<td>
									CARDIAC ION CHANNELOPATHIES (EG, BRUGADA SYNDROME, LONG QT SYNDROME, SHORT QT SYNDROME, CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 10 GENES, INCLUDING ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, AND SCN5A
								</td>
							</tr>
							<tr>
								<td>
									81414
								</td>
								<td>
									CARDIAC ION CHANNELOPATHIES (EG, BRUGADA SYNDROME, LONG QT SYNDROME, SHORT QT SYNDROME, CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA); DUPLICATION/DELETION GENE ANALYSIS PANEL, MUST INCLUDE ANALYSIS OF AT LEAST 2 GENES, INCLUDING KCNH2 AND KCNQ1
								</td>
							</tr>
							<tr>
								<td>
									81415
								</td>
								<td>
									EXOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81416
								</td>
								<td>
									EXOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); SEQUENCE ANALYSIS, EACH COMPARATOR EXOME (EG, PARENTS, SIBLINGS) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)
								</td>
							</tr>
							<tr>
								<td>
									81417
								</td>
								<td>
									EXOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); RE-EVALUATION OF PREVIOUSLY OBTAINED EXOME SEQUENCE (EG, UPDATED KNOWLEDGE OR UNRELATED CONDITION/SYNDROME)
								</td>
							</tr>
							<tr>
								<td>
									81420
								</td>
								<td>
									FETAL CHROMOSOMAL ANEUPLOIDY (EG, TRISOMY 21, MONOSOMY X) GENOMIC SEQUENCE ANALYSIS PANEL, CIRCULATING CELL-FREE FETAL DNA IN MATERNAL BLOOD, MUST INCLUDE ANALYSIS OF CHROMOSOMES 13, 18, AND 21
								</td>
							</tr>
							<tr>
								<td>
									81422
								</td>
								<td>
									FETAL CHROMOSOMAL MICRODELETION(S) GENOMIC SEQUENCE ANALYSIS (EG, DIGEORGE SYNDROME, CRI-DU-CHAT SYNDROME), CIRCULATING CELL-FREE FETAL DNA IN MATERNAL BLOOD
								</td>
							</tr>
							<tr>
								<td>
									81425
								</td>
								<td>
									GENOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); SEQUENCE ANALYSIS
								</td>
							</tr>
							<tr>
								<td>
									81426
								</td>
								<td>
									GENOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); SEQUENCE ANALYSIS, EACH COMPARATOR GENOME (EG, PARENTS, SIBLINGS) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)
								</td>
							</tr>
							<tr>
								<td>
									81427
								</td>
								<td>
									GENOME (EG, UNEXPLAINED CONSTITUTIONAL OR HERITABLE DISORDER OR SYNDROME); RE-EVALUATION OF PREVIOUSLY OBTAINED GENOME SEQUENCE (EG, UPDATED KNOWLEDGE OR UNRELATED CONDITION/SYNDROME)
								</td>
							</tr>
							<tr>
								<td>
									81430
								</td>
								<td>
									HEARING LOSS (EG, NONSYNDROMIC HEARING LOSS, USHER SYNDROME, PENDRED SYNDROME); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 60 GENES, INCLUDING CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, AND WFS1
								</td>
							</tr>
							<tr>
								<td>
									81431
								</td>
								<td>
									HEARING LOSS (EG, NONSYNDROMIC HEARING LOSS, USHER SYNDROME, PENDRED SYNDROME); DUPLICATION/DELETION ANALYSIS PANEL, MUST INCLUDE COPY NUMBER ANALYSES FOR STRC AND DFNB1 DELETIONS IN GJB2 AND GJB6 GENES
								</td>
							</tr>
							<tr>
								<td>
									81432
								</td>
								<td>
									HEREDITARY BREAST CANCER-RELATED DISORDERS (EG, HEREDITARY BREAST CANCER, HEREDITARY OVARIAN CANCER, HEREDITARY ENDOMETRIAL CANCER); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 10 GENES, ALWAYS INCLUDING BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, AND TP53
								</td>
							</tr>
							<tr>
								<td>
									81433
								</td>
								<td>
									HEREDITARY BREAST CANCER-RELATED DISORDERS (EG, HEREDITARY BREAST CANCER, HEREDITARY OVARIAN CANCER, HEREDITARY ENDOMETRIAL CANCER); DUPLICATION/DELETION ANALYSIS PANEL, MUST INCLUDE ANALYSES FOR BRCA1, BRCA2, MLH1, MSH2, AND STK11
								</td>
							</tr>
							<tr>
								<td>
									81434
								</td>
								<td>
									HEREDITARY RETINAL DISORDERS (EG, RETINITIS PIGMENTOSA, LEBER CONGENITAL AMAUROSIS, CONE-ROD DYSTROPHY), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 15 GENES, INCLUDING ABCA4, CNGA1, CRB1, EYS, PDE6A, PDE6B, PRPF31, PRPH2, RDH12, RHO, RP1, RP2, RPE65, RPGR, AND USH2A
								</td>
							</tr>
							<tr>
								<td>
									81435
								</td>
								<td>
									HEREDITARY COLON CANCER DISORDERS (EG, LYNCH SYNDROME, PTEN HAMARTOMA SYNDROME, COWDEN SYNDROME, FAMILIAL ADENOMATOSIS POLYPOSIS); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 10 GENES, INCLUDING APC, BMPR1A, CDH1, MLH1, MSH2, MSH6, MUTYH, PTEN, SMAD4, AND STK11
								</td>
							</tr>
							<tr>
								<td>
									81436
								</td>
								<td>
									HEREDITARY COLON CANCER DISORDERS (EG, LYNCH SYNDROME, PTEN HAMARTOMA SYNDROME, COWDEN SYNDROME, FAMILIAL ADENOMATOSIS POLYPOSIS); DUPLICATION/DELETION ANALYSIS PANEL, MUST INCLUDE ANALYSIS OF AT LEAST 5 GENES, INCLUDING MLH1, MSH2, EPCAM, SMAD4, AND STK11
								</td>
							</tr>
							<tr>
								<td>
									81437
								</td>
								<td>
									HEREDITARY NEUROENDOCRINE TUMOR DISORDERS (EG, MEDULLARY THYROID CARCINOMA, PARATHYROID CARCINOMA, MALIGNANT PHEOCHROMOCYTOMA OR PARAGANGLIOMA); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 6 GENES, INCLUDING MAX, SDHB, SDHC, SDHD, TMEM127, AND VHL
								</td>
							</tr>
							<tr>
								<td>
									81438
								</td>
								<td>
									HEREDITARY NEUROENDOCRINE TUMOR DISORDERS (EG, MEDULLARY THYROID CARCINOMA, PARATHYROID CARCINOMA, MALIGNANT PHEOCHROMOCYTOMA OR PARAGANGLIOMA); DUPLICATION/DELETION ANALYSIS PANEL, MUST INCLUDE ANALYSES FOR SDHB, SDHC, SDHD, AND VHL
								</td>
							</tr>
							<tr>
								<td>
									81439
								</td>
								<td>
									HEREDITARY CARDIOMYOPATHY (EG, HYPERTROPHIC CARDIOMYOPATHY, DILATED CARDIOMYOPATHY, ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 5 CARDIOMYOPATHY-RELATED GENES (EG, DSG2, MYBPC3, MYH7, PKP2, TTN)
								</td>
							</tr>
							<tr>
								<td>
									81440
								</td>
								<td>
									NUCLEAR ENCODED MITOCHONDRIAL GENES (EG, NEUROLOGIC OR MYOPATHIC PHENOTYPES), GENOMIC SEQUENCE PANEL, MUST INCLUDE ANALYSIS OF AT LEAST 100 GENES, INCLUDING BCS1L, C10ORF2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, AND TYMP
								</td>
							</tr>
							<tr>
								<td>
									81442
								</td>
								<td>
									NOONAN SPECTRUM DISORDERS (EG, NOONAN SYNDROME, CARDIO-FACIO-CUTANEOUS SYNDROME, COSTELLO SYNDROME, LEOPARD SYNDROME, NOONAN-LIKE SYNDROME), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 12 GENES, INCLUDING BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, AND SOS1
								</td>
							</tr>
							<tr>
								<td>
									81443
								</td>
								<td>
									GENETIC TESTING FOR SEVERE INHERITED CONDITIONS (EG, CYSTIC FIBROSIS, ASHKENAZI JEWISH-ASSOCIATED DISORDERS [EG, BLOOM SYNDROME, CANAVAN DISEASE, FANCONI ANEMIA TYPE C, MUCOLIPIDOSIS TYPE VI, GAUCHER DISEASE, TAY-SACHS DISEASE], BETA HEMOGLOBINOPATHIES, PHENYLKETONURIA, GALACTOSEMIA), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 15 GENES (EG, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)
								</td>
							</tr>
							<tr>
								<td>
									81448
								</td>
								<td>
									HEREDITARY PERIPHERAL NEUROPATHIES (EG, CHARCOT-MARIE-TOOTH, SPASTIC PARAPLEGIA), GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 5 PERIPHERAL NEUROPATHY-RELATED GENES (EG, BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1)
								</td>
							</tr>
							<tr>
								<td>
									81460
								</td>
								<td>
									WHOLE MITOCHONDRIAL GENOME (EG, LEIGH SYNDROME, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES [MELAS], MYOCLONIC EPILEPSY WITH RAGGED-RED FIBERS [MERFF], NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA [NARP], LEBER HEREDITARY OPTIC NEUROPATHY [LHON]), GENOMIC SEQUENCE, MUST INCLUDE SEQUENCE ANALYSIS OF ENTIRE MITOCHONDRIAL GENOME WITH HETEROPLASMY DETECTION
								</td>
							</tr>
							<tr>
								<td>
									81465
								</td>
								<td>
									WHOLE MITOCHONDRIAL GENOME LARGE DELETION ANALYSIS PANEL (EG, KEARNS-SAYRE SYNDROME, CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA), INCLUDING HETEROPLASMY DETECTION, IF PERFORMED
								</td>
							</tr>
							<tr>
								<td>
									81470
								</td>
								<td>
									X-LINKED INTELLECTUAL DISABILITY (XLID) (EG, SYNDROMIC AND NON-SYNDROMIC XLID); GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE SEQUENCING OF AT LEAST 60 GENES, INCLUDING ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, AND SLC16A2
								</td>
							</tr>
							<tr>
								<td>
									81471
								</td>
								<td>
									X-LINKED INTELLECTUAL DISABILITY (XLID) (EG, SYNDROMIC AND NON-SYNDROMIC XLID); DUPLICATION/DELETION GENE ANALYSIS, MUST INCLUDE ANALYSIS OF AT LEAST 60 GENES, INCLUDING ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, AND SLC16A2
								</td>
							</tr>
							<tr>
								<td>
									81493
								</td>
								<td>
									CORONARY ARTERY DISEASE, MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 23 GENES, UTILIZING WHOLE PERIPHERAL BLOOD, ALGORITHM REPORTED AS A RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81500
								</td>
								<td>
									ONCOLOGY (OVARIAN), BIOCHEMICAL ASSAYS OF TWO PROTEINS (CA-125 AND HE4), UTILIZING SERUM, WITH MENOPAUSAL STATUS, ALGORITHM REPORTED AS A RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81503
								</td>
								<td>
									ONCOLOGY (OVARIAN), BIOCHEMICAL ASSAYS OF FIVE PROTEINS (CA-125, APOLIPOPROTEIN A1, BETA-2 MICROGLOBULIN, TRANSFERRIN, AND PRE-ALBUMIN), UTILIZING SERUM, ALGORITHM REPORTED AS A RISK SCORE
								</td>
							</tr>
							<tr>
								<td>
									81504
								</td>
								<td>
									ONCOLOGY (TISSUE OF ORIGIN), MICROARRAY GENE EXPRESSION PROFILING OF &gt; 2000 GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS TISSUE SIMILARITY SCORES
								</td>
							</tr>
							<tr>
								<td>
									81507
								</td>
								<td>
									FETAL ANEUPLOIDY (TRISOMY 21, 18, AND 13) DNA SEQUENCE ANALYSIS OF SELECTED REGIONS USING MATERNAL PLASMA, ALGORITHM REPORTED AS A RISK SCORE FOR EACH TRISOMY
								</td>
							</tr>
							<tr>
								<td>
									81521
								</td>
								<td>
									ONCOLOGY (BREAST), MRNA, MICROARRAY GENE EXPRESSION PROFILING OF 70 CONTENT GENES AND 465 HOUSEKEEPING GENES, UTILIZING FRESH FROZEN OR FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS INDEX RELATED TO RISK OF DISTANT METASTASIS
								</td>
							</tr>
							<tr>
								<td>
									81525
								</td>
								<td>
									ONCOLOGY (COLON), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 12 GENES (7 CONTENT AND 5 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS A RECURRENCE SCORE
								</td>
							</tr>
							<tr>
								<td>
									81535
								</td>
								<td>
									ONCOLOGY (GYNECOLOGIC), LIVE TUMOR CELL CULTURE AND CHEMOTHERAPEUTIC RESPONSE BY DAPI STAIN AND MORPHOLOGY, PREDICTIVE ALGORITHM REPORTED AS A DRUG RESPONSE SCORE; FIRST SINGLE DRUG OR DRUG COMBINATION
								</td>
							</tr>
							<tr>
								<td>
									81536
								</td>
								<td>
									ONCOLOGY (GYNECOLOGIC), LIVE TUMOR CELL CULTURE AND CHEMOTHERAPEUTIC RESPONSE BY DAPI STAIN AND MORPHOLOGY, PREDICTIVE ALGORITHM REPORTED AS A DRUG RESPONSE SCORE; EACH ADDITIONAL SINGLE DRUG OR DRUG COMBINATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)
								</td>
							</tr>
							<tr>
								<td>
									81538
								</td>
								<td>
									ONCOLOGY (LUNG), MASS SPECTROMETRIC 8-PROTEIN SIGNATURE, INCLUDING AMYLOID A, UTILIZING SERUM, PROGNOSTIC AND PREDICTIVE ALGORITHM REPORTED AS GOOD VERSUS POOR OVERALL SURVIVAL
								</td>
							</tr>
							<tr>
								<td>
									81540
								</td>
								<td>
									ONCOLOGY (TUMOR OF UNKNOWN ORIGIN), MRNA, GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 92 GENES (87 CONTENT AND 5 HOUSEKEEPING) TO CLASSIFY TUMOR INTO MAIN CANCER TYPE AND SUBTYPE, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS A PROBABILITY OF A PREDICTED MAIN CANCER TYPE AND SUBTYPE
								</td>
							</tr>
							<tr>
								<td>
									81541
								</td>
								<td>
									ONCOLOGY (PROSTATE), MRNA GENE EXPRESSION PROFILING BY REAL-TIME RT-PCR OF 46 GENES (31 CONTENT AND 15 HOUSEKEEPING), UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS A DISEASE-SPECIFIC MORTALITY RISK SCORE
								</td>
							</tr>
					</tbody>
				</table>

		</div>
	</div>
	<div id="divHcpcsCodesGroup4" class="document-view-code-group-section">
		<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcsCodesGroup4">
			<h4 class="document-view-code-group-title d-inline">Group 4</h4>
			<span id="lblTotalHcpcsCodes" class="document-view-section-text" style="margin-left: 7px;">(10 Codes)</span>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup4Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup4Chevron"></i> --></div>
		</div>

		<div id="divHcpcsCodesGroup4Fields" class="document-view-code-group-fields hcpcs-code-group-fields d-print-block">
			<span class="document-view-section-subheader">Group 4 Paragraph</span>
			<span class="document-view-section-text"><p></p><p style="line-height: normal;"><strong><u>Tier 2 CPT and NOC Codes</u></strong></p>
<p style="line-height: normal;">Refer to indications and Limitations of Coverage section (L35000).</p>
<p style="line-height: normal;"><strong><u>Tier 2/NOC Covered Code/Gene Combinations</u></strong></p>
<p style="line-height: normal;">Limited coverage may be provided for specific genes reported below:</p>
<p style="line-height: normal;"><strong>81400</strong> ACE, F13B, F5, F7, FGB</p>
<p style="line-height: normal;"><strong>81401</strong> CBFB-MYH11, E2A/PBX1, EML4-ALK, ETV6-RUNX1, EWSR1/ERG, EWSR1/FLI1, EWSR1/WT1, F11coagulation factor XI, FIP1L1-PDGFR, FOXO1/PAX3, FOXO1/PAX7, MUTYH (mutY homolog [E.coli]), NPM/ALK, PAX8/PPARG, RUNX1/RUNX1T1</p>
<p style="line-height: normal;"><strong>81403</strong> F8 (coagulation factor VIII), VHL (von Hippel-Lindau tumor suppressor)</p>
<p style="line-height: normal;"><strong>81404</strong> CDKN2A (cyclin-dependent kinase inhibitor 2A), PRSS1 (protease, serine, 1 [trypsin 1]), MEN1 (multiple endocrine neoplasia 1) (eg, multiple endocrine neoplasia type 1, Wermer syndrome), duplication/deletion, TP53 (tumor protein 53) (e.g. tumor samples), targeted sequence analysis of 2-5 exons, VHL (von Hippel-Lindau tumor suppressor)</p>
<p style="line-height: normal;"><strong>81405</strong> TP53 (tumor protein 53) (e.g. Li-Fraumeni syndrome, tumor samples), full gene sequence or targeted sequence analysis of &gt;5 exons,</p>
<p style="line-height: normal;"><strong>81406</strong> ATP7B (ATPase, Cu++ transporting, beta polypeptide)</p>
<p style="line-height: normal;"><strong><u>Tier 2/NOC Individual Review Code/Gene Combinations</u></strong></p>
<p style="line-height: normal;">Any genetic test reported with a Tier 2 CPT code, not listed above or below, is subject to individual review.</p>
<p style="line-height: normal;"><strong><u>Tier 2/NOC Non-covered Code/Gene Combinations</u></strong></p>
<p style="line-height: normal;">The following individual Tier 2 genetic tests are unlikely to impact therapeutic decision-making, directly impact treatment, outcome and/or clinical management in the care of the beneficiary and will be denied as not medically necessary (Please note that this list of non-covered genes is not exhaustive, and the fact that a specific gene is not mentioned does not mean it is covered. In addition, many genes have several names that are used. The most common names have been used in this article):</p>
<p style="line-height: normal;"><strong>81400 </strong>ABCC8, ACADM, AGTR1, CCR5, CLRN1, DYT1 (TOR1A), FGFR3, IL28B, IVD, TOR1A</p>
<p style="line-height: normal;"><strong>81401</strong> ADRB2, APOE, ATN1, CFH/ARMS2, DEK/NUP214, FGFR3, GALT (galactose-1-phosphate uridylyltransferase), H19, KCNQ10T1 (KCNQ1 overlapping transcript 1), MEG3/DLK1, MLL/AFF, MT-ATP6, MT-ND4, MT-ND6, MT-ND5 mitochondrially encoded tRNA leucine 1 [UUA/G] mitochondrially encoded NADH dehydrogenase 5), MT-RNR1 (mitochondrially encoded 12S RNA), MT-TK (mitochondrially encoded tRNA lysine), MT-TL1, MT-TS1, PRSS1 (protease, serine, 1 [trypsin 1])</p>
<p style="line-height: normal;"><strong>81402</strong> CYP21A2, Chromosome 18q-, MEFV (Mediterranean fever) (eg, familial Mediterranean fever), TRD 81402 Uniparental disomy (UPD)</p>
<p style="line-height: normal;"><strong>81403</strong> ANG (angiogenin, ribonuclease, RNase A family, 5), FGFR3 (fibroblast growth factor receptor 3) one exon, GJB1 (gap junction protein, beta 1) (eg, Charcot-Marie-Tooth X-linked), full gene sequence, HRAS (v-Ha-ras Harvey rat sarcoma viral oncogene homolog Costello syndrome), MT-RNR1 (mitochondrially encoded 12S RNA), MT-TS1 (mitochondrially encoded tRNA serine 1)</p>
<p style="line-height: normal;"><strong>81404</strong> ACADS (acyl-CoA dehydrogenase), AQP2 (aquaporin 2 [collecting duct]), ARX (aristaless related homeobox), BTD (biotinidase), CAV3 (caveolin 3) (eg, CAV3-related distal myopathy, limb-girdle muscular dystrophy type 1C), full gene sequence, CLRN1 (clarin 1), CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1), EGR2 (early growth response 2) (eg, Charcot-Marie-Tooth), FGFR2 (fibroblast growth factor receptor 2) (2 EXONS), FGFR3 (fibroblast growth factor receptor 3) (4 EXONS), FKRP (Fukutin related protein), FOXG1 (forkhead box G1), FSHMD1A (facioscapulohumeral muscular dystrophy 1A), FSHMD1A (facioscapulohumeral muscular dystrophy 1A), HNF1B (HNF1 homeobox B), HRAS (v-Ha-ras Harvey rat sarcoma viral oncogene homolog), KCNJ10 (potassium inwardly-rectifying channel, subfamily J, member 10), SLC25A4 (solute carrier family 25 [mitochondrial carrier; adenine nucleotide translocation], VWF (von Willebrand factor)</p>
<p style="line-height: normal;"><strong>81405</strong> CASR (CAR, EIG8, extracellular calcium-sensing receptor, FHH, FIH, GPRC2A, HHC, HHC1, NSHPT, PCAR1), CYP21A2 (cytochrome P450, family 21, subfamily A, polypeptide2), MPZ (myelin protein zero)</p>
<p style="line-height: normal;"><strong>81406</strong> ACADVL (acyl-CoA dehydrogenase, very long chain), CBS (cystathionine-beta-synthase), CDKL5 (cyclin-dependent kinase-like 5) DLAT (dihydrolipoamide S-acetyltransferase), DLD (dihydrolipoamide dehydrogenase), F8 (coagulation factor VIII), GALT (galactose-1-phosphate uridylyltransferase), HADHA (hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase [trifunctional protein] alpha subunit), HEXA (hexosaminidase A, alpha polypeptide), LMNA (lamin A/C), MUTYH (mutY homolog [E. coli]), NF2 (neurofibromin 2 [merlin]), NSD1 (nuclear receptor binding SET domain protein 1), PAH (phenylalanine hydroxylase), PAX2 (paired box 2), PDHA1 (pyruvate dehydrogenase [lipoamide] alpha1), POLG (polymerase [DNA directed], gamma), PRKAG2 (protein kinase, AMP-activated, gamma 2 non-catalytic subunit), PTPN11 (protein tyrosine phosphatase, non-receptor type 11), RET (ret-proto-oncogene) (eg, Hirschsprung disease), full gene sequence, SLC9A6 (solute carrier family 9 [sodium/hydrogen exchanger] member 6), SOS1 (son of sevenless homolog 1), TAZ (tafazzin), TSC1 (tuberous sclerosis 1), TSC2 (tuberous sclerosis 2), UBE3A (ubiquitin protein ligase)</p>
<p style="line-height: normal;"><strong>81407</strong> Level 8 Molecular Pathology Procedures, F8 (coagulation factor VIII)</p>
<p style="line-height: normal;"><strong>81408</strong> Level 9 Molecular Pathology Procedures</p>
<p style="line-height: normal;"><strong>81479</strong> PIK3C, PI3Ks, PI(3)Ks, PI-3Ks, AKT1, MEK1, VEGFR2 (CD309, FLK1, VEGFR), LPA intron 25 genotype, KIF6, SPG4, C9orf72, MLH1, AIRE (APSI), SDA2, HAX1 (HAX1_HUMAN, HCLS1- associated protein X-1, HCLSBP1, HS1-associating protein X-1, HS1 binding protein, HS1-binding protein 1, HS1BP1, HSP1BP-1)</p>
<p><strong>Note:</strong> When a panel with greater than one or less than five genes is ordered, use the corresponding existing panel CPT code or CPT code 81479 if none exists.</p><p></p></span>

			<span class="document-view-section-subheader">Group 4 Codes</span>

				<table id="gdvHcpcsCodes4" class="table table-striped table-lg" summary="The CPT/HCPCS Code data">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody>
							<tr>
								<td>
									81400
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 1 (EG, IDENTIFICATION OF SINGLE GERMLINE VARIANT [EG, SNP] BY TECHNIQUES SUCH AS RESTRICTION ENZYME DIGESTION OR MELT CURVE ANALYSIS)
								</td>
							</tr>
							<tr>
								<td>
									81401
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 2 (EG, 2-10 SNPS, 1 METHYLATED VARIANT, OR 1 SOMATIC VARIANT [TYPICALLY USING NONSEQUENCING TARGET VARIANT ANALYSIS], OR DETECTION OF A DYNAMIC MUTATION DISORDER/TRIPLET REPEAT)
								</td>
							</tr>
							<tr>
								<td>
									81402
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 3 (EG, &gt;10 SNPS, 2-10 METHYLATED VARIANTS, OR 2-10 SOMATIC VARIANTS [TYPICALLY USING NON-SEQUENCING TARGET VARIANT ANALYSIS], IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE REARRANGEMENTS, DUPLICATION/DELETION VARIANTS OF 1 EXON, LOSS OF HETEROZYGOSITY [LOH], UNIPARENTAL DISOMY [UPD])
								</td>
							</tr>
							<tr>
								<td>
									81403
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 4 (EG, ANALYSIS OF SINGLE EXON BY DNA SEQUENCE ANALYSIS, ANALYSIS OF &gt;10 AMPLICONS USING MULTIPLEX PCR IN 2 OR MORE INDEPENDENT REACTIONS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF 2-5 EXONS)
								</td>
							</tr>
							<tr>
								<td>
									81404
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 5 (EG, ANALYSIS OF 2-5 EXONS BY DNA SEQUENCE ANALYSIS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF 6-10 EXONS, OR CHARACTERIZATION OF A DYNAMIC MUTATION DISORDER/TRIPLET REPEAT BY SOUTHERN BLOT ANALYSIS) UGT1A1 (UDP GLUCURONOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1) (EG, HEREDITARY UNCONJUGATED HYPERBILIRUBINEMIA [CRIGLER-NAJJAR SYNDROME]) FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81405
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 6 (EG, ANALYSIS OF 6-10 EXONS BY DNA SEQUENCE ANALYSIS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF 11-25 EXONS, REGIONALLY TARGETED CYTOGENOMIC ARRAY ANALYSIS)
								</td>
							</tr>
							<tr>
								<td>
									81406
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 7 (EG, ANALYSIS OF 11-25 EXONS BY DNA SEQUENCE ANALYSIS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF 26-50 EXONS, CYTOGENOMIC ARRAY ANALYSIS FOR NEOPLASIA)
								</td>
							</tr>
							<tr>
								<td>
									81407
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 8 (EG, ANALYSIS OF 26-50 EXONS BY DNA SEQUENCE ANALYSIS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF &gt;50 EXONS, SEQUENCE ANALYSIS OF MULTIPLE GENES ON ONE PLATFORM) APOB (APOLIPOPROTEIN B) (EG, FAMILIAL HYPERCHOLESTEROLEMIA TYPE B) FULL GENE SEQUENCE
								</td>
							</tr>
							<tr>
								<td>
									81408
								</td>
								<td>
									MOLECULAR PATHOLOGY PROCEDURE, LEVEL 9 (EG, ANALYSIS OF &gt;50 EXONS IN A SINGLE GENE BY DNA SEQUENCE ANALYSIS)
								</td>
							</tr>
							<tr>
								<td>
									81479
								</td>
								<td>
									UNLISTED MOLECULAR PATHOLOGY PROCEDURE
								</td>
							</tr>
					</tbody>
				</table>

		</div>
	</div>
	<div id="divHcpcsCodesGroup5" class="document-view-code-group-section">
		<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcsCodesGroup5">
			<h4 class="document-view-code-group-title d-inline">Group 5</h4>
			<span id="lblTotalHcpcsCodes" class="document-view-section-text" style="margin-left: 7px;">(1 Code)</span>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup5Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-code-group-chevron" id="iHcpcsCodesGroup5Chevron"></i> --></div>
		</div>

		<div id="divHcpcsCodesGroup5Fields" class="document-view-code-group-fields hcpcs-code-group-fields d-print-block">
			<span class="document-view-section-subheader">Group 5 Paragraph</span>
			<span class="document-view-section-text"><p></p><p style="line-height: normal;">The following PLA codes in Group 5 below are unlikely to impact therapeutic decision-making in the clinical management of the patient and will be denied automatically as not medically necessary:</p><p></p></span>

			<span class="document-view-section-subheader">Group 5 Codes</span>

				<table id="gdvHcpcsCodes5" class="table table-striped table-lg" summary="The CPT/HCPCS Code data">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody>
							<tr>
								<td>
									0119U
								</td>
								<td>
									CARDIOLOGY, CERAMIDES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, PLASMA, QUANTITATIVE REPORT WITH RISK SCORE FOR MAJOR CARDIOVASCULAR EVENTS
								</td>
							</tr>
					</tbody>
				</table>

		</div>
	</div>
</div>

				<span id="lblHcpcsCodes" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divHcpcModifiersTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divHcpcModifiers" class="document-view-section-code-field ">
				<h3 id="h3HcpcModifiersHeader" class="document-view-section-header">CPT/HCPCS Modifiers</h3>

				<div id="divHcpcModifiersExpandCollapse" class="py-3 w-100 text-right d-print-none ">
					<a href="#" id="aExpandAllHcpcModifiers" class="no-link log-click" data-page-action="Clicked the Expand All CPT/HCPCS Modifiers groups link">Expand All</a> |
					<a href="#" id="aCollapseAllHcpcModifiers" class="no-link log-click" data-page-action="Clicked the Collapse All CPT/HCPCS Modifiers groups link">Collapse All</a>
				</div>

				<div id="rptHcpcModifierGroups" class="">
							<div id="divHcpcModifiersGroup1" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="HcpcModifiersGroup1" title="Expand/Collapse the Group 1 (1 Code) section" data-page-action="Clicked to Expand/Collapse the Group 1 (1 Code) section.">
									<h4 class="document-view-code-group-title d-inline">Group 1</h4>
									<span id="lblTotalHcpcModifierCodes" class="document-view-section-text" style="margin-left: 7px;">(1 Code)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron hcpcs-modifier-code-group-chevron" id="iHcpcModifiersGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron hcpcs-modifier-code-group-chevron" id="iHcpcModifiersGroup1Chevron"></i> --></div>
								</div>

								<div id="divHcpcModifiersGroup1Fields" class="document-view-code-group-fields hcpcs-modifier-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 1 Paragraph</span>
									<span class="document-view-section-text"><p>The 91 modifier is used for laboratory tests paid under the clinical laboratory fee schedule, as stated in the Medicare Claims Processing Manual Chapter 16, Laboratory Services Section 100.5.1.<br><br></p></span>

									<span class="document-view-section-subheader">Group 1 Codes</span>

										<table id="gdvHcpcModifiers1" class="table table-striped table-lg" summary="CPT/HCPCS Modifiers data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															91
														</td>
														<td>
															REPEAT CLINICAL DIAGNOSTIC LABORATORY TEST: IN THE COURSE OF TREATMENT OF THE PATIENT, IT MAY BE NECESSARY TO REPEAT THE SAME LABORATORY TEST ON THE SAME DAY TO OBTAIN SUBSEQUENT (MULTIPLE) TEST RESULTS. UNDER THESE CIRCUMSTANCES, THE LABORATORY TEST PERFORMED CAN BE IDENTIFIED BY ITS USUAL PROCEDURE NUMBER AND THE ADDITION OF THE MODIFIER '-91'. NOTE: THIS MODIFIER MAY NOT BE USED WHEN TESTS ARE RERUN TO CONFIRM INITIAL RESULTS; DUE TO TESTING PROBLEMS WITH SPECIMENS OR EQUIPMENT; OR FOR ANY OTHER REASON WHEN A NORMAL, ONE-TIME, REPORTABLE RESULT IS ALL THAT IS REQUIRED. THIS MODIFIER MAY NOT BE USED WHEN OTHER CODE(S) DESCRIBE A SERIES OF TEST RESULTS (E.G., GLUCOSE TOLERANCE TESTS, EVOCATIVE/SUPPRESSION TESTING). THIS MODIFIER MAY ONLY BE USED FOR LABORATORY TEST(S) PERFORMED MORE THAN ONCE ON THE SAME DAY ON THE SAME PATIENT.
														</td>
													</tr>
											</tbody>
										</table>

								</div>
							</div>
				</div>

				<span id="lblHcpcModifiers" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divIcd10CoveredTop" class="w-100 document-view-section-code-field-top"></div>
			<div id="divIcd10Covered" class="document-view-section-code-field">
				<h3 id="h3Icd10CoveredHeader" class="document-view-section-header">ICD-10-CM Codes that Support Medical Necessity</h3>

				<div id="divIcd10CoveredExpandCollapse" class="py-3 w-100 text-right d-print-none ">
					<a href="#" id="aExpandAllIcd10Covered" class="no-link log-click" data-page-action="Clicked the Expand All ICD-10 Support groups link">Expand All</a> |
					<a href="#" id="aCollapseAllIcd10Covered" class="no-link log-click" data-page-action="Clicked the Collapse All ICD-10 Support groups link">Collapse All</a>
				</div>

				<div id="rptIcd10CoveredGroups" class="">
							<div id="divIcd10CoveredGroup1" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup1" title="Expand/Collapse the Group 1 (78 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 1 (78 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 1</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(78 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup1Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup1Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 1 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81162-81167, 81212, 81215, 81216, 81217 are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 1 Codes</span>

										<table id="gdvIcd10CoveredCodes1" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C25.0
														</td>
														<td>
															Malignant neoplasm of head of pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.1
														</td>
														<td>
															Malignant neoplasm of body of pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.2
														</td>
														<td>
															Malignant neoplasm of tail of pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.3
														</td>
														<td>
															Malignant neoplasm of pancreatic duct
														</td>
													</tr>
													<tr>
														<td>
															C25.4
														</td>
														<td>
															Malignant neoplasm of endocrine pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.7
														</td>
														<td>
															Malignant neoplasm of other parts of pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.8
														</td>
														<td>
															Malignant neoplasm of overlapping sites of pancreas
														</td>
													</tr>
													<tr>
														<td>
															C25.9
														</td>
														<td>
															Malignant neoplasm of pancreas, unspecified
														</td>
													</tr>
													<tr>
														<td>
															C48.1
														</td>
														<td>
															Malignant neoplasm of specified parts of peritoneum
														</td>
													</tr>
													<tr>
														<td>
															C50.011
														</td>
														<td>
															Malignant neoplasm of nipple and areola, right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.012
														</td>
														<td>
															Malignant neoplasm of nipple and areola, left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.019
														</td>
														<td>
															Malignant neoplasm of nipple and areola, unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.021
														</td>
														<td>
															Malignant neoplasm of nipple and areola, right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.022
														</td>
														<td>
															Malignant neoplasm of nipple and areola, left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.029
														</td>
														<td>
															Malignant neoplasm of nipple and areola, unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.111
														</td>
														<td>
															Malignant neoplasm of central portion of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.112
														</td>
														<td>
															Malignant neoplasm of central portion of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.119
														</td>
														<td>
															Malignant neoplasm of central portion of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.121
														</td>
														<td>
															Malignant neoplasm of central portion of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.122
														</td>
														<td>
															Malignant neoplasm of central portion of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.129
														</td>
														<td>
															Malignant neoplasm of central portion of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.211
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.212
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.219
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.221
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.222
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.229
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.311
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.312
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.319
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.321
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.322
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.329
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.411
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.412
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.419
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.421
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.422
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.429
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.511
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.512
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.519
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.521
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.522
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.529
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.611
														</td>
														<td>
															Malignant neoplasm of axillary tail of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.612
														</td>
														<td>
															Malignant neoplasm of axillary tail of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.619
														</td>
														<td>
															Malignant neoplasm of axillary tail of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.621
														</td>
														<td>
															Malignant neoplasm of axillary tail of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.622
														</td>
														<td>
															Malignant neoplasm of axillary tail of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.629
														</td>
														<td>
															Malignant neoplasm of axillary tail of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.811
														</td>
														<td>
															Malignant neoplasm of overlapping sites of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.812
														</td>
														<td>
															Malignant neoplasm of overlapping sites of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.819
														</td>
														<td>
															Malignant neoplasm of overlapping sites of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.821
														</td>
														<td>
															Malignant neoplasm of overlapping sites of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.822
														</td>
														<td>
															Malignant neoplasm of overlapping sites of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.829
														</td>
														<td>
															Malignant neoplasm of overlapping sites of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.911
														</td>
														<td>
															Malignant neoplasm of unspecified site of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.912
														</td>
														<td>
															Malignant neoplasm of unspecified site of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.919
														</td>
														<td>
															Malignant neoplasm of unspecified site of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.921
														</td>
														<td>
															Malignant neoplasm of unspecified site of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.922
														</td>
														<td>
															Malignant neoplasm of unspecified site of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.929
														</td>
														<td>
															Malignant neoplasm of unspecified site of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C56.1
														</td>
														<td>
															Malignant neoplasm of right ovary
														</td>
													</tr>
													<tr>
														<td>
															C56.2
														</td>
														<td>
															Malignant neoplasm of left ovary
														</td>
													</tr>
													<tr>
														<td>
															C56.3
														</td>
														<td>
															Malignant neoplasm of bilateral ovaries
														</td>
													</tr>
													<tr>
														<td>
															C56.9
														</td>
														<td>
															Malignant neoplasm of unspecified ovary
														</td>
													</tr>
													<tr>
														<td>
															C57.00
														</td>
														<td>
															Malignant neoplasm of unspecified fallopian tube
														</td>
													</tr>
													<tr>
														<td>
															C57.01
														</td>
														<td>
															Malignant neoplasm of right fallopian tube
														</td>
													</tr>
													<tr>
														<td>
															C57.02
														</td>
														<td>
															Malignant neoplasm of left fallopian tube
														</td>
													</tr>
													<tr>
														<td>
															C61
														</td>
														<td>
															Malignant neoplasm of prostate
														</td>
													</tr>
													<tr>
														<td>
															D05.11
														</td>
														<td>
															Intraductal carcinoma in situ of right breast
														</td>
													</tr>
													<tr>
														<td>
															D05.12
														</td>
														<td>
															Intraductal carcinoma in situ of left breast
														</td>
													</tr>
													<tr>
														<td>
															Z85.07
														</td>
														<td>
															Personal history of malignant neoplasm of pancreas
														</td>
													</tr>
													<tr>
														<td>
															Z85.3
														</td>
														<td>
															Personal history of malignant neoplasm of breast
														</td>
													</tr>
													<tr>
														<td>
															Z85.43
														</td>
														<td>
															Personal history of malignant neoplasm of ovary
														</td>
													</tr>
													<tr>
														<td>
															Z85.46
														</td>
														<td>
															Personal history of malignant neoplasm of prostate
														</td>
													</tr>
													<tr>
														<td>
															Z86.000
														</td>
														<td>
															Personal history of in-situ neoplasm of breast
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup2" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup2" title="Expand/Collapse the Group 2 (9 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 2 (9 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 2</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(9 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup2Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup2Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup2Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 2 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81170 is considered medically necessary for the following ICD-10-CM codes</p><p></p></span>

									<span class="document-view-section-subheader">Group 2 Codes</span>

										<table id="gdvIcd10CoveredCodes2" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 2" id="56199|108|C91.00|C91.02|2698|2700|2">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.10 - C92.12 in Group 2" id="56199|108|C92.10|C92.12|2739|2741|2">C92.10 - C92.12</a>
														</td>
														<td>
															Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.20 - C92.22 in Group 2" id="56199|108|C92.20|C92.22|2743|2745|2">C92.20 - C92.22</a>
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission - Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup3" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup3" title="Expand/Collapse the Group 3 (14 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 3 (14 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 3</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(14 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup3Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup3Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup3Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 3 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81206, 81207, and 81208 (BCR/ABL) are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 3 Codes</span>

										<table id="gdvIcd10CoveredCodes3" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 3" id="56199|108|C91.00|C91.02|2698|2700|3">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.10 - C92.12 in Group 3" id="56199|108|C92.10|C92.12|2739|2741|3">C92.10 - C92.12</a>
														</td>
														<td>
															Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.20 - C92.22 in Group 3" id="56199|108|C92.20|C92.22|2743|2745|3">C92.20 - C92.22</a>
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission - Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.90 - C92.92 in Group 3" id="56199|108|C92.90|C92.92|2771|2773|3">C92.90 - C92.92</a>
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission - Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															D47.3
														</td>
														<td>
															Essential (hemorrhagic) thrombocythemia
														</td>
													</tr>
													<tr>
														<td>
															D72.829
														</td>
														<td>
															Elevated white blood cell count, unspecified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup4" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup4" title="Expand/Collapse the Group 4 (93 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 4 (93 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 4</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(93 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup4Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup4Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup4Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 4 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81210 (BRAF) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 4 Codes</span>

										<table id="gdvIcd10CoveredCodes4" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C17.0 - C17.9 in Group 4" id="56199|108|C17.0|C17.9|1403|1408|4">C17.0 - C17.9</a>
														</td>
														<td>
															Malignant neoplasm of duodenum - Malignant neoplasm of small intestine, unspecified
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C18.0 - C19 in Group 4" id="56199|108|C18.0|C19|1410|1420|4">C18.0 - C19</a>
														</td>
														<td>
															Malignant neoplasm of cecum - Malignant neoplasm of rectosigmoid junction
														</td>
													</tr>
													<tr>
														<td>
															C20
														</td>
														<td>
															Malignant neoplasm of rectum
														</td>
													</tr>
													<tr>
														<td>
															C21.1
														</td>
														<td>
															Malignant neoplasm of anal canal
														</td>
													</tr>
													<tr>
														<td>
															C21.2
														</td>
														<td>
															Malignant neoplasm of cloacogenic zone
														</td>
													</tr>
													<tr>
														<td>
															C21.8
														</td>
														<td>
															Malignant neoplasm of overlapping sites of rectum, anus and anal canal
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C33 - C34.92 in Group 4" id="56199|108|C33|C34.92|1472|1494|4">C33 - C34.92</a>
														</td>
														<td>
															Malignant neoplasm of trachea - Malignant neoplasm of unspecified part of left bronchus or lung
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C43.0 - C43.9 in Group 4" id="56199|108|C43.0|C43.9|1539|1570|4">C43.0 - C43.9</a>
														</td>
														<td>
															Malignant melanoma of lip - Malignant melanoma of skin, unspecified
														</td>
													</tr>
													<tr>
														<td>
															C78.4
														</td>
														<td>
															Secondary malignant neoplasm of small intestine
														</td>
													</tr>
													<tr>
														<td>
															C78.5
														</td>
														<td>
															Secondary malignant neoplasm of large intestine and rectum
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.40 - C91.42 in Group 4" id="56199|108|C91.40|C91.42|2710|2712|4">C91.40 - C91.42</a>
														</td>
														<td>
															Hairy cell leukemia not having achieved remission - Hairy cell leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for D03.0 - D03.9 in Group 4" id="56199|108|D03.0|D03.9|2877|2907|4">D03.0 - D03.9</a>
														</td>
														<td>
															Melanoma in situ of lip - Melanoma in situ, unspecified
														</td>
													</tr>
													<tr>
														<td>
															Z85.038
														</td>
														<td>
															Personal history of other malignant neoplasm of large intestine
														</td>
													</tr>
													<tr>
														<td>
															Z85.048
														</td>
														<td>
															Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus
														</td>
													</tr>
													<tr>
														<td>
															Z85.820
														</td>
														<td>
															Personal history of malignant melanoma of skin
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup5" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup5" title="Expand/Collapse the Group 5 (28 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 5 (28 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 5</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(28 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup5Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup5Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup5Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 5 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT Code 81218 (CEBPA) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 5 Codes</span>

										<table id="gdvIcd10CoveredCodes5" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup6" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup6" title="Expand/Collapse the Group 6 (3 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 6 (3 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 6</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(3 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup6Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup6Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup6Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 6 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81315 and 81316 PML/RARALPHA are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 6 Codes</span>

										<table id="gdvIcd10CoveredCodes6" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.40 - C92.42 in Group 6" id="56199|108|C92.40|C92.42|2751|2753|6">C92.40 - C92.42</a>
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission - Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup7" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup7" title="Expand/Collapse the Group 7 (44 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 7 (44 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 7</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(44 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup7Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup7Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup7Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 7 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81225 (CYP2C19) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 7 Codes</span>

										<table id="gdvIcd10CoveredCodes7" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															I20.0
														</td>
														<td>
															Unstable angina
														</td>
													</tr>
													<tr>
														<td>
															I20.1
														</td>
														<td>
															Angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I20.81
														</td>
														<td>
															Angina pectoris with coronary microvascular dysfunction
														</td>
													</tr>
													<tr>
														<td>
															I20.89
														</td>
														<td>
															Other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I20.9
														</td>
														<td>
															Angina pectoris, unspecified
														</td>
													</tr>
													<tr>
														<td>
															I21.11
														</td>
														<td>
															ST elevation (STEMI) myocardial infarction involving right coronary artery
														</td>
													</tr>
													<tr>
														<td>
															I21.19
														</td>
														<td>
															ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
														</td>
													</tr>
													<tr>
														<td>
															I21.29
														</td>
														<td>
															ST elevation (STEMI) myocardial infarction involving other sites
														</td>
													</tr>
													<tr>
														<td>
															I21.3
														</td>
														<td>
															ST elevation (STEMI) myocardial infarction of unspecified site
														</td>
													</tr>
													<tr>
														<td>
															I21.4
														</td>
														<td>
															Non-ST elevation (NSTEMI) myocardial infarction
														</td>
													</tr>
													<tr>
														<td>
															I24.0
														</td>
														<td>
															Acute coronary thrombosis not resulting in myocardial infarction
														</td>
													</tr>
													<tr>
														<td>
															I24.1
														</td>
														<td>
															Dressler's syndrome
														</td>
													</tr>
													<tr>
														<td>
															I24.81
														</td>
														<td>
															Acute coronary microvascular dysfunction
														</td>
													</tr>
													<tr>
														<td>
															I24.89
														</td>
														<td>
															Other forms of acute ischemic heart disease
														</td>
													</tr>
													<tr>
														<td>
															I24.9
														</td>
														<td>
															Acute ischemic heart disease, unspecified
														</td>
													</tr>
													<tr>
														<td>
															I25.110
														</td>
														<td>
															Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.118
														</td>
														<td>
															Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.119
														</td>
														<td>
															Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.700
														</td>
														<td>
															Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.701
														</td>
														<td>
															Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I25.708
														</td>
														<td>
															Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.710
														</td>
														<td>
															Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.711
														</td>
														<td>
															Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I25.718
														</td>
														<td>
															Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for I25.719 - I25.721 in Group 7" id="56199|108|I25.719|I25.721|11617|11620|7">I25.719 - I25.721</a>
														</td>
														<td>
															Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris - Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for I25.728 - I25.731 in Group 7" id="56199|108|I25.728|I25.731|11622|11626|7">I25.728 - I25.731</a>
														</td>
														<td>
															Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris - Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I25.738
														</td>
														<td>
															Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.739
														</td>
														<td>
															Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.750
														</td>
														<td>
															Atherosclerosis of native coronary artery of transplanted heart with unstable angina
														</td>
													</tr>
													<tr>
														<td>
															I25.751
														</td>
														<td>
															Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for I25.758 - I25.761 in Group 7" id="56199|108|I25.758|I25.761|11634|11638|7">I25.758 - I25.761</a>
														</td>
														<td>
															Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris - Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I25.769
														</td>
														<td>
															Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.790
														</td>
														<td>
															Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.791
														</td>
														<td>
															Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
														</td>
													</tr>
													<tr>
														<td>
															I25.798
														</td>
														<td>
															Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
														</td>
													</tr>
													<tr>
														<td>
															I25.799
														</td>
														<td>
															Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup8" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup8" title="Expand/Collapse the Group 8 (2 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 8 (2 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 8</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(2 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup8Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup8Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup8Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 8 Paragraph</span>
									<span class="document-view-section-text"><p><span style="line-height: 107%;">CPT code 81226&nbsp; (CYP2d6) is considered medically necessary for the following ICD-10-CM codes:<br></span><span style="line-height: 107%;">PLA code 0070U is effective for services, rendered on or after May 15, 2021.</span></p></span>

									<span class="document-view-section-subheader">Group 8 Codes</span>

										<table id="gdvIcd10CoveredCodes8" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															E75.22
														</td>
														<td>
															Gaucher disease
														</td>
													</tr>
													<tr>
														<td>
															G10
														</td>
														<td>
															Huntington's disease
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup9" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup9" title="Expand/Collapse the Group 9 (17 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 9 (17 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 9</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(17 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup9Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup9Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup9Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 9 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81235 (EGFR) is considered medically necessary for the following ICD-10-CM codes:</p>
<p><span style="line-height: 107%;"><br> <br> </span></p><p></p></span>

									<span class="document-view-section-subheader">Group 9 Codes</span>

										<table id="gdvIcd10CoveredCodes9" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C33 - C34.92 in Group 9" id="56199|108|C33|C34.92|1472|1494|9">C33 - C34.92</a>
														</td>
														<td>
															Malignant neoplasm of trachea - Malignant neoplasm of unspecified part of left bronchus or lung
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup10" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup10" title="Expand/Collapse the Group 10 (28 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 10 (28 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 10</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(28 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup10Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup10Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup10Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 10 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81245, 81246 (FLT3) are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 10 Codes</span>

										<table id="gdvIcd10CoveredCodes10" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup11" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup11" title="Expand/Collapse the Group 11 (5 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 11 (5 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 11</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(5 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup11Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup11Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup11Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 11 Paragraph</span>
									<span class="document-view-section-text"><p><span style="line-height: 107%;">CPT code 81256 (HFE) is considered medically necessary the following ICD-10-CM codes:<br> <br> </span></p></span>

									<span class="document-view-section-subheader">Group 11 Codes</span>

										<table id="gdvIcd10CoveredCodes11" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															E83.10
														</td>
														<td>
															Disorder of iron metabolism, unspecified
														</td>
													</tr>
													<tr>
														<td>
															E83.110
														</td>
														<td>
															Hereditary hemochromatosis
														</td>
													</tr>
													<tr>
														<td>
															E83.118
														</td>
														<td>
															Other hemochromatosis
														</td>
													</tr>
													<tr>
														<td>
															E83.119
														</td>
														<td>
															Hemochromatosis, unspecified
														</td>
													</tr>
													<tr>
														<td>
															E83.19
														</td>
														<td>
															Other disorders of iron metabolism
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup12" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup12" title="Expand/Collapse the Group 12 (230 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 12 (230 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 12</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(230 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup12Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup12Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup12Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 12 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81261-81264 (IGH) are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 12 Codes</span>

										<table id="gdvIcd10CoveredCodes12" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C82.00 - C83.99 in Group 12" id="56199|108|C82.00|C83.99|2297|2489|12">C82.00 - C83.99</a>
														</td>
														<td>
															Follicular lymphoma grade I, unspecified site - Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C85.10 - C85.99 in Group 12" id="56199|108|C85.10|C85.99|2591|2636|12">C85.10 - C85.99</a>
														</td>
														<td>
															Unspecified B-cell lymphoma, unspecified site - Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 12" id="56199|108|C91.00|C91.02|2698|2700|12">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C91.10
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.11
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in remission
														</td>
													</tr>
													<tr>
														<td>
															C91.12
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.11
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup13" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup13" title="Expand/Collapse the Group 13 (34 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 13 (34 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 13</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(34 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup13Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup13Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup13Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 13 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81270 (JAK2), 81338 (MPL), 81339 (MPL), 81279 (JAK2 exons 12 and 13), 81219 (CALR), and 0027U (JAK2 exons 12-15) are considered medically necessary for the following ICD-10-CM codes when criteria in Indications and Limitations of Coverage are met:</p><p></p></span>

									<span class="document-view-section-subheader">Group 13 Codes</span>

										<table id="gdvIcd10CoveredCodes13" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C88.80
														</td>
														<td>
															Other malignant immunoproliferative diseases not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.20
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.22
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.10
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.12
														</td>
														<td>
															Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.Z0
														</td>
														<td>
															Other monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.Z2
														</td>
														<td>
															Other monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.90
														</td>
														<td>
															Monocytic leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.92
														</td>
														<td>
															Monocytic leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.40
														</td>
														<td>
															Acute panmyelosis with myelofibrosis not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.41
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in remission
														</td>
													</tr>
													<tr>
														<td>
															C94.42
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.6
														</td>
														<td>
															Myelodysplastic disease, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.Z
														</td>
														<td>
															Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D45
														</td>
														<td>
															Polycythemia vera
														</td>
													</tr>
													<tr>
														<td>
															D47.1
														</td>
														<td>
															Chronic myeloproliferative disease
														</td>
													</tr>
													<tr>
														<td>
															D47.3
														</td>
														<td>
															Essential (hemorrhagic) thrombocythemia
														</td>
													</tr>
													<tr>
														<td>
															D47.4
														</td>
														<td>
															Osteomyelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D47.Z9
														</td>
														<td>
															Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D47.9
														</td>
														<td>
															Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.821
														</td>
														<td>
															Monocytosis (symptomatic)
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.829
														</td>
														<td>
															Elevated white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
													<tr>
														<td>
															D72.9
														</td>
														<td>
															Disorder of white blood cells, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D75.1
														</td>
														<td>
															Secondary polycythemia
														</td>
													</tr>
													<tr>
														<td>
															D75.81
														</td>
														<td>
															Myelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D75.89
														</td>
														<td>
															Other specified diseases of blood and blood-forming organs
														</td>
													</tr>
													<tr>
														<td>
															D75.9
														</td>
														<td>
															Disease of blood and blood-forming organs, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D77
														</td>
														<td>
															Other disorders of blood and blood-forming organs in diseases classified elsewhere
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup14" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup14" title="Expand/Collapse the Group 14 (101 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 14 (101 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 14</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(101 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup14Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup14Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup14Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 14 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81272 (KIT) is considered medically necessary for the following ICD-10-CM codes: CPT code 81273 (KIT) is considered medically necessary only for the diagnosis of mastocytosis.</p><p></p></span>

									<span class="document-view-section-subheader">Group 14 Codes</span>

										<table id="gdvIcd10CoveredCodes14" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C43.0 - C43.9 in Group 14" id="56199|108|C43.0|C43.9|1539|1570|14">C43.0 - C43.9</a>
														</td>
														<td>
															Malignant melanoma of lip - Malignant melanoma of skin, unspecified
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C49.A0 - C49.A9 in Group 14" id="56199|108|C49.A0|C49.A9|1807|1813|14">C49.A0 - C49.A9</a>
														</td>
														<td>
															Gastrointestinal stromal tumor, unspecified site - Gastrointestinal stromal tumor of other sites
														</td>
													</tr>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.20
														</td>
														<td>
															Malignant mast cell neoplasm, unspecified
														</td>
													</tr>
													<tr>
														<td>
															C96.21
														</td>
														<td>
															Aggressive systemic mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															C96.22
														</td>
														<td>
															Mast cell sarcoma
														</td>
													</tr>
													<tr>
														<td>
															C96.29
														</td>
														<td>
															Other malignant mast cell neoplasm
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for D03.0 - D03.9 in Group 14" id="56199|108|D03.0|D03.9|2877|2907|14">D03.0 - D03.9</a>
														</td>
														<td>
															Melanoma in situ of lip - Melanoma in situ, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D47.01
														</td>
														<td>
															Cutaneous mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															D47.02
														</td>
														<td>
															Systemic mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															D47.09
														</td>
														<td>
															Other mast cell neoplasms of uncertain behavior
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for D48.110 - D48.19 in Group 14" id="56199|108|D48.110|D48.19|3443|3453|14">D48.110 - D48.19</a>
														</td>
														<td>
															Desmoid tumor of head and neck - Other specified neoplasm of uncertain behavior of connective and other soft tissue
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															Z85.820
														</td>
														<td>
															Personal history of malignant melanoma of skin
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup15" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup15" title="Expand/Collapse the Group 15 (40 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 15 (40 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 15</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(40 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup15Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup15Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup15Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 15 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81275 and 81276 (KRAS) are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 15 Codes</span>

										<table id="gdvIcd10CoveredCodes15" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C17.0 - C17.9 in Group 15" id="56199|108|C17.0|C17.9|1403|1408|15">C17.0 - C17.9</a>
														</td>
														<td>
															Malignant neoplasm of duodenum - Malignant neoplasm of small intestine, unspecified
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C18.0 - C19 in Group 15" id="56199|108|C18.0|C19|1410|1420|15">C18.0 - C19</a>
														</td>
														<td>
															Malignant neoplasm of cecum - Malignant neoplasm of rectosigmoid junction
														</td>
													</tr>
													<tr>
														<td>
															C20
														</td>
														<td>
															Malignant neoplasm of rectum
														</td>
													</tr>
													<tr>
														<td>
															C21.1
														</td>
														<td>
															Malignant neoplasm of anal canal
														</td>
													</tr>
													<tr>
														<td>
															C21.2
														</td>
														<td>
															Malignant neoplasm of cloacogenic zone
														</td>
													</tr>
													<tr>
														<td>
															C21.8
														</td>
														<td>
															Malignant neoplasm of overlapping sites of rectum, anus and anal canal
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C33 - C34.92 in Group 15" id="56199|108|C33|C34.92|1472|1494|15">C33 - C34.92</a>
														</td>
														<td>
															Malignant neoplasm of trachea - Malignant neoplasm of unspecified part of left bronchus or lung
														</td>
													</tr>
													<tr>
														<td>
															Z85.038
														</td>
														<td>
															Personal history of other malignant neoplasm of large intestine
														</td>
													</tr>
													<tr>
														<td>
															Z85.048
														</td>
														<td>
															Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup16" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup16" title="Expand/Collapse the Group 16 (10 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 16 (10 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 16</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(10 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup16Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup16Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup16Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 16 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81287 (MGMT) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 16 Codes</span>

										<table id="gdvIcd10CoveredCodes16" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C71.0 - C71.9 in Group 16" id="56199|108|C71.0|C71.9|2043|2052|16">C71.0 - C71.9</a>
														</td>
														<td>
															Malignant neoplasm of cerebrum, except lobes and ventricles - Malignant neoplasm of brain, unspecified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup17" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup17" title="Expand/Collapse the Group 17 (40 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 17 (40 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 17</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(40 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup17Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup17Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup17Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 17 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81301 Microsatellite instability analysis (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 17 Codes</span>

										<table id="gdvIcd10CoveredCodes17" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C17.0 - C17.9 in Group 17" id="56199|108|C17.0|C17.9|1403|1408|17">C17.0 - C17.9</a>
														</td>
														<td>
															Malignant neoplasm of duodenum - Malignant neoplasm of small intestine, unspecified
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C18.0 - C19 in Group 17" id="56199|108|C18.0|C19|1410|1420|17">C18.0 - C19</a>
														</td>
														<td>
															Malignant neoplasm of cecum - Malignant neoplasm of rectosigmoid junction
														</td>
													</tr>
													<tr>
														<td>
															C20
														</td>
														<td>
															Malignant neoplasm of rectum
														</td>
													</tr>
													<tr>
														<td>
															C21.1
														</td>
														<td>
															Malignant neoplasm of anal canal
														</td>
													</tr>
													<tr>
														<td>
															C21.2
														</td>
														<td>
															Malignant neoplasm of cloacogenic zone
														</td>
													</tr>
													<tr>
														<td>
															C21.8
														</td>
														<td>
															Malignant neoplasm of overlapping sites of rectum, anus and anal canal
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C33 - C34.92 in Group 17" id="56199|108|C33|C34.92|1472|1494|17">C33 - C34.92</a>
														</td>
														<td>
															Malignant neoplasm of trachea - Malignant neoplasm of unspecified part of left bronchus or lung
														</td>
													</tr>
													<tr>
														<td>
															Z85.038
														</td>
														<td>
															Personal history of other malignant neoplasm of large intestine
														</td>
													</tr>
													<tr>
														<td>
															Z85.048
														</td>
														<td>
															Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup18" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup18" title="Expand/Collapse the Group 18 (23 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 18 (23 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 18</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(23 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup18Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup18Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup18Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 18 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT Code 81311 (NRAS) is considered medically necessary for the following ICD-10-CM codes</p><p></p></span>

									<span class="document-view-section-subheader">Group 18 Codes</span>

										<table id="gdvIcd10CoveredCodes18" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C17.0 - C17.9 in Group 18" id="56199|108|C17.0|C17.9|1403|1408|18">C17.0 - C17.9</a>
														</td>
														<td>
															Malignant neoplasm of duodenum - Malignant neoplasm of small intestine, unspecified
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C18.0 - C19 in Group 18" id="56199|108|C18.0|C19|1410|1420|18">C18.0 - C19</a>
														</td>
														<td>
															Malignant neoplasm of cecum - Malignant neoplasm of rectosigmoid junction
														</td>
													</tr>
													<tr>
														<td>
															C20
														</td>
														<td>
															Malignant neoplasm of rectum
														</td>
													</tr>
													<tr>
														<td>
															C21.1
														</td>
														<td>
															Malignant neoplasm of anal canal
														</td>
													</tr>
													<tr>
														<td>
															C21.2
														</td>
														<td>
															Malignant neoplasm of cloacogenic zone
														</td>
													</tr>
													<tr>
														<td>
															C21.8
														</td>
														<td>
															Malignant neoplasm of overlapping sites of rectum, anus and anal canal
														</td>
													</tr>
													<tr>
														<td>
															Z85.038
														</td>
														<td>
															Personal history of other malignant neoplasm of large intestine
														</td>
													</tr>
													<tr>
														<td>
															Z85.048
														</td>
														<td>
															Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup19" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup19" title="Expand/Collapse the Group 19 (24 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 19 (24 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 19</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(24 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup19Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup19Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup19Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 19 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT Code 81314 (PDGFRA only) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 19 Codes</span>

										<table id="gdvIcd10CoveredCodes19" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C49.A0 - C49.A9 in Group 19" id="56199|108|C49.A0|C49.A9|1807|1813|19">C49.A0 - C49.A9</a>
														</td>
														<td>
															Gastrointestinal stromal tumor, unspecified site - Gastrointestinal stromal tumor of other sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C92.10 - C92.12 in Group 19" id="56199|108|C92.10|C92.12|2739|2741|19">C92.10 - C92.12</a>
														</td>
														<td>
															Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C93.10 - C93.12 in Group 19" id="56199|108|C93.10|C93.12|2780|2782|19">C93.10 - C93.12</a>
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission - Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for D48.110 - D48.19 in Group 19" id="56199|108|D48.110|D48.19|3443|3453|19">D48.110 - D48.19</a>
														</td>
														<td>
															Desmoid tumor of head and neck - Other specified neoplasm of uncertain behavior of connective and other soft tissue
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup20" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup20" title="Expand/Collapse the Group 20 (1 Code) section" data-page-action="Clicked to Expand/Collapse the Group 20 (1 Code) section.">
									<h4 class="document-view-code-group-title d-inline">Group 20</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(1 Code)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup20Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup20Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup20Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 20 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81332 (SERPINA1) is considered medically necessary for the following ICD-10-CM code:</p><p></p></span>

									<span class="document-view-section-subheader">Group 20 Codes</span>

										<table id="gdvIcd10CoveredCodes20" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															E88.01
														</td>
														<td>
															Alpha-1-antitrypsin deficiency
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup21" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup21" title="Expand/Collapse the Group 21 (23 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 21 (23 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 21</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(23 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup21Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup21Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup21Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 21 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81340 (TRB@, PCR), 81341 (TRB@ Southern blot), and 81342 (TRG@) are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 21 Codes</span>

										<table id="gdvIcd10CoveredCodes21" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 21" id="56199|108|C91.00|C91.02|2698|2700|21">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C95.90 - C95.92 in Group 21" id="56199|108|C95.90|C95.92|2827|2829|21">C95.90 - C95.92</a>
														</td>
														<td>
															Leukemia, unspecified not having achieved remission - Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.20
														</td>
														<td>
															Malignant mast cell neoplasm, unspecified
														</td>
													</tr>
													<tr>
														<td>
															C96.21
														</td>
														<td>
															Aggressive systemic mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															C96.22
														</td>
														<td>
															Mast cell sarcoma
														</td>
													</tr>
													<tr>
														<td>
															C96.29
														</td>
														<td>
															Other malignant mast cell neoplasm
														</td>
													</tr>
													<tr>
														<td>
															D47.01
														</td>
														<td>
															Cutaneous mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															D47.02
														</td>
														<td>
															Systemic mastocytosis
														</td>
													</tr>
													<tr>
														<td>
															D47.09
														</td>
														<td>
															Other mast cell neoplasms of uncertain behavior
														</td>
													</tr>
													<tr>
														<td>
															D60.0
														</td>
														<td>
															Chronic acquired pure red cell aplasia
														</td>
													</tr>
													<tr>
														<td>
															D60.1
														</td>
														<td>
															Transient acquired pure red cell aplasia
														</td>
													</tr>
													<tr>
														<td>
															D60.8
														</td>
														<td>
															Other acquired pure red cell aplasias
														</td>
													</tr>
													<tr>
														<td>
															D61.01
														</td>
														<td>
															Constitutional (pure) red blood cell aplasia
														</td>
													</tr>
													<tr>
														<td>
															D61.09
														</td>
														<td>
															Other constitutional aplastic anemia
														</td>
													</tr>
													<tr>
														<td>
															D61.1
														</td>
														<td>
															Drug-induced aplastic anemia
														</td>
													</tr>
													<tr>
														<td>
															D61.2
														</td>
														<td>
															Aplastic anemia due to other external agents
														</td>
													</tr>
													<tr>
														<td>
															D61.3
														</td>
														<td>
															Idiopathic aplastic anemia
														</td>
													</tr>
													<tr>
														<td>
															D61.89
														</td>
														<td>
															Other specified aplastic anemias and other bone marrow failure syndromes
														</td>
													</tr>
													<tr>
														<td>
															D61.9
														</td>
														<td>
															Aplastic anemia, unspecified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup22" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup22" title="Expand/Collapse the Group 22 (43 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 22 (43 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 22</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(43 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup22Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup22Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup22Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 22 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81168 CCND1/IGH is considered medically necessary for patients who have non- Hodgkin’s lymphoma.</p><p></p></span>

									<span class="document-view-section-subheader">Group 22 Codes</span>

										<table id="gdvIcd10CoveredCodes22" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C85.10 - C85.99 in Group 22" id="56199|108|C85.10|C85.99|2591|2636|22">C85.10 - C85.99</a>
														</td>
														<td>
															Unspecified B-cell lymphoma, unspecified site - Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup23" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup23" title="Expand/Collapse the Group 23 (6 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 23 (6 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 23</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(6 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup23Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup23Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup23Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 23 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81404 and 81405 (RET- MEN Types 2B (81404) and 2A (81405) are considered medically necessary for the following ICD-10-CM codes: <br> </p><p></p></span>

									<span class="document-view-section-subheader">Group 23 Codes</span>

										<table id="gdvIcd10CoveredCodes23" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C73
														</td>
														<td>
															Malignant neoplasm of thyroid gland
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C74.10 - C74.12 in Group 23" id="56199|108|C74.10|C74.12|2079|2081|23">C74.10 - C74.12</a>
														</td>
														<td>
															Malignant neoplasm of medulla of unspecified adrenal gland - Malignant neoplasm of medulla of left adrenal gland
														</td>
													</tr>
													<tr>
														<td>
															C75.0
														</td>
														<td>
															Malignant neoplasm of parathyroid gland
														</td>
													</tr>
													<tr>
														<td>
															D35.1
														</td>
														<td>
															Benign neoplasm of parathyroid gland
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup24" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup24" title="Expand/Collapse the Group 24 (1 Code) section" data-page-action="Clicked to Expand/Collapse the Group 24 (1 Code) section.">
									<h4 class="document-view-code-group-title d-inline">Group 24</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(1 Code)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup24Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup24Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup24Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 24 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81406 (ATP7B) is considered medically necessary for the following ICD-10-CM code:</p><p></p></span>

									<span class="document-view-section-subheader">Group 24 Codes</span>

										<table id="gdvIcd10CoveredCodes24" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															E83.01
														</td>
														<td>
															Wilson's disease
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup25" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup25" title="Expand/Collapse the Group 25 (67 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 25 (67 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 25</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(67 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup25Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup25Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup25Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 25 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81518, 81519, 81522, 81523 (Oncology, breast mRNA) and CPT 81520 Prosigna® Breast Cancer Prognostic Gene Signature Assay are considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 25 Codes</span>

										<table id="gdvIcd10CoveredCodes25" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C50.011
														</td>
														<td>
															Malignant neoplasm of nipple and areola, right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.012
														</td>
														<td>
															Malignant neoplasm of nipple and areola, left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.019
														</td>
														<td>
															Malignant neoplasm of nipple and areola, unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.021
														</td>
														<td>
															Malignant neoplasm of nipple and areola, right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.022
														</td>
														<td>
															Malignant neoplasm of nipple and areola, left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.029
														</td>
														<td>
															Malignant neoplasm of nipple and areola, unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.111
														</td>
														<td>
															Malignant neoplasm of central portion of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.112
														</td>
														<td>
															Malignant neoplasm of central portion of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.119
														</td>
														<td>
															Malignant neoplasm of central portion of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.121
														</td>
														<td>
															Malignant neoplasm of central portion of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.122
														</td>
														<td>
															Malignant neoplasm of central portion of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.129
														</td>
														<td>
															Malignant neoplasm of central portion of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.211
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.212
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.219
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.221
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.222
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.229
														</td>
														<td>
															Malignant neoplasm of upper-inner quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.311
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.312
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.319
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.321
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.322
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.329
														</td>
														<td>
															Malignant neoplasm of lower-inner quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.411
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.412
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.419
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.421
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.422
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.429
														</td>
														<td>
															Malignant neoplasm of upper-outer quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.511
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.512
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.519
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.521
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.522
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.529
														</td>
														<td>
															Malignant neoplasm of lower-outer quadrant of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.611
														</td>
														<td>
															Malignant neoplasm of axillary tail of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.612
														</td>
														<td>
															Malignant neoplasm of axillary tail of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.619
														</td>
														<td>
															Malignant neoplasm of axillary tail of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.621
														</td>
														<td>
															Malignant neoplasm of axillary tail of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.622
														</td>
														<td>
															Malignant neoplasm of axillary tail of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.629
														</td>
														<td>
															Malignant neoplasm of axillary tail of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.811
														</td>
														<td>
															Malignant neoplasm of overlapping sites of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.812
														</td>
														<td>
															Malignant neoplasm of overlapping sites of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.819
														</td>
														<td>
															Malignant neoplasm of overlapping sites of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.821
														</td>
														<td>
															Malignant neoplasm of overlapping sites of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.822
														</td>
														<td>
															Malignant neoplasm of overlapping sites of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.829
														</td>
														<td>
															Malignant neoplasm of overlapping sites of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.911
														</td>
														<td>
															Malignant neoplasm of unspecified site of right female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.912
														</td>
														<td>
															Malignant neoplasm of unspecified site of left female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.919
														</td>
														<td>
															Malignant neoplasm of unspecified site of unspecified female breast
														</td>
													</tr>
													<tr>
														<td>
															C50.921
														</td>
														<td>
															Malignant neoplasm of unspecified site of right male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.922
														</td>
														<td>
															Malignant neoplasm of unspecified site of left male breast
														</td>
													</tr>
													<tr>
														<td>
															C50.929
														</td>
														<td>
															Malignant neoplasm of unspecified site of unspecified male breast
														</td>
													</tr>
													<tr>
														<td>
															D05.00
														</td>
														<td>
															Lobular carcinoma in situ of unspecified breast
														</td>
													</tr>
													<tr>
														<td>
															D05.01
														</td>
														<td>
															Lobular carcinoma in situ of right breast
														</td>
													</tr>
													<tr>
														<td>
															D05.02
														</td>
														<td>
															Lobular carcinoma in situ of left breast
														</td>
													</tr>
													<tr>
														<td>
															D05.10
														</td>
														<td>
															Intraductal carcinoma in situ of unspecified breast
														</td>
													</tr>
													<tr>
														<td>
															D05.11
														</td>
														<td>
															Intraductal carcinoma in situ of right breast
														</td>
													</tr>
													<tr>
														<td>
															D05.12
														</td>
														<td>
															Intraductal carcinoma in situ of left breast
														</td>
													</tr>
													<tr>
														<td>
															D05.80
														</td>
														<td>
															Other specified type of carcinoma in situ of unspecified breast
														</td>
													</tr>
													<tr>
														<td>
															D05.81
														</td>
														<td>
															Other specified type of carcinoma in situ of right breast
														</td>
													</tr>
													<tr>
														<td>
															D05.82
														</td>
														<td>
															Other specified type of carcinoma in situ of left breast
														</td>
													</tr>
													<tr>
														<td>
															D05.90
														</td>
														<td>
															Unspecified type of carcinoma in situ of unspecified breast
														</td>
													</tr>
													<tr>
														<td>
															D05.91
														</td>
														<td>
															Unspecified type of carcinoma in situ of right breast
														</td>
													</tr>
													<tr>
														<td>
															D05.92
														</td>
														<td>
															Unspecified type of carcinoma in situ of left breast
														</td>
													</tr>
													<tr>
														<td>
															Z17.0
														</td>
														<td>
															Estrogen receptor positive status [ER+]
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup26" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup26" title="Expand/Collapse the Group 26 (2 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 26 (2 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 26</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(2 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup26Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup26Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup26Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 26 Paragraph</span>
									<span class="document-view-section-text"><p><span style="line-height: 107%;">CPT code 81595 Cardiology (heart transplant), mRNA is considered medically necessary for the following ICD-10-CM codes:</span></p></span>

									<span class="document-view-section-subheader">Group 26 Codes</span>

										<table id="gdvIcd10CoveredCodes26" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															Z48.21
														</td>
														<td>
															Encounter for aftercare following heart transplant
														</td>
													</tr>
													<tr>
														<td>
															Z94.1
														</td>
														<td>
															Heart transplant status
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup27" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup27" title="Expand/Collapse the Group 27 (28 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 27 (28 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 27</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(28 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup27Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup27Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup27Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 27 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81310 NPM1 (nucleophosmin) is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 27 Codes</span>

										<table id="gdvIcd10CoveredCodes27" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup28" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup28" title="Expand/Collapse the Group 28 (84 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 28 (84 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 28</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(84 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup28Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup28Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup28Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 28 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81352 TP53 (tumor protein 53) (e.g. tumor samples), targeted sequence analysis of 2-5 exons, and CPT code 81351 TP53 (tumor protein 53) (e.g. Li-Fraumeni syndrome, tumor samples), full gene sequence or targeted sequence analysis of &gt;5 exons are considered medically necessary for the following ICD-10-CM codes</p><p></p></span>

									<span class="document-view-section-subheader">Group 28 Codes</span>

										<table id="gdvIcd10CoveredCodes28" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C88.80
														</td>
														<td>
															Other malignant immunoproliferative diseases not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.10
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.11
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in remission
														</td>
													</tr>
													<tr>
														<td>
															C91.12
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.20
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.22
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.10
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.12
														</td>
														<td>
															Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.Z0
														</td>
														<td>
															Other monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.Z2
														</td>
														<td>
															Other monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.90
														</td>
														<td>
															Monocytic leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.92
														</td>
														<td>
															Monocytic leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.40
														</td>
														<td>
															Acute panmyelosis with myelofibrosis not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.41
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in remission
														</td>
													</tr>
													<tr>
														<td>
															C94.42
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.6
														</td>
														<td>
															Myelodysplastic disease, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.Z
														</td>
														<td>
															Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															C96.9
														</td>
														<td>
															Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D45
														</td>
														<td>
															Polycythemia vera
														</td>
													</tr>
													<tr>
														<td>
															D46.0
														</td>
														<td>
															Refractory anemia without ring sideroblasts, so stated
														</td>
													</tr>
													<tr>
														<td>
															D46.1
														</td>
														<td>
															Refractory anemia with ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.20
														</td>
														<td>
															Refractory anemia with excess of blasts, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.21
														</td>
														<td>
															Refractory anemia with excess of blasts 1
														</td>
													</tr>
													<tr>
														<td>
															D46.22
														</td>
														<td>
															Refractory anemia with excess of blasts 2
														</td>
													</tr>
													<tr>
														<td>
															D46.A
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia
														</td>
													</tr>
													<tr>
														<td>
															D46.B
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia and ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.C
														</td>
														<td>
															Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
														</td>
													</tr>
													<tr>
														<td>
															D46.4
														</td>
														<td>
															Refractory anemia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.Z
														</td>
														<td>
															Other myelodysplastic syndromes
														</td>
													</tr>
													<tr>
														<td>
															D46.9
														</td>
														<td>
															Myelodysplastic syndrome, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D47.1
														</td>
														<td>
															Chronic myeloproliferative disease
														</td>
													</tr>
													<tr>
														<td>
															D47.3
														</td>
														<td>
															Essential (hemorrhagic) thrombocythemia
														</td>
													</tr>
													<tr>
														<td>
															D47.4
														</td>
														<td>
															Osteomyelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D47.Z9
														</td>
														<td>
															Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D47.9
														</td>
														<td>
															Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D61.818
														</td>
														<td>
															Other pancytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.49
														</td>
														<td>
															Other primary thrombocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.6
														</td>
														<td>
															Thrombocytopenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D69.8
														</td>
														<td>
															Other specified hemorrhagic conditions
														</td>
													</tr>
													<tr>
														<td>
															D69.9
														</td>
														<td>
															Hemorrhagic condition, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D70.8
														</td>
														<td>
															Other neutropenia
														</td>
													</tr>
													<tr>
														<td>
															D70.9
														</td>
														<td>
															Neutropenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.810
														</td>
														<td>
															Lymphocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D72.818
														</td>
														<td>
															Other decreased white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.819
														</td>
														<td>
															Decreased white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.821
														</td>
														<td>
															Monocytosis (symptomatic)
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.829
														</td>
														<td>
															Elevated white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
													<tr>
														<td>
															D72.9
														</td>
														<td>
															Disorder of white blood cells, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D75.81
														</td>
														<td>
															Myelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D75.89
														</td>
														<td>
															Other specified diseases of blood and blood-forming organs
														</td>
													</tr>
													<tr>
														<td>
															D75.9
														</td>
														<td>
															Disease of blood and blood-forming organs, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D77
														</td>
														<td>
															Other disorders of blood and blood-forming organs in diseases classified elsewhere
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup29" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup29" title="Expand/Collapse the Group 29 (14 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 29 (14 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 29</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(14 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup29Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup29Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup29Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 29 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81335 TPMT gene is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 29 Codes</span>

										<table id="gdvIcd10CoveredCodes29" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 29" id="56199|108|C91.00|C91.02|2698|2700|29">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C91.10
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.11
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in remission
														</td>
													</tr>
													<tr>
														<td>
															C91.12
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in relapse
														</td>
													</tr>
													<tr>
														<td>
															C91.30
														</td>
														<td>
															Prolymphocytic leukemia of B-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.40
														</td>
														<td>
															Hairy cell leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.50
														</td>
														<td>
															Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.60
														</td>
														<td>
															Prolymphocytic leukemia of T-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.A0
														</td>
														<td>
															Mature B-cell leukemia Burkitt-type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.Z0
														</td>
														<td>
															Other lymphoid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															K50.00
														</td>
														<td>
															Crohn's disease of small intestine without complications
														</td>
													</tr>
													<tr>
														<td>
															Z94.84
														</td>
														<td>
															Stem cells transplant status
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup30" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup30" title="Expand/Collapse the Group 30 (63 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 30 (63 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 30</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(63 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup30Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup30Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup30Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 30 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81334 RUNX1 gene is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 30 Codes</span>

										<table id="gdvIcd10CoveredCodes30" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.10
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.12
														</td>
														<td>
															Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.Z0
														</td>
														<td>
															Other monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.Z2
														</td>
														<td>
															Other monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.90
														</td>
														<td>
															Monocytic leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.92
														</td>
														<td>
															Monocytic leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.6
														</td>
														<td>
															Myelodysplastic disease, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.Z
														</td>
														<td>
															Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															C96.9
														</td>
														<td>
															Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.0
														</td>
														<td>
															Refractory anemia without ring sideroblasts, so stated
														</td>
													</tr>
													<tr>
														<td>
															D46.1
														</td>
														<td>
															Refractory anemia with ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.20
														</td>
														<td>
															Refractory anemia with excess of blasts, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.21
														</td>
														<td>
															Refractory anemia with excess of blasts 1
														</td>
													</tr>
													<tr>
														<td>
															D46.22
														</td>
														<td>
															Refractory anemia with excess of blasts 2
														</td>
													</tr>
													<tr>
														<td>
															D46.A
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia
														</td>
													</tr>
													<tr>
														<td>
															D46.B
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia and ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.C
														</td>
														<td>
															Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
														</td>
													</tr>
													<tr>
														<td>
															D46.4
														</td>
														<td>
															Refractory anemia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.Z
														</td>
														<td>
															Other myelodysplastic syndromes
														</td>
													</tr>
													<tr>
														<td>
															D46.9
														</td>
														<td>
															Myelodysplastic syndrome, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D61.818
														</td>
														<td>
															Other pancytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.49
														</td>
														<td>
															Other primary thrombocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.6
														</td>
														<td>
															Thrombocytopenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D69.8
														</td>
														<td>
															Other specified hemorrhagic conditions
														</td>
													</tr>
													<tr>
														<td>
															D69.9
														</td>
														<td>
															Hemorrhagic condition, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D70.8
														</td>
														<td>
															Other neutropenia
														</td>
													</tr>
													<tr>
														<td>
															D70.9
														</td>
														<td>
															Neutropenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.810
														</td>
														<td>
															Lymphocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D72.818
														</td>
														<td>
															Other decreased white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.819
														</td>
														<td>
															Decreased white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D75.89
														</td>
														<td>
															Other specified diseases of blood and blood-forming organs
														</td>
													</tr>
													<tr>
														<td>
															D75.9
														</td>
														<td>
															Disease of blood and blood-forming organs, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D77
														</td>
														<td>
															Other disorders of blood and blood-forming organs in diseases classified elsewhere
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup31" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup31" title="Expand/Collapse the Group 31 (81 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 31 (81 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 31</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(81 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup31Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup31Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup31Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 31 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81175-81176-ASXL1 gene is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 31 Codes</span>

										<table id="gdvIcd10CoveredCodes31" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															C88.80
														</td>
														<td>
															Other malignant immunoproliferative diseases not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.20
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.22
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.10
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.12
														</td>
														<td>
															Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.Z0
														</td>
														<td>
															Other monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.Z2
														</td>
														<td>
															Other monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.90
														</td>
														<td>
															Monocytic leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.92
														</td>
														<td>
															Monocytic leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.40
														</td>
														<td>
															Acute panmyelosis with myelofibrosis not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.41
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in remission
														</td>
													</tr>
													<tr>
														<td>
															C94.42
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.6
														</td>
														<td>
															Myelodysplastic disease, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.Z
														</td>
														<td>
															Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															C96.9
														</td>
														<td>
															Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D45
														</td>
														<td>
															Polycythemia vera
														</td>
													</tr>
													<tr>
														<td>
															D46.0
														</td>
														<td>
															Refractory anemia without ring sideroblasts, so stated
														</td>
													</tr>
													<tr>
														<td>
															D46.1
														</td>
														<td>
															Refractory anemia with ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.20
														</td>
														<td>
															Refractory anemia with excess of blasts, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.21
														</td>
														<td>
															Refractory anemia with excess of blasts 1
														</td>
													</tr>
													<tr>
														<td>
															D46.22
														</td>
														<td>
															Refractory anemia with excess of blasts 2
														</td>
													</tr>
													<tr>
														<td>
															D46.A
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia
														</td>
													</tr>
													<tr>
														<td>
															D46.B
														</td>
														<td>
															Refractory cytopenia with multilineage dysplasia and ring sideroblasts
														</td>
													</tr>
													<tr>
														<td>
															D46.C
														</td>
														<td>
															Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
														</td>
													</tr>
													<tr>
														<td>
															D46.4
														</td>
														<td>
															Refractory anemia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D46.Z
														</td>
														<td>
															Other myelodysplastic syndromes
														</td>
													</tr>
													<tr>
														<td>
															D46.9
														</td>
														<td>
															Myelodysplastic syndrome, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D47.1
														</td>
														<td>
															Chronic myeloproliferative disease
														</td>
													</tr>
													<tr>
														<td>
															D47.3
														</td>
														<td>
															Essential (hemorrhagic) thrombocythemia
														</td>
													</tr>
													<tr>
														<td>
															D47.4
														</td>
														<td>
															Osteomyelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D47.Z9
														</td>
														<td>
															Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D47.9
														</td>
														<td>
															Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D61.818
														</td>
														<td>
															Other pancytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.49
														</td>
														<td>
															Other primary thrombocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D69.6
														</td>
														<td>
															Thrombocytopenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D69.8
														</td>
														<td>
															Other specified hemorrhagic conditions
														</td>
													</tr>
													<tr>
														<td>
															D69.9
														</td>
														<td>
															Hemorrhagic condition, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D70.8
														</td>
														<td>
															Other neutropenia
														</td>
													</tr>
													<tr>
														<td>
															D70.9
														</td>
														<td>
															Neutropenia, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.810
														</td>
														<td>
															Lymphocytopenia
														</td>
													</tr>
													<tr>
														<td>
															D72.818
														</td>
														<td>
															Other decreased white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.819
														</td>
														<td>
															Decreased white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.821
														</td>
														<td>
															Monocytosis (symptomatic)
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.829
														</td>
														<td>
															Elevated white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
													<tr>
														<td>
															D72.9
														</td>
														<td>
															Disorder of white blood cells, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D75.81
														</td>
														<td>
															Myelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D75.89
														</td>
														<td>
															Other specified diseases of blood and blood-forming organs
														</td>
													</tr>
													<tr>
														<td>
															D75.9
														</td>
														<td>
															Disease of blood and blood-forming organs, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D77
														</td>
														<td>
															Other disorders of blood and blood-forming organs in diseases classified elsewhere
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup32" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup32" title="Expand/Collapse the Group 32 (68 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 32 (68 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 32</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(68 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup32Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup32Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup32Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 32 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT codes 81120-81121, IDH1 and IDH2, are considered medically necessary for the following ICD-10-CM codes:</p>
<p style="line-height: normal;">CPT code 81345, TERT, is considered medically necessary for C71.0-C71.9 only.</p><p></p></span>

									<span class="document-view-section-subheader">Group 32 Codes</span>

										<table id="gdvIcd10CoveredCodes32" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C71.0 - C71.9 in Group 32" id="56199|108|C71.0|C71.9|2043|2052|32">C71.0 - C71.9</a>
														</td>
														<td>
															Malignant neoplasm of cerebrum, except lobes and ventricles - Malignant neoplasm of brain, unspecified
														</td>
													</tr>
													<tr>
														<td>
															C88.80
														</td>
														<td>
															Other malignant immunoproliferative diseases not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.00
														</td>
														<td>
															Acute myeloblastic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.02
														</td>
														<td>
															Acute myeloblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.20
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.22
														</td>
														<td>
															Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.30
														</td>
														<td>
															Myeloid sarcoma, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.32
														</td>
														<td>
															Myeloid sarcoma, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.40
														</td>
														<td>
															Acute promyelocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.42
														</td>
														<td>
															Acute promyelocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.50
														</td>
														<td>
															Acute myelomonocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.52
														</td>
														<td>
															Acute myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.60
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.62
														</td>
														<td>
															Acute myeloid leukemia with 11q23-abnormality in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.A0
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.A2
														</td>
														<td>
															Acute myeloid leukemia with multilineage dysplasia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.Z0
														</td>
														<td>
															Other myeloid leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.Z2
														</td>
														<td>
															Other myeloid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C92.90
														</td>
														<td>
															Myeloid leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C92.92
														</td>
														<td>
															Myeloid leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.00
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.02
														</td>
														<td>
															Acute monoblastic/monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.10
														</td>
														<td>
															Chronic myelomonocytic leukemia not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.12
														</td>
														<td>
															Chronic myelomonocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.Z0
														</td>
														<td>
															Other monocytic leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.Z2
														</td>
														<td>
															Other monocytic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C93.90
														</td>
														<td>
															Monocytic leukemia, unspecified, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C93.92
														</td>
														<td>
															Monocytic leukemia, unspecified in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.00
														</td>
														<td>
															Acute erythroid leukemia, not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.02
														</td>
														<td>
															Acute erythroid leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.40
														</td>
														<td>
															Acute panmyelosis with myelofibrosis not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.41
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in remission
														</td>
													</tr>
													<tr>
														<td>
															C94.42
														</td>
														<td>
															Acute panmyelosis with myelofibrosis, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C94.80
														</td>
														<td>
															Other specified leukemias not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C94.82
														</td>
														<td>
															Other specified leukemias, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.00
														</td>
														<td>
															Acute leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.02
														</td>
														<td>
															Acute leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.90
														</td>
														<td>
															Leukemia, unspecified not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.92
														</td>
														<td>
															Leukemia, unspecified, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C96.Z
														</td>
														<td>
															Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D45
														</td>
														<td>
															Polycythemia vera
														</td>
													</tr>
													<tr>
														<td>
															D47.1
														</td>
														<td>
															Chronic myeloproliferative disease
														</td>
													</tr>
													<tr>
														<td>
															D47.3
														</td>
														<td>
															Essential (hemorrhagic) thrombocythemia
														</td>
													</tr>
													<tr>
														<td>
															D47.4
														</td>
														<td>
															Osteomyelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D47.Z9
														</td>
														<td>
															Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
														</td>
													</tr>
													<tr>
														<td>
															D47.9
														</td>
														<td>
															Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.821
														</td>
														<td>
															Monocytosis (symptomatic)
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.829
														</td>
														<td>
															Elevated white blood cell count, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
													<tr>
														<td>
															D72.9
														</td>
														<td>
															Disorder of white blood cells, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D75.81
														</td>
														<td>
															Myelofibrosis
														</td>
													</tr>
													<tr>
														<td>
															D75.89
														</td>
														<td>
															Other specified diseases of blood and blood-forming organs
														</td>
													</tr>
													<tr>
														<td>
															D75.9
														</td>
														<td>
															Disease of blood and blood-forming organs, unspecified
														</td>
													</tr>
													<tr>
														<td>
															D77
														</td>
														<td>
															Other disorders of blood and blood-forming organs in diseases classified elsewhere
														</td>
													</tr>
													<tr>
														<td>
															R16.1
														</td>
														<td>
															Splenomegaly, not elsewhere classified
														</td>
													</tr>
													<tr>
														<td>
															R16.2
														</td>
														<td>
															Hepatomegaly with splenomegaly, not elsewhere classified
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup33" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup33" title="Expand/Collapse the Group 33 (21 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 33 (21 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 33</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(21 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup33Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup33Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup33Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 33 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">CPT code 81305 MYD88 is considered medically necessary for the following ICD-10-CM codes:</p><p></p></span>

									<span class="document-view-section-subheader">Group 33 Codes</span>

										<table id="gdvIcd10CoveredCodes33" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C83.00 - C83.09 in Group 33" id="56199|108|C83.00|C83.09|2406|2415|33">C83.00 - C83.09</a>
														</td>
														<td>
															Small cell B-cell lymphoma, unspecified site - Small cell B-cell lymphoma, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C85.80 - C85.89 in Group 33" id="56199|108|C85.80|C85.89|2615|2624|33">C85.80 - C85.89</a>
														</td>
														<td>
															Other specified types of non-Hodgkin lymphoma, unspecified site - Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															C88.00
														</td>
														<td>
															Waldenstrom macroglobulinemia not having achieved remission
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup34" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup34" title="Expand/Collapse the Group 34 (1 Code) section" data-page-action="Clicked to Expand/Collapse the Group 34 (1 Code) section.">
									<h4 class="document-view-code-group-title d-inline">Group 34</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(1 Code)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup34Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup34Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup34Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 34 Paragraph</span>
									<span class="document-view-section-text"><p><span style="line-height: 106%;">Use CPT code 81227 CYP2C9 for individuals who have relapsing forms of multiple sclerosis. The following ICD-10-CM diagnosis code is effective for services rendered on or after July 1. 2020.</span></p></span>

									<span class="document-view-section-subheader">Group 34 Codes</span>

										<table id="gdvIcd10CoveredCodes34" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															G35
														</td>
														<td>
															Multiple sclerosis
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
							<div id="divIcd10CoveredGroup35" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10CoveredGroup35" title="Expand/Collapse the Group 35 (230 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 35 (230 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 35</h4>
									<span id="lblTotalIcdCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(230 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup35Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-covered-code-group-chevron" id="iIcd10CoveredGroup35Chevron"></i> --></div>
								</div>

								<div id="divIcd10CoveredGroup35Fields" class="document-view-code-group-fields icd10-covered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 35 Paragraph</span>
									<span class="document-view-section-text"><p>CPT code 81261, 81262, 81263, and 81264 (IGH) are considered medically necessary for the following ICD-10-CM diagnosis codes. Please use Modifier 91 as appropriate, based on the Medicare Claims Processing Manual Chapter 16, Laboratory Services Section 100.5.1. Modifier 91 may be is used <em>"to indicate that a test was performed more than once on the same day for </em><em>the same patient., only when it is necessary to obtain multiple results in the course of treatment."</em><br><br></p></span>

									<span class="document-view-section-subheader">Group 35 Codes</span>

										<table id="gdvIcd10CoveredCodes35" class="table table-striped table-lg" summary="The ICD-10-CM Codes that Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C82.00 - C83.99 in Group 35" id="56199|108|C82.00|C83.99|2297|2489|35">C82.00 - C83.99</a>
														</td>
														<td>
															Follicular lymphoma grade I, unspecified site - Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C85.10 - C85.99 in Group 35" id="56199|108|C85.10|C85.99|2591|2636|35">C85.10 - C85.99</a>
														</td>
														<td>
															Unspecified B-cell lymphoma, unspecified site - Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
														</td>
													</tr>
													<tr>
														<td>
															<a href="#" data-toggle="modal" data-target="#modalCodeRange" class="aIcd10CovRange system-link no-click log-click" data-page-action="Clicked on aIcd10CovRange for C91.00 - C91.02 in Group 35" id="56199|108|C91.00|C91.02|2698|2700|35">C91.00 - C91.02</a>
														</td>
														<td>
															Acute lymphoblastic leukemia not having achieved remission - Acute lymphoblastic leukemia, in relapse
														</td>
													</tr>
													<tr>
														<td>
															C91.10
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C91.11
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in remission
														</td>
													</tr>
													<tr>
														<td>
															C91.12
														</td>
														<td>
															Chronic lymphocytic leukemia of B-cell type in relapse
														</td>
													</tr>
													<tr>
														<td>
															C95.10
														</td>
														<td>
															Chronic leukemia of unspecified cell type not having achieved remission
														</td>
													</tr>
													<tr>
														<td>
															C95.11
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in remission
														</td>
													</tr>
													<tr>
														<td>
															C95.12
														</td>
														<td>
															Chronic leukemia of unspecified cell type, in relapse
														</td>
													</tr>
													<tr>
														<td>
															D72.828
														</td>
														<td>
															Other elevated white blood cell count
														</td>
													</tr>
													<tr>
														<td>
															D72.89
														</td>
														<td>
															Other specified disorders of white blood cells
														</td>
													</tr>
											</tbody>
										</table>


								</div>
							</div>
				</div>

				<span id="lblIcd10Covered" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divIcd10NoncoveredTop" class="w-100 document-view-section-code-field-top"></div>
			<div id="divIcd10Noncovered" class="document-view-section-code-field">
				<h3 id="h3Icd10NoncoveredHeader" class="document-view-section-header">ICD-10-CM Codes that DO NOT Support Medical Necessity</h3>

				<div id="divIcd10NoncoveredExpandCollapse" class="py-3 w-100 text-right d-print-none ">
					<a href="#" id="aExpandAllIcd10Noncovered" class="no-link log-click" data-page-action="Clicked the Expand All ICD-10 Don't Support groups link">Expand All</a> |
					<a href="#" id="aCollapseAllIcd10Noncovered" class="no-link log-click" data-page-action="Clicked the Collapse All ICD-10 Don't Support groups link">Collapse All</a>
				</div>

				<div id="rptIcd10NoncoveredGroups" class="">
							<div id="divIcd10NoncoveredGroup1" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10NoncoveredGroup1" title="Expand/Collapse the Group 1 (9 Codes) section" data-page-action="Clicked to Expand/Collapse the Group 1 (9 Codes) section.">
									<h4 class="document-view-code-group-title d-inline">Group 1</h4>
									<span id="lblTotalIcdNotCoveredCodes" class="document-view-section-text" style="margin-left: 7px;">(9 Codes)</span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-noncovered-code-group-chevron" id="iIcd10NoncoveredGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-noncovered-code-group-chevron" id="iIcd10NoncoveredGroup1Chevron"></i> --></div>
								</div>

								<div id="divIcd10NoncoveredGroup1Fields" class="document-view-code-group-fields icd10-noncovered-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 1 Paragraph</span>
									<span class="document-view-section-text"><p></p><p style="line-height: normal;">The following ICD-10-CM codes are considered non-covered for all molecular pathology procedures:</p><p></p></span>

									<span class="document-view-section-subheader">Group 1 Codes</span>

										<table id="gdvIcd10NoncoveredCodes1" class="table table-striped table-lg" summary="The ICD-10-CM Codes that DO NOT Support Medical Necessity data.">
											<thead>
												<tr class="thead-light">
													<th scope="col">Code</th>
													<th scope="col">Description</th>
												</tr>
											</thead>
											<tbody>
													<tr>
														<td>
															Z13.71
														</td>
														<td>
															Encounter for nonprocreative screening for genetic disease carrier status
														</td>
													</tr>
													<tr>
														<td>
															Z13.79
														</td>
														<td>
															Encounter for other screening for genetic and chromosomal anomalies
														</td>
													</tr>
													<tr>
														<td>
															Z31.430
														</td>
														<td>
															Encounter of female for testing for genetic disease carrier status for procreative management
														</td>
													</tr>
													<tr>
														<td>
															Z31.438
														</td>
														<td>
															Encounter for other genetic testing of female for procreative management
														</td>
													</tr>
													<tr>
														<td>
															Z31.440
														</td>
														<td>
															Encounter of male for testing for genetic disease carrier status for procreative management
														</td>
													</tr>
													<tr>
														<td>
															Z31.441
														</td>
														<td>
															Encounter for testing of male partner of patient with recurrent pregnancy loss
														</td>
													</tr>
													<tr>
														<td>
															Z31.448
														</td>
														<td>
															Encounter for other genetic testing of male for procreative management
														</td>
													</tr>
													<tr>
														<td>
															Z31.5
														</td>
														<td>
															Encounter for procreative genetic counseling
														</td>
													</tr>
													<tr>
														<td>
															Z36.0
														</td>
														<td>
															Encounter for antenatal screening for chromosomal anomalies
														</td>
													</tr>
											</tbody>
										</table>

								</div>
							</div>
				</div>

				<span id="lblIcd10Noncovered" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divIcd10PcsTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divIcd10Pcs" class="document-view-section-code-field ">
				<h3 id="h3Icd10PcsHeader" class="document-view-section-header">ICD-10-PCS Codes</h3>

				<div id="divIcd10PcsExpandCollapse" class="py-3 w-100 text-right d-print-none d-none">
					<a href="#" id="aExpandAllIcd10Pcs" class="no-link log-click" data-page-action="Clicked the Expand All ICD-10 PCS groups link">Expand All</a> |
					<a href="#" id="aCollapseAllIcd10Pcs" class="no-link log-click" data-page-action="Clicked the Collapse All ICD-10 PCS groups link">Collapse All</a>
				</div>

				<div id="rptIcd10PcsGroups" class="d-none">
							<div id="divIcd10PcsGroup1" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="Icd10PcsGroup1" title="Expand/Collapse the Group 1 section" data-page-action="Clicked to Expand/Collapse the Group 1 section.">
									<h4 class="document-view-code-group-title d-inline">Group 1</h4>
									<span id="lblTotalIcd10PcsCodes" class="document-view-section-text" style="margin-left: 7px;"></span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron icd10-pcs-code-group-chevron" id="iIcd10PcsGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron icd10-pcs-code-group-chevron" id="iIcd10PcsGroup1Chevron"></i> --></div>
								</div>

								<div id="divIcd10PcsGroup1Fields" class="document-view-code-group-fields icd10-pcs-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 1 Paragraph</span>
									<span class="document-view-section-text"><p>N/A</p></span>

									<span class="document-view-section-subheader">Group 1 Codes</span>


										<p><span id="lblIcd10PcsNoCodes1" class="document-view-section-text">N/A</span></p>
								</div>
							</div>
				</div>

				<span id="lblIcd10Pcs" class="document-view-section-text ">N/A</span>
			</div>

			<div id="divAdditionalIcd10InfoTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divAdditionalIcd10Info" class="document-view-section-code-field ">
				<h3 id="h3AdditionalIcd10InfoHeader" class="document-view-section-header">Additional ICD-10 Information</h3>
				<span id="lblAdditionalIcd10Info" class="document-view-section-text">N/A</span>
			</div>

			<div id="divBillCodesTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divBillCodes" class="document-view-section-code-field ">
				<h3 id="h3BillCodesHeader" class="document-view-section-header">Bill Type Codes</h3>

				<p class="document-view-section-text"><span id="lblBillCodesIntro">
		Contractors may specify Bill Types to help providers identify those Bill Types typically
		used to report this service. Absence of a Bill Type does not guarantee that the
		article does not apply to that Bill Type. Complete absence of all Bill Types indicates
		that coverage is not influenced by Bill Type and the article should be assumed to
		apply equally to all claims.
	</span></p>

				<table id="gdvBillCodes" class="table table-striped table-lg d-none" summary="The Bill Type Code data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody class="bill-codes-display">


</tbody>
				</table>

				<span id="lblBillCodes" class="document-view-section-text ">N/A</span>
			</div>

			<div id="divRevenueCodesTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divRevenueCodes" class="document-view-section-code-field ">
				<h3 id="h3RevenueCodesHeader" class="document-view-section-header">Revenue Codes</h3>

				<p class="document-view-section-text"><span id="lblRevenueCodesIntro">
		Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service.
		In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other
		Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates
		that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes.
	</span></p>
				<span id="lblRevenueCodesParagraph" class="document-view-section-text"></span>

				<table id="gdvRevenueCodes" class="table table-striped table-lg d-none" summary="The Revenue Code data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Code</th>
							<th scope="col">Description</th>
						</tr>
					</thead>
					<tbody class="revenue-codes-display">


</tbody>
				</table>

				<span id="lblRevenueCodes" class="document-view-section-text ">N/A</span>
			</div>

			<div id="divOtherCodingTop" class="w-100 document-view-section-code-field-top "></div>
			<div id="divOtherCoding" class="document-view-section-code-field ">
				<h3 id="h3OtherCodingHeader" class="document-view-section-header">Other Coding Information</h3>

				<div id="divOtherCodingExpandCollapse" class="py-3 w-100 text-right d-print-none d-none">
					<a href="#" id="aExpandAllOtherCoding" class="no-link log-click" data-page-action="Clicked the Expand All Other Coding groups link">Expand All</a> |
					<a href="#" id="aCollapseAllOtherCoding" class="no-link log-click" data-page-action="Clicked the Collapse All Other Coding groups link">Collapse All</a>
				</div>

				<div id="rptOtherCodingGroups" class="d-none">
							<div id="divOtherCodingGroup1" class="document-view-code-group-section">
								<div class="py-3 document-view-code-group-collapser log-click" tabindex="0" data-collapser-name="OtherCodingGroup1" title="Expand/Collapse the Group 1 section" data-page-action="Clicked to Expand/Collapse the Group 1 section.">
									<h4 class="document-view-code-group-title d-inline">Group 1</h4>
									<span id="lblTotalOtherCodingCodes" class="document-view-section-text" style="margin-left: 7px;"></span>
									<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-code-group-chevron other-coding-code-group-chevron" id="iOtherCodingGroup1Chevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-code-group-chevron other-coding-code-group-chevron" id="iOtherCodingGroup1Chevron"></i> --></div>
								</div>

								<div id="divOtherCodingGroup1Fields" class="document-view-code-group-fields other-coding-code-group-fields d-print-block">
									<span class="document-view-section-subheader">Group 1 Paragraph</span>
									<span class="document-view-section-text"><p>N/A</p></span>

									<span class="document-view-section-subheader">Group 1 Codes</span>


										<p><span id="lblOtherCodingNoCodes1" class="document-view-section-text">N/A</span></p>
								</div>
							</div>
				</div>

				<span id="lblOtherCoding" class="document-view-section-text ">N/A</span>
			</div>
		</div>
	</div>

	<div id="pnlCodingTableInformation" class="document-view-section d-none">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="CodingTableInformation" title="Expand/Collapse the Coding Table Information section" data-page-action="Clicked to Expand/Collapse the Coding Table Information section.">
			<h2 class="document-view-section-title d-inline">Coding Table Information</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iCodingTableInformationChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iCodingTableInformationChevron"></i> --></div>
		</div>

		<div id="divCodingTableInformationFields" class="document-view-fields d-print-block">
			<div id="divSadCodes" class="document-view-section-field">
				<span id="lblSadCodesSubheader" class="document-view-section-subheader">Excluded CPT/HCPCS Codes - Table Format</span><br>

				<div id="rptSadCodes" class="">
					<table class="table table-striped table-lg">
						<thead class="thead-light">
							<tr>
								<th scope="col">Code</th>
								<th scope="col">Descriptor Generic Name</th>
								<th scope="col">Descriptor Brand Name</th>
								<th scope="col">Exclusion Effective Date</th>
								<th scope="col">Exclusion End Date</th>
								<th scope="col">Reason for Exclusion</th>
							</tr>
						</thead>
						<tbody>
										<tr>
											<td></td>
											<td></td>
											<td></td>
											<td>N/A</td>
											<td>N/A</td>
											<td></td>
										</tr>
						</tbody>
					</table>
				</div>

				<span id="lblSadCodes" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divNonExcludedCodes" class="document-view-section-field">
				<span id="lblNonExcludedCodesSubheader" class="document-view-section-subheader">Non-Excluded CPT/HCPCS Ended Codes - Table Format</span><br>

				<div id="rptNonExcludedCodes">
					<table class="table table-striped table-lg">
						<thead class="thead-light">
							<tr>
								<th scope="col">Code</th>
								<th scope="col">Descriptor Generic Name</th>
								<th scope="col">Descriptor Brand Name</th>
								<th scope="col">Exclusion Effective Date</th>
								<th scope="col">Exclusion End Date</th>
								<th scope="col">Reason for Exclusion</th>
							</tr>
						</thead>
						<tbody>
						</tbody>
					</table>
				</div>

				<span id="lblNonExcludedCodes" class="document-view-section-text d-none">N/A</span>
			</div>
		</div>
	</div>

	<div id="pnlRevisionHistoryInformation" class="document-view-section ">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="RevisionHistoryInformation" title="Expand/Collapse the Revision History Information section" data-page-action="Clicked to Expand/Collapse the Revision History Information section.">
			<h2 class="document-view-section-title d-inline">Revision History Information</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iRevisionHistoryInformationChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iRevisionHistoryInformationChevron"></i> --></div>
		</div>

		<div id="divRevisionHistoryInformationFields" class="document-view-fields d-print-block">
			<div id="divRevisionHistory" class="document-view-section-field">
				<table id="gdvRevisionHistory" class="table table-striped table-lg " summary="The Revision History data.">
					<thead>
						<tr class="thead-light">
							<th scope="col">Revision History Date</th>
							<th scope="col">Revision History Number</th>
							<th scope="col">Revision History Explanation</th>
						</tr>
					</thead>
					<tbody>
								<tr>
									<td class="text-nowrap">
										10/01/2024
									</td>
									<td>
										R27
									</td>
									<td class="text-break">
										<p>- An inadvertent typographical error has been corrected in The "ICD-10-CM Codes That Support Medical Necessity" section - Group 33. C88.80 has been revised to read C88.00, effective 10/1/2024.</p>
<p>- ICD-10-CM codes C91.10 and C91.11 have been added to the "ICD-10-CM Codes that Support Medical Necessity" section- Group 29, effective 1/1/2024.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										10/01/2024
									</td>
									<td>
										R26
									</td>
									<td class="text-break">
										<p>Due to the annual ICD-10-CM update, the ICD-10-CM code C88.8 has been deleted and replaced by C88.80 in the ICD-10-CM That Supports Medical Necessity section- Groups 13, 28, 31, 32, and 33, effective for services rendered on or after 10/1/2024.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										08/01/2024
									</td>
									<td>
										R25
									</td>
									<td class="text-break">
										<p>PLA code 0119U was added to CPT/HCPS Section- Group 5, effective for services rendered on or after 8/1/2024.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2024
									</td>
									<td>
										R24
									</td>
									<td class="text-break">
										<p class="xmsonormal"><span style="font-size: 10.5pt; font-family: 'Verdana',sans-serif; color: #212529;">- ICD-10-CM codes C91.10 and C91.11 have been added to the ICD-10-CM Codes that Support Medical Necessity section- Group 29.</span></p>
<p class="xmsonormal"><span style="font-size: 10.5pt; font-family: 'Verdana',sans-serif; color: #212529;">- Due to the 1/1/2024 CPT/HCPCS quarterly update, the following code descriptors have been changed in Group1- </span><span style="font-size: 10.5pt; font-family: 'Verdana',sans-serif; color: #212529;">81449 and 81456. Group 3- 81171, 81172, 81243, and 81244.</span></p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										10/01/2023
									</td>
									<td>
										R23
									</td>
									<td class="text-break">
										<p>Effective for services rendered on or after 10/1/2023, due to the annual ICD-10-CM update, the ICD-10-CM That Supports Medical Necessity section- Group 7 was updated with the following: diagnosis codes I20.8 was deleted and replaced by I20.81 and I20.89. Diagnosis code I24.8 was deleted and replaced by I24.81 and I24.89.</p>
<p>The ICD-10-CM That Supports Medical Necessity section- Groups 14 and 19 was updated with the following: diagnosis codes: D48.1 was deleted and replaced by code range D48.110 through D48.19.&nbsp;</p>
<p style="line-height: normal;">&nbsp;</p>
<p>&nbsp;</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										08/06/2023
									</td>
									<td>
										R22
									</td>
									<td class="text-break">
										<p>Due to a typographical error in the Notice Period, the effective date has been moved to August 6, 2023.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										08/01/2023
									</td>
									<td>
										R21
									</td>
									<td class="text-break">
										<p>- Deleted CPT code 81352 from CPT/HCPS Section Group 2</p>
<p>- Established Group 35 under the "ICD-10-CM Codes that Support Medical Necessity" section for CPT codes 81261-81264, effective for services rendered on or after August 1, 2023.</p>
<p>- Added Modifier 91 to the CPT/HCPCS Modifier section. The 91 modifier is used for laboratory tests paid under the clinical laboratory fee schedule, as stated in the Medicare Claims Processing Manual Chapter 16, Laboratory Services Section 100.5.1.</p>
<p>- Added the following Modifier 91 information to the Article Text:</p>
<p style="line-height: normal; background: white;"><strong>Modifier 91</strong></p>
<p style="line-height: normal; background: white;">Please use Modifier 91 as appropriate, based on the Medicare Claims Processing Manual Chapter 16, Laboratory Services Section 100.5.1. Modifier 91 may be is used <em>"to indicate that a test was performed more than once on the same day for </em><em>the same patient., only when it is necessary to obtain multiple results in the course of treatment."</em></p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2023
									</td>
									<td>
										R20
									</td>
									<td class="text-break">
										<p>Added CPT codes 81449, 81451, and 81456 to Specific Coding of Molecular Testing Panels in the "Article Text" section.</p>
<p>Added CPT codes 81418 and 81441 to the "CPT/HCPCS Code" section-Group 2 (Individual Review).</p>
<p>Deleted the “ICD10 Codes That Support Medical Necessity “ section- Group 6- CPT Code 81313 (PCA3). Please refer to L37733 Biomarker Testing for Prostate Cancer.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										11/01/2022
									</td>
									<td>
										R19
									</td>
									<td class="text-break">
										<p style="line-height: normal; background: white;">CPT code 81313 has been removed from Group 1- Tier 1 Covered codes section ( Please refer to L37733 Biomarkers for Prostate Cancer Diagnosis)</p>
<p style="line-height: normal; background: white;">CPT code 81551 has been removed from Group 3 Tier 1 Non-covered codes section ( Please refer to L37733 Biomarkers for Prostate Cancer Diagnosis)</p>
<p style="line-height: normal; background: white;">Duplicative language currently in L35000 regarding medical necessity ( Abstract and Indications of Coverage by CPT Code) have been removed from A56199. ( Please refer to L35000)</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										10/01/2022
									</td>
									<td>
										R18
									</td>
									<td class="text-break">
										<p>Due to the annual ICD-10-CM code update, the following codes had descriptor changes occur in the ICD-10-CM section that supports Medical Necessity.:&nbsp;C94.6 descriptor was changed in Group 14; C94.6 descriptor was changed in Group 29;&nbsp;<br>C94.6 descriptor was changed in Group 31; C94.6 descriptor was changed in Group 32.&nbsp;</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										05/01/2022
									</td>
									<td>
										R17
									</td>
									<td class="text-break">
										<p>5/1/2022&nbsp; Correction: ICD-10-CM diagnosis code, C56.3&nbsp; is effective for services rendered on or after 10/1/2021,</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										05/01/2022
									</td>
									<td>
										R16
									</td>
									<td class="text-break">
										<p>Added ICD-10-CM diagnosis code C56.3 to the "ICD-10-CM Codes that Support Medical Necessity" section- Group1, effective for services rendered on or after 5/1/2022.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										04/01/2022
									</td>
									<td>
										R15
									</td>
									<td class="text-break">
										<p>The following, underlined language was added to the Correct Coding of Molecular Testing Panels under Specific Coding of Molecular Testing Panels in the Article text:</p>
<p>CPT code 81455 should be billed when 51 or greater genes are ordered for molecular biomarkers. <span style="text-decoration: underline;">Please refer to Local Coverage Determination L37810 Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms and the associated Article A56867</span></p>
<p>CPT code 81455 was removed from CPT/HCPCS Code section-Group 3.</p>
<p>&nbsp;</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2022
									</td>
									<td>
										R14
									</td>
									<td class="text-break">
										<p>Due to the annual CPT/HCPCS code update, CPT code 81523 was added to the CPT/HCPCS Codes section- Group 1,&nbsp; and CPT code 81349 was added to the CPT/HCPCS Codes section- Group 3.</p>
<p>CPT codes 81522 and 81523 were added to the "ICD-10-CM Codes that Support Medical Necessity" section- Group 26 paragraph, effective for services rendered on or after 1/1/2022.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										11/30/2021
									</td>
									<td>
										R13
									</td>
									<td class="text-break">
										<p>CPT code 81546 was deleted from CPT/HCPCS Codes section- Group 2. Please refer to LCD L38968 Thyroid Nodule Molecular Testing and Billing and Coding Article A58656.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										05/15/2021
									</td>
									<td>
										R12
									</td>
									<td class="text-break">
										<p style="line-height: 27.0pt; background: white;"><u>-The following clarifying guidance which was published on our website on 7/29/2021 regarding the Correct Coding of Molecular Testing Panels was added under Specific Coding of Molecular Testing Panels in the Article text above:</u></p>
<p>The submission of claims using individual gene CPT codes, when either 5-50 or &gt;50 gene panels are ordered, is considered incorrect coding. Correct coding requires that when a panel code is ordered, it should be billed, rather than the individual gene codes. CPT code 81445 or 81450 should be billed when 5 to 50 genes are ordered. CPT code 81455 should be billed when 51 or greater genes are ordered for molecular biomarkers. When a panel with greater than one or less than five genes is ordered, use the corresponding existing panel CPT code or CPT code 81479 if none exists.</p>
<p><u>-The following note was added to the CPT/HCPCS Section paragraph- Group 4: </u></p>
<p><strong>Note:</strong> When a panel with greater than one or less than five genes is ordered, use the corresponding existing panel CPT code or CPT code 81479 if none exists.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										05/15/2021
									</td>
									<td>
										R11
									</td>
									<td class="text-break">
										<p>Added CPT code 81353 which had been inadvertently omitted to CPT/HCPCS Code section-Group2, effective January 1, 2021.</p>
<p>Deleted SCA1 CPT code 81479 from the CPT/HCPCS code section- Group 4 Paragraph, <u>Tier 2/NOC Non-covered Code/Gene Combinations</u><strong><u>,</u></strong> due to the inadvertent inclusion of SCA1 as a gene in error.</p>
<p>Added PLA code 0070U to the ICD-10-CM Diagnosis Codes That Support Medical Necessity and to the Paragraph, Group 9, effective May 15, 2021</p>
<p>Added PLA code 0070U to CPT/HCPCS Code Section- Group 1, effective May 15, 2021</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										04/01/2021
									</td>
									<td>
										R10
									</td>
									<td class="text-break">
										<p>Added Proprietary Laboratory Analysis (PLA) code 0027U &nbsp;to the coding information section.:</p>
<p><span style="text-decoration: underline;"><strong>CPT Codes 81279</strong></span> JAK2 (Janus kinase 2) (eg, myeloproliferative disorder), (exon 12 sequence and exon 13 sequence) and <span style="text-decoration: underline;"><strong>0027U</strong> </span>(Janus kinase 2) (e.g., myeloproliferative disorder), gene analysis, targeted sequence analysis exons 12-15 are considered medically necessary in the initial work-up of BCR-ABL and JAK2 (V617F variant) negative adults with clinical, laboratory, or pathological findings suggesting polycythemia vera.</p>
<p>Added PLA code 0027U to the CPT/HCPCS Code section-Group 1.</p>
<p>Added PLA code 0027U to the ICD-10-CM Diagnosis Codes That Support Medical Necessity section-Group 14.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2021
									</td>
									<td>
										R9
									</td>
									<td class="text-break">
										<p>Due to the HCPCS update, effective 1/1/2021, the following CPT codes were added to the Group 1 tabular CPT code listing: 81168, 81338, 81339, 81347, 81348, 81351, 81352 and removed from the Group 1 paragraph section.</p>
<p>Due to the HCPCS update, effective 1/1/2021, the following CPT codes were added to the Group 2 tabular code listing: 81191, 81192, 81193, 81194, 81353, 81357, 81419, 81529, 81546, 81554, and 81360 and removed from the Group 2 paragraph section.</p>
<p><span style="line-height: 107%; background: white;">Due to the annual HCPCS update, CPT code 81545 was deleted from Group 3, effective 1/1/2021:</span></p>
<p><span style="line-height: 107%;"><br><br></span></p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2021
									</td>
									<td>
										R8
									</td>
									<td class="text-break">
										<p><strong><u><span style="line-height: 107%;">The Indications of Coverage by CPT code section was revised as follows</span></u></strong><u><span style="line-height: 107%;">: </span></u></p>
<p style="line-height: normal;">CPT Code 81401 was replaced by CPT codes (81168) CCND1/IGH;(81278) BCL1/IgH, t</p>
<p style="line-height: normal;">CPT Code 81402 was replaced by CPT code (81338) MPL</p>
<p style="line-height: normal;">CPT Code 81403 was replaced by CPT code 81339) MPL</p>
<p>CPT Code 81403 was replaced by CPT code (81279) JAK2</p>
<p>CPT code 81404 was replaced by CPT code (81352) TP53, and CPT code 81405 was replaced by CPT code (81351) TP53</p>
<p style="line-height: normal;">CPT code 81479 was replaced by CPT code (81347) RARS</p>
<p><strong><u><span style="line-height: 107%;"><span style="text-decoration: none;"> </span></span></u></strong></p>
<p><strong><u><span style="line-height: 107%;">The </span></u></strong><strong><u><span style="line-height: 107%;">CPT/HCPCS Codes Section was revised as follows:</span></u></strong></p>
<p><strong>Group 1 Tier 1 Covered Codes: </strong>Added CPT codes 81168, 81338, 81339, 81347, 81348, 81351, 81352.</p>
<p style="line-height: normal;"><strong>Group 2 </strong><strong>Tier 1 Individual Review Codes: </strong>Added CPT codes 81191, 81192, 81193, 81194, 81353, 81357, 81419, 81529, 81546, 81554, 81360.</p>
<p style="line-height: normal;"><strong>Group 4 Tier 2 CPT and NOC Codes: </strong>CPT code 81401 CND1/IGH was replaced by 81168-now in Group 1; CPT code 81405 TP53 was replaced by 81353- now in Group 2 ; CPT code 81479 RARS was replaced by 81347- now in Group 1.</p>
<p style="line-height: normal;"><strong><u><span style="text-decoration: none;"> </span></u></strong></p>
<p style="line-height: normal;"><strong><u>ICD-10 Codes that Support Medical Necessity Section was revised as follows</u></strong></p>
<p style="line-height: normal;"><strong>Group 14: Paragraph: </strong>CPT codes Deleted code 81402 MPL was replaced by 81338; 81403 MPL was replaced by 81339, and 81403 JAK2 was replaced by 81279.</p>
<p style="line-height: normal;"><strong>Group 23: Paragraph: </strong>CPT code 81401 CCND1/IGH was replaced by 81168.</p>
<p style="line-height: normal;"><strong> </strong></p>
<p style="line-height: normal;"><strong>Group 29: Paragraph: </strong>CPT codes 81404 TP53 was replaced by 81352; CPT code 81405 TP53 was replaced by 81351.</p>
<p style="line-height: normal;">&nbsp;</p>
<p>&nbsp;</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										07/01/2020
									</td>
									<td>
										R7
									</td>
									<td class="text-break">
										<p>Deleted 81227 from the CPT/HCPCS section Group 3 and added CPT code 81227 to the “CPT/HCPCS section” Group 1.</p>
<p>Added 81227 to the “ICD-10-CM that support Medically Necessity section-Group 35</p>
<p>Added the following explanatory language to the Article Text: Use 81227 for CYP2C9 genotyping for individuals who have a relapsing form of multiple sclerosis, and require CYP2C9 genotyping for dosing in accordance with the FDA prescribing information for Mayzent. CYP2C9 testing must include the *1, *2, and *3 alleles that are necessary to safely dose the FDA-approved drug Mayzent.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2020
									</td>
									<td>
										R6
									</td>
									<td class="text-break">
										<p>The following wording for CPT code 81445 was corrected:</p>
<p>"please refer to LCD L36376" was revised to read "please refer to L37810".</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2020
									</td>
									<td>
										R5
									</td>
									<td class="text-break">
										<p style="line-height: normal;">Due to the annual CPT/HCPCS code update, CPT codes 81307-81309, 81522, and 81552 have been added to Group1- Tier 1 Covered Codes. CPT codes 81277 and 81542 have been added to CPT/HCPCS Codes Group2- Individual Review, effective for services rendered on or after January 1, 2020.</p>
<p style="line-height: normal;">&nbsp;</p>
<p style="line-height: normal;"><span style="text-decoration: underline;">The following Revision History language, effective for services rendered on or after 1/1/2019,&nbsp;was&nbsp;relocated from the Article Text section to the&nbsp;Revision History section:</span></p>
<p style="line-height: normal;"><strong>" Annual CPT/HCPCS Revisions Effective 1/1/2019</strong></p>
<p style="line-height: normal;">Due to the annual CPT/HCPCS Code update and transition of coding guidance to this article, the following codes have been deleted from Group 1 in LCD L35000: CPT codes 81211, and 81213 have been deleted- to report see CPT code(s) 81162, 81163, 81164; CPT code 81214 has been deleted- to report see CPT codes 81165, 81166.</p>
<p style="line-height: normal;">Due to the annual new CPT/HCPCS Code update and transition of coding guidance to this article, the following new 2019 CPT codes have been added to The CPT/HCPCS section -Group 2 which will require individual review: CPT codes 81177, 81178, 81179, 81180, 81181, 81182, 81183, 81184, 81185, 81186, 81187, 81188, 81189, 81190, 81233, 81306, 81312, 81320, 81333, 81343, 81344.</p>
<p style="line-height: normal;">Due to the annual new CPT/HCPCS Code update and transition of coding guidance to this article, the following new Tier 1, 2019 CPT codes replaced existing Tier 2 Non-covered codes and have been added to the CPT/HCPCS section- Group 3: CPT codes 81171, 81172, 81173, 81174, 81204, 81234, 81239, 81271, 81274, 81284, 81285, 81286, 81289, 81329, 81336, and 81337. CPT code 81443 was added to CPT/HCPCS section- Group 3 because it is considered screening and is not covered.</p>
<p style="line-height: normal;">Due to the annual new CPT/HCPCS Code update and transition of coding guidance to this article, the following new Tier 1, 2019 CPT codes 81305, and 81518 replaced existing Tier 2 Covered codes and were added to CPT/HCPCS section- Group 1. CPT codes 81236, 81237, and 81345 were added to CPT/HCPCS Group 1 due to prior existing coverage.</p>
<p style="line-height: normal;">CPT code 81518 was added to ICD10-CM That Supports Medical Necessity section -Group 26.</p>
<p style="line-height: normal;">CPT code 81305 replaced 81479 and was added to ICD10-CM That Supports Medical Necessity section -Group 34.</p>
<p style="line-height: normal;">CPT codes 81163, 81164, 81165, 81166, and 81167 were added to ICD10-CM That Supports Medical Necessity section -Group 1.</p>
<p style="line-height: normal;">CPT code 81345 was added to ICD10-CM That Supports Medical Necessity section -Group 33."</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										10/15/2019
									</td>
									<td>
										R4
									</td>
									<td class="text-break">
										<p>Added ICD-10-CM diagnosis code D45 to the "ICD-10 Codes that Support Medical Necessity" section-Group 14, effective for services rendered on or after 10/15/2019.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										10/03/2019
									</td>
									<td>
										R3
									</td>
									<td class="text-break">
										<p style="line-height: normal;">This article was converted to the new Billing and Coding Article type.</p>
<p>Bill types and Revenue codes have been removed from this article. Guidance on these codes is available in the Bill type and Revenue code sections.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										08/15/2019
									</td>
									<td>
										R2
									</td>
									<td class="text-break">
										<p>The title has been changed from "Molecular Pathology Procedures- Related to Molecular Policy Procedures LCD (L35000)" to Billing and Coding: Molecular Pathology Procedures.</p>
									</td>
								</tr>
								<tr>
									<td class="text-nowrap">
										01/01/2019
									</td>
									<td>
										R1
									</td>
									<td class="text-break">
										<p>Corrected URL.</p>
									</td>
								</tr>
					</tbody>
				</table>

				<span id="lblRevisionHistory" class="document-view-section-text d-none">N/A</span>
			</div>
		</div>
	</div>

	<div id="pnlAssociatedDocuments" class="document-view-section">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="AssociatedDocuments" title="Expand/Collapse the Associated Documents section" data-page-action="Clicked to Expand/Collapse the Associated Documents section.">
			<h2 class="document-view-section-title d-inline">Associated Documents</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iAssociatedDocumentsChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iAssociatedDocumentsChevron"></i> --></div>
		</div>

		<div id="divAssociatedDocumentsFields" class="document-view-fields d-print-block">
			<div id="divChapter15" class="document-view-section-field d-none">
				<span id="lblChapter15Subheader" class="document-view-section-subheader">Medicare BPM Ch 15.50.2 SAD Determinations</span><br>
				<a id="hplChapter15" class="document-view-section-text log-click system-link" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c15.pdf" target="_blank" rel="noopener noreferrer" data-page-action="Clicked the Medicare BPM Ch 15.50.2 link">Medicare BPM Ch 15.50.2 <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-5" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-5">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
			</div>

			<div id="divRelatedLocal" class="document-view-section-field">
				<span id="lblRelatedLocalSubheader" class="document-view-section-subheader">Related Local Coverage Documents</span><br>
				<span id="lblRelatedLocal" class="document-view-section-text"><strong>LCDs</strong><br><a href="https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=35000&amp;ver=144" target="_blank" class="log-click system-link" data-page-action="Clicked the Related Local Coverage Documents link to LCD 35000:144">L35000 - Molecular Pathology Procedures <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-6" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-6">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a><br></span>
			</div>

			<div id="divRelatedNational" class="document-view-section-field">
				<span id="lblRelatedNationalSubheader" class="document-view-section-subheader">Related National Coverage Documents</span><br>
				<span id="lblRelatedNational" class="document-view-section-text">N/A</span>
			</div>

			<div id="divSadProcessUrl1" class="document-view-section-field d-none">
				<span id="lblSadProcessUrl1Subheader" class="document-view-section-subheader">SAD Process URL 1</span><br>
				<a id="hplSadProcessUrl1" class="document-view-section-text log-click system-link " href="" target="_blank" rel="noopener noreferrer" data-page-action="Clicked the SAD Process URL 1 link"></a>
				<span id="lblSadProcessUrl1" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divSadProcessUrl2" class="document-view-section-field d-none">
				<span id="lblSadProcessUrl2Subheader" class="document-view-section-subheader">SAD Process URL 2</span><br>
				<a id="hplSadProcessUrl2" class="document-view-section-text log-click system-link " href="" target="_blank" rel="noopener noreferrer" data-page-action="Clicked the SAD Process URL 2 link"></a>
				<span id="lblSadProcessUrl2" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divStatutoryRequirementsUrls" class="document-view-section-field ">
				<span id="lblStatutoryRequirementsUrlsSubheader" class="document-view-section-subheader">Statutory Requirements URLs</span><br>

				<div id="rptStatutoryRequirementsUrls" class="">
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.ssa.gov/OP_Home/ssact/title18/1862.htm" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.ssa.gov/OP_Home/ssact/title18/1862.htm">Title XVIII of the Social Security Act (SSA) <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-7" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-7">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.ssa.gov/OP_Home/ssact/title18/1833.htm" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.ssa.gov/OP_Home/ssact/title18/1833.htm">Title XVIII of the Social Security Act (SSA) <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-8" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-8">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim. 
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.ssa.gov/OP_Home/ssact/title18/1862.htm" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.ssa.gov/OP_Home/ssact/title18/1862.htm">Title XVIII of the Social Security Act (SSA) <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-9" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-9">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Section 1862(a)(7) excludes routine physical examinations, unless otherwise covered by statute.
								</div>
				</div>
				<span id="lblStatutoryRequirementsUrls" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divRulesRegulationsUrls" class="document-view-section-field ">
				<span id="lblRulesRegulationsUrlsSubheader" class="document-view-section-subheader">Rules and Regulations URLs</span><br>

				<div id="rptRulesRegulationsUrls" class="d-none">
				</div>
				<span id="lblRulesRegulationsUrls" class="document-view-section-text ">N/A</span>
			</div>

			<div id="divCmsManualExplanationsUrls" class="document-view-section-field ">
				<span id="lblCmsManualExplanationsUrlsSubheader" class="document-view-section-subheader">CMS Manual Explanations URLs</span><br>

				<div id="rptCmsManualExplanationsUrls" class="">
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c15.pdf" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c15.pdf">CMS Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80.1  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-10" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-10">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Laboratory services must meet applicable requirements of CLIA
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c16.pdf" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c16.pdf">CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 16, Section 40.7  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-11" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-11">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Billing for Noncovered Clinical Laboratory Tests Section and 120.1 Clarification of the Use of the Term “Screening” or “Screen” 
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c30.pdf" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c30.pdf">CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 30, Section 50  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-12" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-12">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Advance Beneficiary Notice of Noncoverage (ABN)
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R829PI.pdf" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R829PI.pdf">CMS Publication 100-08, Medicare Program Integrity Manual, Chapter 13 <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-13" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-13">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Local Coverage Determinations
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Medicare/Coding/NationalCorrectCodInitEd/index.html" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Medicare/Coding/NationalCorrectCodInitEd/index.html">CMS National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services, Chapter 10, Pathology/Laboratory Services, (A) <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-14" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-14">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Introduction
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c15.pdf" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c15.pdf">CMS Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80.6. 5  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-15" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-15">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Describes the Surgical/Cytopathology Exception. 
								</div>
								<div class="document-view-section-text">
									<a id="hplUrl" target="_blank" href="https://www.cms.gov/Medicare/Coding/NationalCorrectCodInitEd/index.html" class="system-link log-click" data-page-action="Clicked the Statutory Requirements URLs link to https://www.cms.gov/Medicare/Coding/NationalCorrectCodInitEd/index.html">CMS National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services, Chapter 10 Pathology/Laboratory Services  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-16" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-16">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></a>
									<br><strong>Description: </strong>Addresses reflex testing 
								</div>
				</div>
				<span id="lblCmsManualExplanationsUrls" class="document-view-section-text d-none">N/A</span>
			</div>

			<div id="divOtherUrls" class="document-view-section-field ">
				<span id="lblOtherUrlsSubheader" class="document-view-section-subheader">Other URLs</span><br>

				<div id="rptOtherUrls" class="d-none">
				</div>
				<span id="lblOtherUrls" class="document-view-section-text ">N/A</span>
			</div>

			<div id="divPublicVersions" class="document-view-section-field">
				<span id="lblPublicVersionsSubheader" class="document-view-section-subheader">Public Versions</span><br>

				<div id="rptPublicVersions">
					<table class="table table-lg">
						<thead class="thead-light">
							<tr>
								<th scope="col">Updated On</th>
								<th scope="col" id="lbleffectiveArchived">Effective Dates</th>
								<th scope="col">Status</th>
								<th scope="col" class="text-center"><svg class="svg-inline--fa fa-file-alt fa-w-12 fa-lg" title="View the document version" aria-labelledby="svg-inline--fa-title-17" data-prefix="far" data-icon="file-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512" data-fa-i2svg=""><title id="svg-inline--fa-title-17">View the document version</title><path fill="currentColor" d="M288 248v28c0 6.6-5.4 12-12 12H108c-6.6 0-12-5.4-12-12v-28c0-6.6 5.4-12 12-12h168c6.6 0 12 5.4 12 12zm-12 72H108c-6.6 0-12 5.4-12 12v28c0 6.6 5.4 12 12 12h168c6.6 0 12-5.4 12-12v-28c0-6.6-5.4-12-12-12zm108-188.1V464c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V48C0 21.5 21.5 0 48 0h204.1C264.8 0 277 5.1 286 14.1L369.9 98c9 8.9 14.1 21.2 14.1 33.9zm-128-80V128h76.1L256 51.9zM336 464V176H232c-13.3 0-24-10.7-24-24V48H48v416h288z"></path></svg><!-- <i class="far fa-file-alt fa-lg" title="View the document version"></i> --></th>
							</tr>
						</thead>
						<tbody>
									<tr>
										<td class="align-middle">10/08/2024</td>
										<td class="align-middle">10/01/2024 - N/A       </td>
										<td class="align-middle">Currently in Effect</td>
										<td class="text-center align-middle">
												<span id="lblPublicVersionsView108">You are here</span>
										</td>
									</tr>
									<tr>
										<td class="align-middle">09/17/2024</td>
										<td class="align-middle">10/01/2024 - N/A       </td>
										<td class="align-middle">Superseded</td>
										<td class="text-center align-middle">
												<a id="hplPublicVersionsView105" href="/medicare-coverage-database/view/article.aspx?articleid=56199&amp;ver=105&amp;" class="btn btn-primary log-click system-link" data-page-action="Clicked the Public Versions link to 56199:105">View</a>
										</td>
									</tr>
									<tr>
										<td class="align-middle">06/03/2024</td>
										<td class="align-middle">08/01/2024 - 09/30/2024</td>
										<td class="align-middle">Superseded</td>
										<td class="text-center align-middle">
												<a id="hplPublicVersionsView102" href="/medicare-coverage-database/view/article.aspx?articleid=56199&amp;ver=102&amp;" class="btn btn-primary log-click system-link" data-page-action="Clicked the Public Versions link to 56199:102">View</a>
										</td>
									</tr>
									<tr>
										<td class="align-middle">12/20/2023</td>
										<td class="align-middle">01/01/2024 - 07/31/2024</td>
										<td class="align-middle">Superseded</td>
										<td class="text-center align-middle">
												<a id="hplPublicVersionsView99" href="/medicare-coverage-database/view/article.aspx?articleid=56199&amp;ver=99&amp;" class="btn btn-primary log-click system-link" data-page-action="Clicked the Public Versions link to 56199:99">View</a>
										</td>
									</tr>
									<tr>
										<td class="align-middle">09/18/2023</td>
										<td class="align-middle">10/01/2023 - 12/31/2023</td>
										<td class="align-middle">Superseded</td>
										<td class="text-center align-middle">
												<a id="hplPublicVersionsView95" href="/medicare-coverage-database/view/article.aspx?articleid=56199&amp;ver=95&amp;" class="btn btn-primary log-click system-link" data-page-action="Clicked the Public Versions link to 56199:95">View</a>
										</td>
									</tr>
						</tbody>
								<tfoot id="tftPublicVersionsMcdArchiveRow" class="table-footer-group">
									<tr>
										<td colspan="4">
												Some older versions have been archived. Please visit the
												<a id="hplPublicVersionMcdArchiveLink" href="https://localcoverage.cms.gov/mcd_archive/view/article.aspx?articleInfo=56199:87" target="_blank" class="log-click system-link" data-page-action="Clicked the Public Versions MCD Archive link to 56199:87"><u>MCD Archive Site  <sup><small><svg class="svg-inline--fa fa-external-link-alt fa-w-18" title="Opens in a new window" aria-labelledby="svg-inline--fa-title-18" data-prefix="fas" data-icon="external-link-alt" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512" data-fa-i2svg=""><title id="svg-inline--fa-title-18">Opens in a new window</title><path fill="currentColor" d="M576 24v127.984c0 21.461-25.96 31.98-40.971 16.971l-35.707-35.709-243.523 243.523c-9.373 9.373-24.568 9.373-33.941 0l-22.627-22.627c-9.373-9.373-9.373-24.569 0-33.941L442.756 76.676l-35.703-35.705C391.982 25.9 402.656 0 424.024 0H552c13.255 0 24 10.745 24 24zM407.029 270.794l-16 16A23.999 23.999 0 0 0 384 303.765V448H64V128h264a24.003 24.003 0 0 0 16.97-7.029l16-16C376.089 89.851 365.381 64 344 64H48C21.49 64 0 85.49 0 112v352c0 26.51 21.49 48 48 48h352c26.51 0 48-21.49 48-48V287.764c0-21.382-25.852-32.09-40.971-16.97z"></path></svg><!-- <i class="fas fa-external-link-alt" title="Opens in a new window"></i> --></small></sup></u></a>
												to retrieve them.
										</td>
									</tr>
								</tfoot>
					</table>
				</div>
			</div>
		</div>
	</div>

	<div id="pnlKeywords" class="document-view-section">
		<div class="py-3 document-view-collapser log-click" tabindex="0" data-collapser-name="Keywords" title="Expand/Collapse the Keywords section" data-page-action="Clicked to Expand/Collapse the Keywords section.">
			<h2 class="document-view-section-title d-inline">Keywords</h2>
			<div class="d-inline float-right d-print-none"><svg class="svg-inline--fa fa-chevron-up fa-w-14 document-view-section-chevron" id="iKeywordsChevron" aria-hidden="true" data-prefix="fas" data-icon="chevron-up" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-fa-i2svg=""><path fill="currentColor" d="M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z"></path></svg><!-- <i class="fas fa-chevron-up document-view-section-chevron" id="iKeywordsChevron"></i> --></div>
		</div>

		<div id="divKeywordsFields" class="document-view-fields d-print-block">
			<div id="divKeywords" class="document-view-section-field">
				<span id="lblKeywords" class="document-view-section-text">N/A</span>
			</div>
		</div>
	</div>

	<div class="mt-5 d-print-none">
		<p>
			Read the <a href="#" data-toggle="modal" data-target="#modalArticleDisclaimer" class="log-click" data-page-action="Clicked the Article Disclaimer link.">Article Disclaimer</a>
		</p>
	</div>
</div>